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Impairments of coughing (i.e. dystussia) and swallowing (i.e. dysphagia) frequently co-occur. 
This co-morbidity increases the risk of developing aspiration pneumonia. The aim of this 
research program was to enhance methods of assessment and explore an option for 
rehabilitation of the sensorimotor cough response. This gave rise to a series of studies that 
evaluated (1) methods of citric acid cough reflex testing (CRT) (2) modulation of the 
sensorimotor cough response through sensory stimulation, and (3) the use of acoustic intensity 
as a measure of cough strength. 
 
There is lack of standardization and inadequate data on test-retest variability of citric acid CRT. 
These issues necessitated two methodological studies on citric acid CRT. A systematic review 
that summarized and appraised methods of citric acid CRT across disciplines was completed. 
Data across studies were translated to standardized units of measurement to streamline 
comparison across studies. A total of 136 citric acid CRT protocols were retrieved and 
evaluated by two independent investigators. The study revealed lack of standardization and 
substandard reporting of instrumentation and citric acid CRT protocols across studies, 
preventing the full replication of many. It is anticipated that these findings will contribute to 
the development of standards of methods of citric acid CRT, and highlight implications of 
methods of citric acid CRT on the outcome of the test. 
 
Test-rest variability of citric acid CRT was evaluated in healthy individuals (n = 16) across 
three alternate days (i.e. Monday, Wednesday, Friday). Methods of citric acid CRT were 
chosen to optimize test-retest reproducibility. Estimated increases of 0.43 and 0.32 doubling 
concentrations of citric acid, per day (p < 0.05), were identified for natural (NCT) and 
suppressed (SCT) citric acid cough thresholds, respectively. These data suggest a habituation 
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effect occurs with repeated exposure to citric acid CRT. Quantification of this habituation effect 
enabled the effects of a sensory stimulation protocol in the subsequent study to be evaluated 
against the artefact of repeating the citric acid CRT, which was used as an outcome measure.   
 
A prospective, pseudo-randomized control trial was conducted to evaluate the safety and 
efficacy of a 4-day sensory stimulation protocol, involving inhalations of distilled water to 
modulate cough sensitivity in healthy adults (n = 24). Evaluation of safety was necessary due 
to the known risks of bronchoconstriction following distilled water inhalation. Participants 
were randomly assigned to one of three groups: (1) high intensity stimulation (inhalations of 
distilled water at high flow rate), (2) low intensity stimulation (inhalations of distilled water at 
low flow rate), and (3) a control group (inhalations of 0.9% saline). A citric acid CRT was 
completed at baseline (Day 1), and after the sensory stimulation protocol on alternate days (i.e. 
Day 3 and Day 5) to determine participants NCT and SCT. The sensory stimulation protocol, 
and spirometry (to monitor the safety of the distilled water inhalations on the respiratory 
system) were completed on days two to five. The study revealed that the sensory stimulation 
protocol did not induce bronchoconstriction in any participant. SCTs changed differently 
across days in the high and low intensity sensory stimulation groups, compared to the control 
group (p < 0.05). In the control group, citric acid cough thresholds increased across days, 
resembling the habituation effect observed upon repeated exposure to CRT. In contrast, an 
absence of habituation to citric acid CRT was observed following both of the sensory 
stimulation protocols, suggesting a possible sensitization effect of distilled water.  
 
The final two studies represent a clinical adjunct to this research program. There are no 
clinically applicable, objective measures of cough strength, as it relates to clearance of 
penetration and/or aspiration. This prompted two studies that used acoustic intensity to (1) 
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determine a cut-off value of effective/ineffective clearance of penetration and aspiration on 
videofluoroscopic swallowing studies (VFSS) and (2) compare citric acid induced cough 
strength between healthy individuals and patients with dysphagia. Acoustic intensity was 
chosen as a measure of cough strength as it represents a non-invasive, clinically applicable 
means of measuring coughing. In the first study, patients referred for VFSS were recruited (n 
= 88). Data were included from patients who coughed to penetration and/or aspiration during 
their VFSS (n = 13). An important, yet unexpected finding, was that no patient effectively 
expelled aspirate material from the laryngeal vestibule (n = 10). Coughing expelled penetration 
(n = 7). However, definitive cut-off values of cough effectiveness could not be made due to the 
limited number of observations. There are modifications of the study design that must be 
thoroughly investigated prior to making conclusions regarding the role of coughing in airway 
clearance of aspirate, and the validity of acoustic intensity as a measure of cough strength.  
 
In the second acoustic intensity study, patients with dysphagia (n = 12) and aged-matched 
healthy controls (n = 16) were recruited. Audio recordings of citric acid induced coughing were 
completed for all participants. The study revealed a difference in the acoustic intensity of citric 
acid induced coughing between the two groups (p < 0.05). Healthy individuals were found to 
have a louder cough to CRT than patients with dysphagia. Whether this translates to a 
functional difference between the two groups, in terms of strength of cough, remains to be 
directly tested. The issues detailed above, encountered when attempting to validate acoustic 
intensity for airway clearance in patients with dysphagia on VFSS, prevent inference of the 
current results to functional cough strength. 
 
In summary, this research program enhances understanding of assessment and modulation of 
the sensorimotor cough response and provides important groundwork for future studies. Future 
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research should evaluate test-retest variability of citric acid CRT and the safety and efficacy of 
the distilled water sensory stimulation protocol in patients with dysphagia. Additionally, the 
role of coughing in expelling aspiration from the airway, and the validity of acoustic intensity 
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SECTION I. INTRODUCTION AND 
LITERATURE REVIEW  
 2 
CHAPTER 1: Introduction 
 
This research program details five studies that aimed to enhance methods of assessment and 
rehabilitation of the sensorimotor cough response. Section I provides a literature review, 
outlining the relationship between coughing and swallowing (Chapter 2). It details how 
impairment of both mechanisms frequently co-occur following neurological injury, increasing 
the risk of negative outcomes, such as aspiration and mortality. The neurophysiology of 
coughing is detailed in Chapter 3. The afferent, central and efferent pathways of the 
sensorimotor cough response are outlined, providing rationale for the methods of assessment 
and sensory stimulation used in the subsequent research studies. In addition to this general 
literature review, each section of this thesis includes a more focused literature review related 
to the specific research questions address in those sections.  
 
Section II is dedicated to methodological studies on citric acid CRT. Chapter 4 provides a 
literature review on citric acid CRT methodology, with emphasis on the European Respiratory 
Society (ERS) guidelines for citric acid CRT. This chapter offers insight into the lack of 
standardization and limited data on test-retest reliability of the citric acid CRT. These 
limitations imposed restrictions on the use of the citric acid CRT as a viable outcome measure 
for the subsequent study (Chapter 7), and provided the rationale for the two methodological 
studies. In order to gain insight into methods of citric acid CRT used in published literature, a 
systematic review of instrumentation and citric acid CRT protocols used across disciplines was 
conducted (Chapter 5). This study is presented first, as it outlines a number of methodological 
considerations that are important for understanding the methods and results of the subsequent 
studies. Chapter 6, presents a study quantifying test-retest variability of the citric acid CRT. 
The methods of citric acid CRT utilized in this study were chosen to optimize test-retest 
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reproducibility, based on ERS guidelines for citric acid CRT. The overarching aim of this study 
was to quantify the variability of repeated citric acid CRT to enable the effects of a sensory 
stimulation protocol in Chapter 7 to be evaluated against any variance or order effects 
associated with repeating the test.  
 
Section III (Chapter 7) describes a study that evaluated the safety and efficacy of a 4-day 
sensory stimulation protocol to enhance cough sensitivity. It begins with a literature review of 
research related to sensory rehabilitation, and outlines the lack of rehabilitation options for 
patients with laryngeal sensory deficits and silent aspiration. A framework of sensory 
stimulation in the limb literature is described, and provides the foundation on which the current 
sensory stimulation protocol is based. Inhalations of distilled water were used in an attempt to 
modify cough sensitivity. However, published literature reports risks of bronchoconstriction 
with inhalation of distilled water in patients with asthma. Thus, the primary aim of this study 
was to evaluate the safety of the sensory stimulation protocol in healthy individuals. The 
efficacy of the stimulation protocol at enhancing cough sensitivity (as measured by the citric 
acid CRT) was evaluated as a secondary objective.  
 
Section IV provides a clinical adjunct to this research program, seeking to provide clinicians 
with an objective measure of cough strength. Chapter 8 provides a literature review related to 
limitations of current methods of cough strength evaluation, and the advantages of using 
acoustic intensity as a clinically applicable means of measuring cough strength. Chapter 9 
represents the first study in the literature to objectively measure the strength of a sensorimotor 
cough response to penetration and aspiration. The study aimed to measure the cough strength 
(in decibels) that is required to expel penetration and aspiration from the laryngeal vestibule 
during video-fluoroscopic swallowing studies (VFSS) in patients with dysphagia. Chapter 10 
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compares the acoustic intensity of citric acid induced coughing in healthy individuals to 
patients with neurogenic dysphagia, in an attempt to overcome the challenges associated with 
subjective evaluation of citric acid induced coughing.  
 
In Section V, conclusions are made regarding implications of this research program and 
directions for future research. In particular, directives for further enhancing methods of citric 
acid CRT, to hone the test to evaluating specific neural pathways of coughing, are highlighted. 
The findings from Chapter 7 provide the foundation for future studies to evaluate the safety 
and efficacy of the sensory stimulation protocol in patient populations with laryngeal sensory 
deficits and silent aspiration. Lastly, the impact of methodological limitations on the findings 
of Chapter 9 and 10 suggest that further research is necessary to determine the role of coughing 





CHAPTER 2: The Relationship Between Swallowing and 
Coughing 
 
Swallowing is the process by which a bolus is safely transported from the oral cavity into the 
stomach (Jean, 2001). In doing so, it plays two important roles. Firstly, as a critical component 
of the ingestive process, swallowing can be considered part of the alimentary (or digestive) 
system (Gestreau, Milano, Bianchi, & Grelot, 1996; Jean, 2001). Swallowing also protects the 
upper respiratory tract from aspiration of food, fluids and secretions (Jean, 2001), and within 
this framework, swallowing can be considered part of the respiratory system (Pitts, 2014; 
Troche, Brandimore, Godoy, & Hegland, 2014). This latter view of swallowing has particular 
relevance to this thesis that focuses on the assessment and rehabilitation of coughing in 
response to failed airway protective mechanisms during swallowing. 
 
The process of swallowing is complicated by the shared anatomical pathway for air and food 
through the pharynx, which creates significant risk for airway compromise (Martin-Harris, 
2006; Pitts, 2014). Due to the importance of pulmonary protection for survival, the body is 
equipped with a range of airway protective and airway clearance mechanisms (Bolser, Pitts, 
Davenport, & Morris, 2015). Airway protective mechanisms prevent food or liquids entering 
the laryngeal vestibule (i.e. penetration) and proceeding into the trachea (i.e. aspiration) during 
swallowing (Bolser et al., 2015). Airway clearance mechanisms, such as coughing, occur in 
response to food or liquids in the airway, i.e. in the event that airway protective mechanisms 
fail during swallowing (Bolser et al., 2015). Recently, a theoretical framework for 
understanding the relationship between different levels of airway protection in humans was 
proposed (Troche, Brandimore, Godoy, et al., 2014). Airway protective and airway clearance 
mechanisms occur along a continuum, with coughing and swallowing at opposing ends (Figure 
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1) (Troche, Brandimore, Godoy, et al., 2014). In order to understand what drives the transition 
from protective to clearance mechanisms, the complexity of swallowing - and significant 
potential for airway invasion - must be appreciated.  
 
Figure 1: Continuum of airway protective and airway clearance mechanisms. From “A 
framework for understanding shared substrates of airway protection” by Troche, M. S., 
Brandimore, A. E., Godoy, J., & Hegland, K. W. (2014), Journal of Applied Oral Science, 
22(4), p. 252. CC BY-NC. 
 
 
2.1 The Complexity of Swallowing 
The anatomical configuration of the aerodigestive tract demands a rapid and precise cascade 
of airway protective mechanisms to prevent misdirection of food, fluid or saliva into the airway 
during swallowing. Airway protection begins in the oral phase of swallowing, but differs for 
liquid and solid boluses. For liquids, swallowing related apnoea, vocal cord approximation and 
arytenoid adduction are observed upon introduction of a liquid bolus into the mouth (Dua, Ren, 
Bardan, Xie, & Shaker, 1997; Hiss, Strauss, Treole, Stuart, & Boutilier, 2004; Martin-Harris 
et al., 2005; Ohmae, Logemann, Kaiser, Hanson, & Kahrilas, 1995; Shaker, Dodds, Dantas, 
Hogan, & Arndorfer, 1990). Lower viscosity and larger bolus volumes, which present 
increased risk of airway invasion, evoke earlier swallowing related apnea and laryngeal 
vestibule closure in healthy individuals (Hiss et al., 2004; Humbert et al., 2018). This highlights 
the importance of oral afferents in timely airway protection. For solids, portions of masticated 
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food are transported from the oral cavity to the pharynx. They gradually accumulate in the oro-
pharynx, valleculae, and even as low as the pyriform sinuses, during continued mastication, 
until the entire bolus is ready for swallowing - a process known as pharyngeal bolus 
aggregation (Humbert et al., 2018; Matsuo & Palmer, 2009; Palmer, Hiiemae, Matsuo, & 
Haishima, 2007). Unlike during ingestion of liquids, the larynx remains open and breathing 
continues during pharyngeal bolus aggregation of solid textures (Matsuo, Hiiemae, Gonzalez-
Fernandez, & Palmer, 2008). As the pharynx is used for respiration and food containment 
simultaneously, there is significant risk for airway compromise. This risk is mitigated by highly 
effective and efficient sensorimotor control in a healthy system. For example, brief, partial 
closure of the vocal folds - known as the pharyngo-glottal closure reflex - is associated with 
entry of a bolus into the pharynx (Dua et al., 1997). This serves as an anticipatory protective 
reflex to prevent invasion of food or saliva into the airway prior to swallowing, and is 
dependent on intact pharyngo-laryngeal sensorimotor control. In addition, it is suggested that 
a healthy system produces an optimized bolus cohesiveness, via mastication and lubrication 
with saliva, that enables food particles to combine and collect in the valleculae and piriform 
sinuses prior to swallowing (Prinz & Lucas, 1997). Cohesion of the bolus ensures small 
particles are not aspirated into the respiratory tract (Prinz & Lucas, 1997), and depends on 
adequate sensory input from the oral cavity to inform neural centres in the brain about the state 
of the bolus (Steele & Miller, 2010).  
 
In the pharyngeal phase of swallowing, a highly repeatable sequence of airway protective 
mechanisms occur to seal the entrance of the airway as the bolus passes through the pharynx 
(Jean, 2001). Hyolaryngeal excursion causes the larynx and hyoid bone to move in an superior-
anterior direction during swallowing. This is achieved via contraction of the suprahyoid 
muscles, longitudinal pharyngeal muscles and thyrohyoid muscle (Pearson, Hindson, 
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Langmore, & Zumwalt, 2013; Pearson, Langmore, Yu, & Zumwalt, 2012). This anterior–
superior movement of the larynx is vital for laryngeal vestibule closure, which is achieved via 
pharyngeal shortening, arytenoid adduction and approximation, and epiglottic inversion 
(Logemann, Kahrilas, & Cheng, 1992; Matsuo et al., 2008; Vose & Humbert, 2018). Adduction 
of the true and false vocal folds are independent of laryngeal vestibule closure and serve as a 
secondary line of defence to prevent entry of material into the lower airway (Ekberg, 1982). 
The order and timing of these airway protective events can vary with bolus volume, size and 
viscosity (Ekberg, 1982; Inamoto et al., 2011; Kawasaki, Fukuda, Shiotani, & Kanzaki, 2001; 
Ohmae et al., 1995; Shaker et al., 1990). A bottom to top closure is most often described, which 
serves to squeeze misdirected materials from the laryngeal vestibule in the event of inadvertent 
airway invasion (Ekberg, 1982; Logemann et al., 1992; Ohmae et al., 1995; Shaker et al., 1990; 
Vose & Humbert, 2018). Numerous structures (tongue, pharynx, larynx, hyoid bone) and 
physiologic events (arytenoid adduction and approximation, tongue base retraction, epiglottic 
inversion, hyolaryngeal excursion, pharyngeal constriction) are involved in laryngeal vestibule 
closure during swallowing (Vose & Humbert, 2018). Given the importance of airway 
protection for survival, this complexity offers multiple layers of protection (Vose & Humbert, 
2018). However, it may also increase the risk of airway invasion if a structure or component is 
perturbed.  
 
Two other respiratory related mechanisms - swallowing related apnoea and breathing-
swallowing coordination - offer additional means of airway protection during the pharyngeal 
phase of swallowing (Martin-Harris, 2006). Swallowing related apnoea refers to cessation of 
breathing during swallowing, that occurs independent of laryngeal vestibule closure (Hiss & 
Postma, 2003; Martin-Harris et al., 2005). It highlights the intricate relationship between the 
respiratory and swallowing systems. The onset and duration of swallowing related apnoea 
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varies among healthy adults, with reported apnoea interval durations from 0.5 s – 3.5 s across 
a range of bolus textures and volumes (Martin-Harris, 2006; Martin-Harris et al., 2005). Larger 
bolus volumes are associated with longer apnoeic intervals (Martin, Logemann, Shaker, & 
Dodds, 1994). These data suggest that sensory properties of the bolus may influence the 
apnoeic interval during swallowing, highlighting the importance of afferent input for adequate 
airway protection. Precise respiratory-swallowing coordination is vital for airway protection 
(Brodsky et al., 2010). Expiration before and after swallowing is the most common breathing 
pattern in healthy adults (Martin et al., 1994; Martin-Harris et al., 2005). It serves to expel any 
misdirected materials from the airway after swallowing, offering an additional airway 
protective mechanism. Deviation from this respiratory-swallowing pattern is associated with 
increased risk of airway invasion (Brodsky et al., 2010) This is particularly apparent for 
initiation or completion of swallowing around an inspiration, which serves to bring air, and 
potentially misdirected food or fluid particles, into the lungs (Brodsky et al., 2010; Martin-
Harris, 2006).  
 
Failure of any of these airway protective mechanisms during swallowing may result in 
penetration and/or aspiration. In this event, airway clearance mechanisms, such as coughing, 
act as a safety net by expelling mis-directed material from the upper respiratory tract (Bolser 
et al., 2015; Hegland, Troche, Brandimore, Davenport, & Okun, 2014; Lee & Birring, 2012; 
Watts, Tabor, & Plowman, 2016). It’s important to remember that this type of coughing is not 
to be confused with acute or chronic cough associated with respiratory pathology, and refers 




2.2 Airway Clearance Coughing 
Coughing can be broadly defined as “a forced expulsive manoeuvre against a closed glottis, 
that is associated with a characteristic sound” (Morice et al., 2007, p. 1256). However, not all 
coughing is the same. An understanding of the differences between cough types (e.g. volitional 
coughing, reflexive coughing and the laryngeal expiration reflex) is imperative for interpreting 
the results of studies, and to draw accurate conclusions about airway protective mechanisms. 
Firstly, voluntary coughing has three phases: inspiratory, compressive and expulsive. It is 
preceded by an intention or command to cough, rather than a physiologic drive associated with 
airway irritation (Widdicombe, Addington, Fontana, & Stephens, 2011). In this respect, it is a 
motor, rather than a sensorimotor response. Others suggest that voluntary coughing can be 
produced in response to a sub-threshold urge-to-cough, when the capacity for suppression 
remains (Eccles, 2009). This may have relevance to the type of cough produced in response to 
conscious perception of trace penetration or accumulation of saliva in the airway. However, 
most research studies on voluntary coughing in the dysphagia literature align to Widdicombe’s 
definition, where participants are asked to cough on command, rather than in response to sub-
threshold airway irritation. Thus, caution must be made in interpreting these studies to draw 
inferences about the sensorimotor cough response to penetration or aspiration.  
 
The laryngeal expiration reflex (LER) and reflexive coughing are considered sensorimotor 
cough responses (Widdicombe et al., 2011). The LER is characterised by rapid closing of the 
glottis and an expulsive phase in response to chemical or mechanical laryngeal irritation 
(Fontana & Widdicombe, 2007; Korpas & Jakus, 2000; Widdicombe et al., 2011). It has been 
experimentally elicited in humans by touching the vocal folds with a nylon wire during 
laryngoscopy (Korpas, Misik, & Kalocsayova, 1975), and by inhalation of tussive aerosols 
(Vovk et al., 2007). The absence of an initial inspiration is crucial to the definition of the LER. 
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It prevents inhalation of foreign bodies further into the airway, and expels material from the 
supra-glottic space (Korpas & Jakus, 2000; Widdicombe et al., 2011). In this sense, it acts as a 
specific “anti-aspiration” mechanism (Widdicombe et al., 2011, p. 312). The absence of an 
initial inspiration also distinguishes the LER from reflexive coughing (Widdicombe et al., 
2011). Reflexive coughing is characterised by the same physiologic pattern as voluntary 
coughing but is preceded by a physiologic drive, or urge to cough (Widdicombe et al., 2011). 
The advantage of the initial inspiration is that it provides a greater volume and flow of air to 
expel materials from the lower airways (Widdicombe et al., 2011). However, an inspiration 
draws materials into respiratory tract and in this sense, it represents a “pro-aspiration reflex” 
(Widdicombe et al., 2011, p. 314).  
 
While the LER and reflexive coughing are fundamentally distinct (Fontana & Widdicombe, 
2007), in reality, both occur within a sensorimotor cough response to chemical or mechanical 
laryngeal irritation - the LER preceding reflexive coughing (Fontana, 2008; Korpas & Jakus, 
2000; Nishino, Tagaito, & Isono, 1996; Widdicombe et al., 2011; Widdicombe & Fontana, 
2006). This physiologic pattern is advantageous for the initial expulsion of supra-glottic 
material, followed by high velocity airflow to expel sub-glottic material (Widdicombe et al., 
2011). Physiologic measures of airflow or pressure are required to distinguish between LER 
and reflexive coughing. Given both mechanisms co-occur in response to airway invasion 
(Nishino et al., 1996), the term “reflexive coughing” typically signifies both LERs and 
reflexive cough patterns. It bears mentioning that the term “reflexive coughing” may be 
inaccurate to describe the sensorimotor cough response to tussigenic aerosols (such as 
capsaicin and citric acid), as numerous studies demonstrate the role of supra-medullary 
pathways and the cerebral cortex (Eccles, 2009; Hegland, Bolser, & Davenport, 2012; 
Hutchings, Eccles, Smith, & Jawad, 1993b; Hutchings, Morris, Eccles, & Jawad, 1993a; 
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Mazzone, Cole, Ando, Egan, & Farrell, 2011; Mazzone, McLennan, McGovern, Egan, & 
Farrell, 2007). This is described in detail in Chapter 3. The term ‘sensorimotor cough response’ 
is used herein to denote coughing preceded by chemical or mechanical laryngeal irritation that 
may comprise LER and reflexive cough patterns described above.  
 
There is relatively little research on coughing initiated in response to invasion of food or fluid 
into the airway before, during or after swallowing. This type of coughing is referred to as 
“cough on swallowing” by Widdicombe and colleagues (2011, p. 315), and is considered a 
sensorimotor cough response. Coughing to aspiration has been elicited in animal models by 
dropping water into the larynx, which resulted in a single expiratory effort (recorded with a 
pneumotachograph), analogous to a LER (Sullivan, Murphy, Kozar, & Phillipson, 1978). In 
human participants, Nishino et al. (1996) observed an immediate, vigorous response of 
expiratory efforts, including LERs and reflexive cough patterns, after injecting a small amount 
(0.5 ml) of distilled water on to the vocal folds of conscious human participants during 
endoscopy. This is the only study in the literature to document the physiologic pattern of 
coughing in response to airway invasion in human participants. However, these data are 
published as part of a review article. The number and/or demographics of the participants 
included in the study are not reported, and only one example of the physiologic pattern of 
coughing in response to airway invasion is reported. Thus, these findings should be interpreted 
with caution. Coughing in response to airway invasion can be observed during video-
fluoroscopic swallowing studies (VFSS) in the event of inadvertent penetration or aspiration 
in patients with dysphagia (Garon, Sierzant, & Ormiston, 2009; Watts et al., 2016). However, 
no physiological measures of airflow, respiratory muscle activity or gastric/esophageal 




2.3 Shared Neural Substrates of Coughing and Swallowing 
A growing body of literature demonstrates considerable overlap in the peripheral and central 
neural control of coughing and swallowing (Mutolo, 2017; Pitts, 2014; Troche, Brandimore, 
Godoy, et al., 2014). This relationship is essential to the way in which both behaviours work 
in synchrony to defend the airway from foreign material.  
 
2.3.1 Peripheral Neural Overlap 
The vagus nerve (CN X) provides sensory and motor innervation to the pharynx and larynx, 
and therefore has an obvious role in coughing and swallowing (Mu & Sanders, 2000; Troche, 
Brandimore, Godoy, et al., 2014). CN X divides into two main branches, the superior laryngeal 
nerve (SLN) and the recurrent laryngeal nerve (RLN) (Sanders, Wu, Mu, Li, & Biller, 1993), 
both of which have key roles in sensorimotor control of coughing and swallowing. The internal 
(sensory) branch of the SLN (iSLN) carries sensory information from the pharynx and the 
supraglottic space, specifically, the posterior pharyngeal wall, epiglottis, aryepiglottic folds, 
laryngeal vestibule, cricoarytenoid region and the anterior wall of the larynx (Mu & Sanders, 
2000). Electrical stimulation of the iSLN readily evokes swallowing and coughing in animal 
models (Bolser, 1991; Doty, 1951; Miller, 1972; Tsujimura, Udemgba, Inoue, & Canning, 
2013). Tsujimura and colleagues (2013) found that swallowing and coughing were elicited at 
different stimulation intensities of the SLN (10 Hz versus > 20 Hz respectively) (Tsujimura et 
al., 2013). The greater level of stimulation required to elicit coughing supports the hierarchy of 
airway protective mechanisms proposed by Troche et al. (2014). Anaesthesia of the iSLN 
results in impaired coughing and swallowing in humans (Jafari, Prince, Kim, & Paydarfar, 
2003). Significantly higher incidents of laryngeal penetration and aspiration were found in 
otherwise healthy participants with iSLN anaesthesia, compared to un-anaesthetized controls 
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(Jafari et al., 2003). In all cases of airway invasion under iSLN anaesthesia, coughing was only 
elicited after the entry of the bolus into the trachea (Jafari et al., 2003), from which sensation 
is carried by the sensory branch of the RLN. Unfortunately, no comment is made on the 
physiologic pattern of the cough elicited (i.e. an LER or reflexive cough pattern), or whether 
the cough was effective at expelling the aspirate from the airway. This information would have 
provided insight into the neural control of different types of coughing and whether impaired 
sensation also disrupts the effectiveness of coughing. 
 
Motor innervation of the larynx is supplied by the RLN, with the exception of the cricothyroid 
muscle, which is innervated by the SLN (Sanders et al., 1993). With relevance to coughing and 
swallowing, the RLN innervates the lateral cricoarytenoid and the inter-arytenoid muscles that 
adduct the vocal folds (Sanders et al., 1993). These muscles are critical for airway protection 
during swallowing, and for building-up subglottic pressure prior to the expulsive phase of 
coughing (Shaker et al., 2002). The RLN also plays an important role in innervating the muscles 
that influence the pressure at the upper esophageal sphincter (UES) (Tsujimura et al., 2013), 
which may have implications on coughing and swallowing mechanisms. Pitts (2014) suggests 
the UES and larynx work as “dual valves” during coughing and swallowing (Pitts, 2014, p. 3). 
During swallowing the larynx is adducted, and UES resting pressure falls (via relaxation of the 
cricopharyngeus muscle) to allow the bolus to enter the esophagus (Pitts, 2014). During the 
compression phase of coughing, the larynx is adducted and the cricopharyngeus muscle is 
maximally contracted to provide a barrier against retrograde entry of gastric contents into the 
pharynx (Amaris, Dua, Naini, Samuel, & Shaker, 2012), and to maintain intra-thoracic pressure 
for cough effectiveness (Pitts, 2014; Pitts et al., 2013).  
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2.3.2 Central Neural Overlap 
The neural control of coughing and swallowing also overlaps at a central level (Bianchi & 
Gestreau, 2009; Bolser, Gestreau, Morris, Davenport, & Pitts, 2013). The concept of a central 
pattern generator (CPG) is used to explain how relatively fixed motor patterns - such as 
breathing, swallowing and coughing - are generated by brainstem neuronal networks. In a 
landmark study by Doty and Bosma (1956), observations of the relatively fixed sequence of 
muscle activation in the pharyngeal phase of swallowing led to the concept of the swallowing 
CPG, which is fundamental to our current understanding of the neural control of swallowing. 
The swallowing CPG involves two important centres: the dorsal swallowing group (DSG) and 
the ventral swallowing group (VSG). The DSG houses the nucleus tractus solitarius (NTS) and 
the surrounding reticular formation (Jean & Car, 1979). It receives direct input from peripheral 
afferent nuclei, namely the facial (VII), glossopharyngeal (IX) and vagus (X) nerves, as well 
as supra-medullary input. The ventral swallowing group (VSG), houses the nucleus ambiguous 
(NA) and surrounding reticular formation (Jean & Car, 1979). The NA contains the motor 
neurons for the glossopharyngeal (IX) vagus (X) and spinal accessory (XI) nerves that activate 
muscles in the pharynx and larynx during swallowing. It receives direct input from the DSG. 
 
Understanding of the coughing CPG is still incomplete (Haji, Kimura, & Ohi, 2013), but similar 
to the swallowing CPG, it is known to involve the NTS and the NA (Gestreau, Grelot, & 
Bianchi, 2000; Gestreau et al., 1996; Jordan, 2001; McGovern, Driessen, et al., 2015). It is 
suggested that coughing and swallowing form part of a multifunctional respiratory neuronal 
network in the brainstem (Bolser et al., 2013) (Figure 2). The concept of a behavioural control 
assembly (BCA) was proposed to explain how a single network of neurons exist for interrelated 
behaviours (Bolser et al., 2013). In theory, BCAs activate different CPGs (i.e. coughing, 
swallowing and breathing) by a process of reconfiguration that involves altering the excitability 
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of key elements of the neuronal network, presynaptic modulation, and/or recruitment of 
previously silent elements of the neuronal network in response to preceding sensory stimuli 
(Bolser et al., 2013). In essence, the BCA allows these behaviours in work in synchrony. 
However, the precise frequency and type of sensory stimuli that are necessary to excite 
differential components of the respiratory neuronal network remains unclear. While our 
understanding of this multi-functional neural network is still in its infancy, it supports clinical 
observations in which impairments of breathing, coughing and swallowing frequently co-occur 
(Clayton, Carnaby, Peters, & Ing, 2014; Martin-Harris, 2008; Terzi et al., 2007).  
 
Figure 2: Interactions between the respiratory, coughing and swallowing CPGs From “The 
brainstem respiratory network: an overview of a half century of research” by Bianchi, A. L., & 
Gestreau, C. (2009), Respir Physiol Neurobiol, 168(1-2), p. 10. Reprinted with permission.  
 
 
2.4 Dystussia and Dysphagia 
The disadvantage of the neural overlap of coughing and swallowing is that impairment of both 
mechanisms can co-occur in multiple neurological disorders (Bolser et al., 2015; Pitts, Bolser, 
Rosenbek, Troche, & Sapienza, 2008; Pitts et al., 2010; Smith Hammond et al., 2001; Ward et 
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al., 2010). The term dysphagia refers to impairment in any or all phases of swallowing. Failed 
airway protective mechanisms result in aspiration and/or penetration of food, fluid or saliva, 
and is a common clinical sign observed in up to 30% of patients with dysphagia (Smith 
Hammond & Goldstein, 2006). Dystussia refers to impairment of the motor and/or sensory 
components of coughing (Ebihara, Sekiya, Miyagi, Ebihara, & Okazaki, 2016), the former 
resulting in impaired cough strength, and the latter resulting in a phenomenon known as silent 
aspiration, i.e. an absent cough response to aspiration (Ebihara et al., 2016). 
 
The comorbidity of failed airway protective and airway clearance mechanisms has significant 
clinical consequences. Aspiration pneumonia - a respiratory infection secondary to aspiration 
- is associated with increased medical costs, longer hospital stays, and mortality (Hannawi, 
Hannawi, Rao, Suarez, & Bershad, 2013; Kidd, Lawson, Nesbitt, & MacMahon, 1995; 
Schmidt, Holas, Halvorson, & Reding, 1994). While the development of aspiration pneumonia 
is multi-factorial (Langmore et al., 1998), research has shown a robust relationship between 
dystussia and aspiration pneumonia in patients with dysphagia (Addington, Stephens, Gilliland, 
& Rodriguez, 1999; Bianchi, Baiardi, Khirani, & Cantarella, 2012; Fujiwara et al., 2017; 
Hegland, Okun, & Troche, 2014; Kimura, Takahashi, Wada, & Hachisuka, 2013; Nakazawa, 
Sekizawa, Ujiie, Sasaki, & Takishima, 1993; Pikus et al., 2003; Pitts et al., 2010; Plowman et 
al., 2016; Sekizawa, Ujiie, Itabashi, Sasaki, & Takishima, 1990). For example, among a 
heterogeneous cohort of patients with dysphagia, the relative risk of developing aspiration 
pneumonia was thirteen times higher for patients with silent aspiration, compared to those with 
unimpaired swallowing (Pikus et al., 2003). Among a cohort of stroke patients, the relative risk 
of developing aspiration pneumonia was 5.57 times greater for those with silent aspiration 
compared to those who aspirated with a cough response and those who did not aspirate (Holas 
et al., 1994). Other studies report that a reduction in cough peak flow (i.e. the peak airflow 
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achieved during the expiratory phase of coughing) is associated with higher risk of pulmonary 
morbidity. Bianchi and colleagues (2012) found that patients with aspiration pneumonia had 
lower voluntary cough peak flow than those without pulmonary complications. This was also 
true for the cough peak flow of citric acid induced coughing (Fujiwara et al., 2017). These data 
highlight an important relationship between the development of aspiration pneumonia and the 
integrity of the sensorimotor cough response in patients with dysphagia. As a result, the 
sensorimotor cough response is an important target for assessment and rehabilitation (Watts et 
al., 2016). 
 
2.4.1 Assessment of Coughing in Patients with Dysphagia 
Assessment of coughing in patients with dysphagia is not a new concept. Evaluation of 
volitional coughing (i.e. by asking a patient to cough on command), and/or coughing while 
eating and drinking has always been an integral part of the clinical swallowing evaluation as it 
provides insights into a patients risk of aspiration (Mann, 2002; McCullough et al., 2005; Smith 
Hammond et al., 2001; Suiter & Leder, 2008; Watts et al., 2016). However, the clinical 
swallowing evaluation lacks adequate sensitivity for detecting patients at risk of silent 
aspiration (Ramsey, Smithard, & Kalra, 2003; Smithard et al., 1998). Asking a patient to cough 
on command does not provide information about the integrity of the sensorimotor cough 
response to airway invasion (Addington et al., 1999; Stephens, Addington, & Widdicombe, 
2003). Furthermore, absence of coughing while eating and drinking does not reliably indicate 
absence of aspiration, as aspiration may be silent (Ramsay, Wright, Thompson, Hull, & Morice, 
2008; Smithard et al., 1998). Thus, there is increasing clinical attention in evaluation of the 
sensorimotor cough response via cough reflex testing to make judgements about an individual’s 
ability to protect their airway during swallowing (Watts et al., 2016). 
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2.4.1.1 The Cough Reflex Test 
The cough reflex test (CRT) challenges the integrity of the sensorimotor cough response by 
introducing a tussive agent to the respiratory tract via inhalation, and observing for a cough 
response (Morice et al., 2007). As a test of laryngeal sensitivity to inhaled particles, the CRT 
provides a model for evaluating coughing in response to aspiration. This is evidenced by a 
number of studies demonstrating high sensitivity and specificity of the CRT in detecting silent 
aspiration on instrumental assessment. Wakasugi and colleagues (2008) were among the first 
to validate CRT as a screening tool for identifying risk of silent aspiration on instrumental 
assessments, video-fluoroscopic swallowing study (VFSS) and fibreoptic endoscopic 
evaluation of swallowing (FEES), in patients with cardiovascular disease (39%), head and neck 
cancer (24%), neuromuscular disease (17%), respiratory disease (15%), and other non-
specified diseases (5%). Using 1% (w/v) citric acid, inhaled for one minute via ultrasonic 
nebulizer, the authors found high sensitivity and specificity for detecting silent aspiration (87% 
and 89% respectively). Greater than five coughs within one minute was considered a pass, 
while less than four coughs was considered a failed test. It is unclear why these cut off values 
were used, and how patients who coughed exactly four times were classified. Furthermore, 
rationale for the use of 1% w/v citric acid is not provided. Regardless, these data demonstrate 
that citric acid CRT can identify patients with silent aspiration with high accuracy. These 
findings have been replicated in later studies using a small portable vibrating mesh nebulizer, 
as opposed to an ultrasonic nebulizer, which improves the clinical feasibility of the method 
(Sato et al., 2012; Wakasugi et al., 2014).  
 
More recently, Miles and colleagues evaluated the sensitivity and specificity of a different 
method of CRT on instrumental assessment in a cohort of patients with dysphagia secondary 
to stroke (38%), head and neck cancer (10%), respiratory disorders (17%), progressive 
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neurological disorders (10%), other neurological disorders (9%) and non-specified diagnoses 
(16%) (Miles, Moore, et al., 2013). The concentrations of citric acid used in the study (i.e. 0.4, 
0.6 and 0.8 mol/L) were based on predetermined normative data in healthy adults (Monroe, 
Manco, Bennett, & Huckabee, 2014). Using 0.6 mol/L citric acid, inhaled for up to 15 seconds 
(tidal breathing) via facemask until C2 cough thresholds (based on the European Respiratory 
Society guidelines for cough testing) were achieved (i.e. two consecutive coughs within 15 
seconds), the authors found moderate sensitivity and specificity for detecting silent aspiration 
(71% and 60%, respectively). A higher concentration of citric acid (i.e. 0.8 mol/L) had less 
sensitivity but greater specificity (i.e. 58% and 84% respectively), while a lower concentration 
(i.e. 0.4 mol/L) had higher sensitivity, but lower specificity (77% and 35% respectively). 
Interestingly, patients with dysphagia following stroke were at higher risk of failing the CRT 
that those with a diagnosis of respiratory disorders (odds ratio = 16.7, 95% CI, 2.27, 122.21).  
 
In a more recent study, the sensitivity and specificity of non-acidic tussigenic agents - capsaicin 
and ultrasonically nebulizer distilled water - were evaluated for detecting aspiration (defined 
as penetration-aspiration scale scores of > 5) versus no aspiration (defined as penetration-
aspiration scale scores of < 4) in patients with Parkinson’s Disease (Hegland, Troche, 
Brandimore, Okun, & Davenport, 2016). Using a C2 criteria for classifying responders and non-
responders, 1 minute tidal inhalations of distilled water yielded a high sensitivity and 
specificity (77.8% and 90.9% respectively) for differentiating between patients with 
Parkinson’s disease with and without aspiration (Hegland et al., 2016). In contrast, low 
sensitivity (44.4%) and high specificity (100%), was found for single inhalations of capsaicin. 
These findings suggest that while capsaicin CRT can accurately determine those who are not 
aspirating, its use for identifying patients with aspiration appears limited. No study has 
evaluated the sensitivity and specificity of capsaicin CRT for differentiating between patients 
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with and without silent aspiration. Hegland and colleagues (2016) suggest the lack of 
sensitivity of capsaicin CRT in differentiating between patients with and without aspiration 
may reflect the use of a single inhalation, as opposed to a 1-minute inhalation of the aerosol 
that was used for distilled water CRT. It is unclear why different methods are used for both 
tussive agents in the study. An alternative hypothesis may relate to the underlying 
neurophysiological mechanisms of cough induction, that differ for capsaicin, compared to 
distilled water and citric acid (Canning et al., 2004; Mazzone & Undem, 2016; Morice, 
Higgins, & Yeo, 1992). This is discussed in more detail in Chapter 3, but studies suggest that 
capsaicin may induce coughing through different airway afferents and central pathways when 
compared with distilled water and citric acid (McGovern, Driessen, Simmons, Powell, et al., 
2015, Mazzone & Undem, 2016, McGovern, Davis-Poynter, Simmons, Ferrell, et al., 2015). 
This may in part explain the discrepancies in the sensitivity and specificity of cough reflex 
testing with capsaicin, distilled water and citric acid. Along the same lines, differences in the 
underlying pathophysiology of dystussia and dysphagia (e.g. stroke, progressive neurological 
diseases, respiratory diseases) may also influence the sensitivity and specificity of the CRT, or 
the tussive agent that is most suitable, depending on neural cough pathway that is expected to 
be impaired (i.e. somato-sensory versus viscero-sensory) (see Chapter 3, section 3.2.3 for 
further discussion).  
 
2.4.2 Enhanced Long-Term Clinical Outcomes 
A better understanding of assessment and management of dystussia in patients with dysphagia 
has been shown to have significant health care outcomes in terms of reduced medical costs, 
longer hospital stays and mortality. Addington and colleagues were among the first to evaluate 
whether inclusion of CRT to the clinical swallowing evaluation (CSE) would differentiate 
between stroke patients who did or did not develop aspiration pneumonia (Addington et al., 
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1999). The CRT protocol involved a maximum of three deep inhalations of nebulized tartaric 
acid (20% solution of prescription grade l-tartaric acid dissolved in 2 ml saline). A weak or 
absent cough to all three inhalations was considered a failed test. The results revealed that 1% 
of patients in the CRT group developed aspiration pneumonia, compared to 13% in the non-
CRT group (p < 0.05). These data suggest the inclusion of CRT may facilitate identification of 
patients at risk of silent aspiration, and provide information that has the potential to enhance 
management, although, management options for patients that fail the CRT were not provided 
by the authors. There are several methodological limitations. Firstly, CRT and non-CRT groups 
were from different hospitals. It is possible that different oral care practices or medical 
management may represent confounding variables. Furthermore, the authors note that patients 
in the CRT were required to achieve adequate lip seal around the mouthpiece for an “effective 
inhalation” (Addington et al., 1999, p. 1204). It is not mentioned how many patient were 
excluded due to inadequate lip seal, but it is possible that the patients in the CRT group were 
lower risk of aspiration pneumonia due to better oral motor control. Nevertheless, this study 
implies that inclusion of a CRT may enhance long-term clinical outcomes for patients with 
dysphagia.  
 
More recently, implementation of a structured citric acid CRT protocol, that guided clinicians 
to optimal management decisions in acute stroke patients, reduced rates of pneumonia from 
28% to 10% over a three year period in an acute hospital setting (Perry et al., 2018). Patients 
who failed the CRT were placed on non-oral methods of feeding and referred for VFSS. 
Interestingly, these findings were not replicated in a similar study by Field et al. (2018), who 
found a non-significant (2.2%) reduction in pneumonia following implementation of a citric 
acid CRT protocol. Differences in CRT protocols, or management decisions of patients who 
fail the CRT may explain the discrepancy in the results. Perry and colleagues (2018) evaluate 
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natural coughing (‘cough if you need to’) and suppressed coughing (‘try not to cough’) to 0.8 
mol/L and 1.2 mol/L citric acid aerosols, respectively – which were based on pre-determined 
norms in healthy individuals (Monroe et al., 2014). Field et al. (2018) evaluated natural 
coughing to 0.6 mol/L only. The advantage of evaluating natural and suppressed coughing is 
that they may provide insights into different components or levels of impairment of the 
sensorimotor cough response (e.g. ascending sensory input and descending control of sensory 
processing, discussed further in Chapter 3) (McGovern, Ajayi, Farrell, & Mazzone, 2017). This 
raises an important issue regarding the most appropriate way to assess dystussia in patients 
with dysphagia, and suggests that methods of CRT may have important implications on the 
outcome of the test. The sensorimotor cough response is complex, and a number of factors - 
such as the concentration and type of tussigenic aerosol (e.g. capsaicin versus citric acid), the 
duration of aerosol inhalation, and instructions given to participants - are known to influence 
the afferents and central neural cough pathways that are targeted during CRT (Kollarik, Ru & 
Undem, 2007, Canning et al., 2004). An understanding of these factors is essential for 
developing appropriate methods of assessment of the sensorimotor cough response in patients 
with dysphagia.  
 
Furthermore, enhanced long-term clinical outcomes are likely dependent on clinical 
management of patients with dysphagia and dystussia. Rehabilitation of the respiratory muscles 
involved in coughing has been shown to improve airway protection in patients with neurogenic 
dysphagia (Pitts et al., 2009; Troche et al., 2010). However, there are no rehabilitation 
approaches to address the sensory pathophysiology associated with silent aspiration. 
Pulmonary safety is likely to be compromised if oral intake occurs in the absence of laryngeal 
sensitivity that is required to elicit a sensorimotor cough response, regardless of respiratory 
muscle strength. Thus, rehabilitation of motor and sensory components of the sensorimotor 
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cough response would be advantageous to prevent adverse clinical outcomes associated with 
dystussia in patients with dysphagia. A comprehensive understanding of the neurophysiology 
of coughing is essential for developing appropriate methods of assessment and rehabilitation 
of the sensory and motor components of coughing, and is outlined in the subsequent chapter. 
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CHAPTER 3: Neurophysiology of Coughing 
 
3.1 Afferent Pathway 
Extensive studies in both animals and humans demonstrate that two subtypes of 
extrapulmonary afferents induce coughing when stimulated: jugular C-fibres and nodose A-d 
fibres (Canning et al., 2014; Canning et al., 2004; Mazzone & Undem, 2016). These are distinct 
from intrapulmonary afferents, such as nodose C-fibres and nodose Ab fibres (i.e. rapidly 
adapting receptors and slowly adapting receptors) that induce tachypnoea, bronchoconstriction, 
bronchodilation and the Hering-Breuer reflex (Mazzone & Undem, 2016). The characteristics 
of the cough afferents are summarized in Table 1. Jugular C-fibres and nodose A-d fibres arise 
from distinct ganglionic origin, which reflect their different functions (Canning et al., 2004; 
Kollarik, Ru, & Undem, 2007; Mazzone & Undem, 2016). Cough afferents arising from the 
jugular ganglia are predominantly C-fibres (Canning et al., 2004; Kollarik et al., 2007). C-
fibres are characterised by relatively slower action potential conduction velocity compared to 
A-d fibres (Mazzone & Undem, 2016). C-fibres are broadly classified as chemoreceptors, 
reflecting their sensitivity to chemical stimuli (such as capsaicin, bradykinin, hypertonic saline 
and acid) and relative insensitivity to mechanical stimulation (Canning et al., 2004; Kollarik & 
Undem, 2002; Mazzone & Undem, 2016). Cough afferents arising from the nodose ganglia are 
exclusively A-d fibres (Canning et al., 2004). They are commonly referred to as “cough 
receptors” in the literature (Canning et al., 2004). Nodose A-d fibres (or cough receptors) are 
broadly classified as mechanoreceptors, due to their sensitivity to punctate mechanical 
stimulation. However, they are distinct from intrapulmonary mechanoreceptors (i.e. Ab fibres 
- slowly adapting receptors and rapidly adapting receptors), in that they are insensitive to low 
threshold mechano-stimulation, such as airflow and changes in tracheal configuration 
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associated with breathing (Mazzone & Undem, 2016). Similar to jugular C-fibres, nodose A-d 
fibres are readily activated by chemical stimuli, such as rapid reductions in pH (e.g. citric acid) 
and hypotonic solutions (e.g. distilled water) (Canning et al., 2004; Kollarik et al., 2007; 
Kollarik & Undem, 2002; Mazzone & Undem, 2016). In this respect, they represent a hybrid, 
chemo-mechanical type of airway afferent.  
 
Table 1: Classification of Tracheal and Laryngeal Cough Afferents (adapted from Mazzone & 
Undem, 2016) 
 Jugular Ganglia Nodose Ganglia 
Fibre Type C-fibres A-d fibres (cough receptors) 
Conduction Velocity (m/s) ~ 1 ~ 5 
Termination Extrapulmonary Extrapulmonary 
Responsivity Capsaicin, acid 
Punctate mechanical 
stimulation, acid, hypotonic 
solutions 
Physiological Responses Apnoea, Cough Cough 





The relative contribution of both afferents to coughing in response to aspiration is still a matter 
of debate (Mazzone & Undem, 2016). It’s unclear whether one afferent holds more importance 
than the other, or whether both are critical to adequate airway defence against aspiration. 
Research suggests that nodose A-d fibres play an important role in mediating coughing to 
aspiration (Canning et al., 2004; Mazzone & Undem, 2016). This is based on their site of 
termination in the extrapulmonary bronchi, trachea and larynx, their fast action potential 
conduction velocity, their sensitivity to punctate mechanical stimulation of the laryngeal 
epithelium, and their sensitivity to rapid changes in pH (Canning et al., 2004). These 
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characteristics make A-d fibres highly suitable to respond to aspiration of food, fluid, or reflux. 
A-d fibre stimulation also evokes coughing under general anaesthesia, whereas stimulation of 
C-fibres is ineffective in doing so (Canning et al., 2004). This suggests that nodose A-d fibres 
play a vital role in coughing to airway invasion.  
 
Jugular C-fibres greatly outnumber A-d fibres in the extrapulmonary airway (Mei, Condamin, 
& Boyer, 1980; Ricco, Kummer, Biglari, Myers, & Undem, 1996), suggesting they too play an 
important role in upper airway sensation. C-fibre stimulants (such as capsaicin and bradykinin) 
effectively evoke coughing in conscious humans and animals (Dicpinigaitis, 2007; Karlsson, 
1996). Blunted cough response to capsaicin (a C-fibre stimulant) has been linked with impaired 
airway protection in patient populations (Troche, Brandimore, Okun, Davenport, & Hegland, 
2014). Based on these observations, C-fibres are also likely to play a role in airway protective 
coughing. Distinct central pathways are known to be involved for C-fibre versus A-d fibre 
processing (Mazzone, Mori, & Canning, 2005). This may have implications on the cortical 
influences, and type of cough evoked from each afferent, and is outlined below. 
 
3.2 Central Control of Coughing 
It is now well accepted that at least two distinct central neural pathways exist for coughing 
(Mazzone & Undem, 2016; McGovern, Driessen, et al., 2015). Coughing can be elicited 
reflexively at the level of the brainstem, or via ascending pathways to subcortical and cortical 
regions (See Figure 3) (Mazzone & Undem, 2016). Evidence for a purely reflexive coughing 
pathway is derived from studies demonstrating that coughing can be elicited under general 
anaesthesia and in decerebrate animals (Canning et al., 2004; Haji, Ohi, & Kimura, 2012). This 
suggests, at its most primitive, coughing can be elicited by brainstem mediated process, 
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achieved via sensory input to the NTS, and subsequent activation of brainstem motor neurons 
(e.g. the nucleus ambiguous and rostral ventral respiratory group), innervating respiratory and 
laryngeal musculature (Ambalavanar, Tanaka, Selbie, & Ludlow, 2004; Gestreau et al., 1996; 
Tanaka, Yoshida, & Hirano, 1995).  
 
Figure 3: Central pathway regulating airway afferent processing. From “Vagal Afferent 
Innervation of the Airways in Health and Disease” by Mazzone, S. B., & Undem, B. J. 
(2016), Physiol Rev, 96(3) p. 995. Reprinted with permission.
 
 
3.2.2 Cortical Control of Coughing 
The role of higher subcortical and cortical brain centres in coughing in conscious, awake 
humans, is now well accepted and supported by numerous behavioural and brain imaging 
studies (Eccles, 2009; Hegland et al., 2012; Hutchings et al., 1993b; Hutchings et al., 1993a; 
Mazzone et al., 2011; Mazzone et al., 2007). Higher brain centres decode perceivable 
sensations, such as urge to cough, that arise upon airway irritation, and control voluntary 
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induction or suppression of coughing (Eccles, 2009; Hutchings et al., 1993b; Hutchings et al., 
1993a; Mazzone et al., 2011).  
 
Two landmark studies by Hutchings and colleagues were among the first to empirically 
demonstrate the role of higher brain centres in coughing (Hutchings et al., 1993b; Hutchings et 
al., 1993a). They found that cough thresholds were significantly higher when participants were 
instructed to consciously suppress their cough (Hutchings et al., 1993b; Hutchings et al., 
1993a). The first study evaluated capsaicin-induced cough suppression in healthy volunteers 
(Hutchings et al., 1993a) , while the latter examined suppression of spontaneous coughing as a 
result of an upper respiratory tract infection over a twenty-minute period (Hutchings et al., 
1993b). Based on these findings it was hypothesized that at sub-threshold conditions, an urge 
to cough is perceived, and under voluntary control, a cough may (or may not) be elicited 
(Eccles, 2009; Hutchings et al., 1993b; Hutchings et al., 1993a). In contrast, when the threshold 
is reached and the individual can no longer suppress, reflexive coughing absent of cortical 
control is produced (Eccles, 2009; Hutchings et al., 1993b; Hutchings et al., 1993a).  
 
The absence of cortical control in reflexive coughing was later questioned by Hegland and 
colleagues (2014). They found that healthy individuals can modulate (i.e. up and down-
regulate) parameters (i.e. airflow and respiratory muscle activity) of supra-threshold 
concentrations of capsaicin induced coughing according to instructions. For example, when 
participants were instructed to produce a small cough (i.e. instructed to cough smaller or softer 
than normal), they tended to increase the compression phase duration (CPD) and decrease the 
post-peak phase duration (PPPD) and cough volume acceleration (CVA). CPD relates to sub-
glottic pressure generation, while CVA and PPPD relate to cough airflow acceleration and 
velocity (Hegland et al., 2012). These studies suggest that coughing is subject to cortical 
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modulation – even at supra-threshold levels of tussigenic stimuli when the response is assumed 
to be reflexive. In light of these findings, coughing may be more aptly described as a 
sensorimotor response, as opposed to a reflex. These studies used capsaicin, which uniquely 
stimulates jugular C-fibres (Canning et al., 2004). It is unclear if the same capacity for 
suppression and modulation would be seen with tussigenic stimuli that stimulate other afferent 
pathways, such as in response to citric acid, which stimulates nodose A-d fibres (Canning et 
al., 2004), or cough to aspiration.  
 
3.2.3 Distinct Central Neural Pathways 
Recent studies suggest that distinct ascending pathways exist for afferents arising from the 
jugular and nodose ganglia (i.e. C-fibres and A-d fibres, respectively) (McGovern, Davis-
Poynter, et al., 2015; McGovern, Driessen, et al., 2015). These afferents terminate in different 
anatomical locations in the brainstem (see Figure 4), and project to distinct higher brain regions 
(McGovern, Davis-Poynter, et al., 2015; McGovern, Driessen, et al., 2015). This may reflect 
their fundamentally different roles and different capacity for suppression and modulation. 
Nodose afferents terminate in the NTS, and project to several brainstem and hypothalamic 
nuclei that are well known for their role in viscero-sensory processing and coordination of 
respiratory and autonomic responses (McGovern, Davis-Poynter, et al., 2015; McGovern, 
Driessen, et al., 2015). In contrast, tracheal jugular afferents terminate in the paratrigeminal 
nucleus and project to the ventrobasal and submedial nuclei, which play a role in 
somatosensation (i.e. encoding perceptual awareness of airway irritation and generating 
perceivable sensations, such as urge to cough) (McGovern, Driessen, et al., 2015). Based on 
these observations, nodose A-d fibres are likely to play a key role in reflexive airway protective 
coughing via viscero-sensory pathways, whereas jugular C-fibres are likely to evoke cortically 
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mediated coughing via perceived airway sensations that accompany coughing (i.e. urge-to-
cough)(Mazzone & Undem, 2016).  
 
Figure 4: Distinct terminations of jugular (C-fibres) and nodose (A-d fibres) afferents in the 
brainstem, which give rise to distinct ascending central pathways. From “Vagal Afferent 
Innervation of the Airways in Health and Disease” by Mazzone, S. B., & Undem, B. J. 
(2016), Physiol Rev, 96(3) p. 995. Reprinted with permission.  
 
 
However, notable overlap and interconnections between the two pathways have been identified 
at a central level. Previous studies show non-reciprocal projections of paratrigeminal neurons 
to the NTS (McGovern, Driessen, et al., 2015; Menetrey & Basbaum, 1987), suggesting jugular 
afferents may contribute to elicitation of autonomic reflexes through this pathway. This is 
evidenced by animal studies, in which capsaicin (jugular C-fibre stimulant) was shown to 
increase the sensitivity (i.e. reduce the threshold) of cough evoked by electrical stimulation and 
citric acid in anesthetized guinea pigs (Mazzone et al., 2005), alluding to central interactions 
between jugular C-fibres and nodose A-d fibres. In addition, capsaicin desensitization (via 
TRPV1 receptor antagonist) did not prevent coughing, but significantly reduced the number of 
coughs elicited by citric acid (Mazzone et al., 2005). This cannot be attributed to peripheral 
sensitization of nodose A-d fibres, as they do not express the capsaicin (TRPV1) receptor, thus 
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must arise from central interactions of the afferent nerve subtypes (Mazzone et al., 2005). 
Interestingly, sensitizing intrapulmonary C-fibres (via nebulized bradykinin to the lower 
airways) sensitized the cough reflex evoked by citric acid and mechanical stimulation of the 
trachea (Mazzone et al., 2005). The trachea was treated topically with bradykinin receptor 
antagonist, which eliminated any chance of peripheral sensitization of extrapulmonary cough 
receptors (Mazzone et al., 2005). This provides evidence for a central site of interaction 
between jugular and nodose afferents that exists throughout the respiratory tract, and suggests 
remote sensitization of the lower airways may have implications on upper airway sensitivity 
(Mazzone et al., 2005).  
 
3.3 Efferent Pathway and Descending Motor Control  
In the efferent (or descending motor) cough pathway, central impulses from the retroambiguus 
and nucleus ambiguous in the brainstem travel via the vagus, phrenic and spinal motor nerves 
to the diaphragm, abdominal wall and respiratory and laryngeal muscles to action a cough 
(Polverino et al., 2012). It was recently proposed that sensory information, processed at higher 
brain regions, also descends for volitional inhibition or facilitation of cough motor output 
(Hegland et al., 2012; McGovern et al., 2017). These pathways are believed to be analogous to 
the descending analgesia pathway that is described for somatosensory processing of noxious 
stimuli in the pain literature (McGovern et al., 2017). Midbrain nuclei, such as the 
periaqueductal grey, are believed to play a key role in these descending neural pathways that 
suppress or facilitate sensorimotor responses (McGovern et al., 2017). McGovern and 
colleagues (2017) questioned whether these descending pathways are impaired in disease, 
resulting in up and down-regulation of coughing that give rise to clinical impairments such as 
chronic cough or silent aspiration. This concept offers an alternative way of viewing 
downregulation of coughing in patients with dysphagia and suggests that the nature of silent 
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aspiration, or down-regulated coughing, may be partly attributed to enhanced inhibition of the 
descending motor cough pathway. This concept may hold most relevance for small amounts 
aspiration or, accumulation of saliva in the laryngeal vestibule, which may trigger a 
sensorimotor cough response through cortical processing of afferent input. The authors suggest 
that this pathway may represent a promising therapeutic target. 
 
Interestingly, a recent study by Brandimore, Hegland, Okun, Davenport, and Troche (2017) 
demonstrated that patients with Parkinson’s Disease and healthy elderly adults were able to 
upregulate capsaicin induced coughing using biofeedback. Participants were told to cough as 
hard as you can in response to capsaicin, to reach a grey target area on a computer screen, 
which was set to 25% above the participant’s average baseline peak expiratory flow rate 
(PEFR) (Brandimore et al., 2017). Capsaicin induced cough expired volume (CEV) and PEFR 
were significantly increased from baseline when biofeedback was provided (Brandimore et al., 
2017). Interestingly, PEFR of tartaric induced coughing has been shown to be reduced in 
patients with dysphagia with a history of aspiration pneumonia (Fujiwara et al., 2017), 
suggesting this may provide a therapeutic option for patients with dysphagia and dystussia.  
 
While the precise underlying neural mechanisms of the observed increased in CEV and PEFR 
are unknown, it is possible that the effect of the biofeedback may represents enhanced 
facilitation of sensorimotor processing via the descending cough motor pathway. The use of 
biofeedback enables the cough response to be consciously monitored, facilitating on-line 
modification and enhancement (Athukorala, Jones, Sella, & Huckabee, 2014; Huckabee & 
Lamvik-Gozdzikowska, 2018). However, further research is necessary to clarify these 
hypotheses. The clinical implications of these findings are also unknown. The grey target on 
the screen was arbitrarily set to 25% above the participant’s average baseline PEFR 
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(Brandimore et al., 2017). It remains unknown whether increasing PEFR to 25% above baseline 
would have any clinical significance in terms of more effective clearance of material from the 
airway or lower risk of aspiration pneumonia. In addition, it is unclear whether the observed 
improvements in cough motor output (i.e. CEV and PEFR) are accompanied by enhanced 
sensation. According to Mazzone and colleagues (2016), the afferent pathway is the “driving 
force” of the sensorimotor cough response (Mazzone, 2016, p. 1325), suggesting that an intact 
efferent pathway may be redundant if afferent input is impaired. Brandimore and colleagues 
(2017) evaluate the urge to cough (UTC), (i.e. the perceived intensity of the tussigenic 
stimulus), in response to 200 µm capsaicin, and found that patients with Parkinson’s Disease 
had a lower UTC than healthy controls, suggestive of reduced laryngeal sensation, or central 
sensory processing of tussigenic stimuli at baseline. UTC was not evaluated post-therapy. 
However, it would be interesting to evaluate cough sensitivity, pre- and post-intervention in 
future studies to determine whether voluntary upregulation of cough motor output was 









CHAPTER 4: Introduction to Methodological Studies on 
the Citric Acid Cough Reflex Test  
 
The citric acid cough reflex test (CRT) has been used in the field of respiratory medicine for 
over 60 years, primarily as an outcome measure to evaluate the effects of antitussive 
medications. The earliest method was described by Bickerman and colleagues in 1954, and 
since then citric acid CRT has been used across a range of disciplines and populations 
(Bickerman & Barach, 1954). In the past 20 years, citric acid CRT has been adapted to the field 
of dysphagia, where it’s used as a clinical test to evaluate laryngeal sensory deficits associated 
with silent aspiration (Lee et al., 2013; Miles, Moore, et al., 2013; Sato et al., 2012; Wakasugi 
et al., 2008).  
 
4.1 Underlying Mechanisms of the Citric Acid Cough Reflex Test 
The advantage of using citric acid as a tussigenic stimulus for patients with dysphagia is that it 
stimulates jugular C-fibres and nodose A-d fibres (i.e. cough receptors) (Canning et al., 2004; 
Kollarik & Undem, 2002) which are hypothesized to play an important role in coughing to 
aspiration (Canning et al., 2004; Kollarik & Undem, 2002; Mazzone & Undem, 2016). 
However, it is important to acknowledge that the underlying mechanisms of how these airway 
afferents are stimulated are not fully understood. A number of studies suggest that pH plays an 
important role (Canning et al., 2004; Kollarik & Undem, 2002; Lowry, Wood, & Higenbottam, 
1988; Rai, Fowles, Wright, Howard, & Morice, 2018; Wong, Matai, & Morice, 1999). Wong 
and colleagues (1999) report highly consistent tussive responses to aerosols of citric acid, acetic 
acid and phosphoric acid of the same pH in healthy individuals (Wong et al., 1999). More 
recently, citric acid aerosols of different pH (pH = 3.13, 5.05, 5.99) were found to evoke 
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inconsistent tussive responses in healthy individuals, with greater coughing rates at pH 3 (60%) 
compared with pH 6 (10%) (Rai et al., 2018).  
 
Previous studies have also suggested that the rate at which the pH decreases in the respiratory 
tract has important implications on the airway afferents that are stimulated by citric acid. 
Electrophysiological studies in animal models demonstrate that A-d fibres (or cough receptors) 
are sensitive to rapid decreases in pH, but are entirely insensitive to gradual drops in pH 
(Kollarik & Undem, 2002). For example, rapid transient (~ 3 s) administration of citric acid to 
the receptive field of airway afferents consistently evoked action potential discharge in nodose 
A-d fibres, as well as jugular C-fibres (Kollarik & Undem, 2002). Whereas, gradual reductions 
in the pH of the receptive field of airway afferents evoked action potential discharge in C-fibres 
alone (Kollarik & Undem, 2002). These findings may have important implications on methods 
of citric acid CRT, in that, coughing may be induced by differential airway afferents depending 
on the method of citric acid administration. However, it is important to acknowledge that these 
findings are limited to animal models. Thus, the extent to which they apply to humans remains 
unknown.  
 
4.2 Methods of Citric Acid Cough Reflex Testing 
As outlined in Chapter 2, there is lack of consensus in the dysphagia literature on methods of 
citric acid cough reflex testing. Lack of standardization precludes comparison of cough 
sensitivity data across studies (Morice et al., 2007), and results in an inability to provide 
cohesive practice recommendations to clinicians (Watts et al., 2016). This may have 
implications for patient care, and have serious clinical consequences, given that citric acid CRT 
contributes to determining patient safety for oral intake and risk of silent aspiration (Miles, 
Moore, et al., 2013; Perry & Huckabee, 2017; Sato et al., 2012; Wakasugi et al., 2008). 
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Lack of standardization of the citric acid CRT is not unique to field of dysphagia. In reviewing 
the literature, it’s apparent that no standardized method of citric acid CRT exists (Morice et al., 
2007). In 2007, the European Respiratory Society (ERS) published guidelines for citric acid 
cough reflex testing (Morice et al., 2007). These guidelines aimed to standardize methods and 
optimize reproducibility. They included recommendations for preparation of citric acid 
solutions, methods of citric acid administration, nebulizer characteristics, inspiratory flow 
rates, end of test criteria, and methods of interpretation (Morice et al., 2007). A summary of 
these recommendations is provided in Table 2. While these guidelines provide a benchmark on 
which to base methods of citric acid CRT, there is a lack of empirical evidence on which many 
of the recommendations are based (discussed in detail below). This may go some way in 
explaining why they are poorly adhered to in the literature. It’s also important to note that these 
guidelines were developed specifically for the respiratory physiology field, and predominantly 
focus on evaluation of chronic refractory cough or cough associated with respiratory diseases 
such as COPD or asthma (Morice et al., 2007). Thus, the extent to which these guidelines are 
relevant for evaluating coughing in response to aspiration are unknown. Critical analysis of the 
ERS guidelines for citric acid CRT, and other methodological factors that are known to 
influence citric acid cough thresholds are outlined below and form the basis on which the 




Table 2: ERS guidelines for citric acid CRT (Morice et al., 2007). 
Method ERS Recommendation 
Preparation of 
Solutions 
Serial dilution of 3M citric acid stock solution in sterile 0.9% saline 
solution is performed in order to obtain serial doubling concentrations 
ranging from 1.95 – 3,000 mM (Kastelik et al., 2002; Wong & Morice, 




Single-dose: Single concentration of citric acid (concentration 
unspecified). 
Dose-response: 
1. Single vital capacity breaths of incremental concentrations of 
citric acid via dosimeter controlled nebulizer 
2. Tidal breath inhalations of incremental concentrations of tussive 
agent, each over a fixed period, usually 15-60 seconds. 
Nebulizer 
Characteristics 
The exact output of the nebulizer in ml/min should be determined. This 
should be used to calculate exact output of aerosol per breath. The same 
nebulizer, or one with an identical output, should be used in studies 




The ERS recommend the use of a compressed air driven nebulizer (model 
646, De Vilbiss) controlled by a dosimeter (KoKo Digidoser) that is 
modified by the addition of an inspiratory flow regulator valve (RIFR, 
nSpire Health Inc.). The valve limits inspiratory flow rate to 0.5 L/s 
regardless of excessive inspiratory force (Morice et al., 2007). 
Placebo 
Inhalations of saline should be randomly interspersed to increase 
challenge blindness. 
Instructions 
Participants should be instruction not to attempt to suppress any coughs 
and not to talk immediately after inhalations as this may suppress 
coughing - “allow yourself to cough if you need to, and as much as you 






Only coughs occurring within 15 s of citric acid delivery should be 
counted when using a single-breath method, as the response should be 
immediate and brief. 
Interpretation 
of the cough 
challenge 
The concentration of citric acid causing two (C2) and five coughs (C5) 
are reported. 
 
4.3 Citric Acid Solutions  
An understanding of the different units of concentration and methods of dilution is important 
for interpreting studies using citric acid CRT. Citric acid concentrations are reported in molar 
(mol/L), millimolar (mM), mass concentration (g/L), or percentage weight over volume (% 
w/v). The relationship between these values is as follows: 1 mM = 0.001 mol/L = 0.2 g/L, = 
0.02% w/v (PubChem Compound Database, 2019). There is no consensus on which unit of 
measurement is optimal. This creates confusion in comparing methods and interpreting results 
across studies. In studies where a range of citric acid concentrations are used (i.e. a dose-
response method, described below), solutions of citric acid can be diluted in doubling 
concentrations (i.e. 0.4, 0.8, 1.6 mol/L), incremental concentrations (e.g. 0.1 mol/L, 5% w/v 
increments, etc.), or logarithmic dilutions. Logarithmic dilutions are non-linear and based on 
orders of magnitude, with a 10-fold dilution for a logarithmic dilution, and a 3.16-fold dilution 
for a half log scale.  
 
The ERS guidelines recommend serial doubling concentrations of citric acid ranging from 1.95 
– 3,000 mM (Morice et al., 2007). Highly specific starting points of 1.98 mM citric acid (for 
patient populations) and 7.8 mM citric acid (for healthy individuals) are recommended (Morice 
et al., 2007). However, there are no normative data on which these concentrations are based. 
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The ERS recommended concentrations are referenced to two studies on patients with COPD 
and chronic cough (Kastelik et al., 2002; Wong & Morice, 1999). However, these studies used 
half log concentrations of citric acid [i.e. 10, 30, 100, 300, 1000 mM] (Kastelik et al., 2002; 
Wong & Morice, 1999), inconsistent with the ERS recommendations. This creates confusion 
among researchers and clinicians in knowing which concentrations and increments to use. Only 
one published study has compiled normative data for citric acid CRT in healthy individuals 
(Monroe et al., 2014), with methods based, in part, on the ERS guidelines (Morice et al., 2007). 
Concentrations ranging from 0.1 mol/L to 2.6 mol/L (in 0.1 mol/L increments) were inhaled 
for up to 15 seconds (tidal breathing) via facemask, until C2 cough thresholds were achieved. 
These concentrations translate to 100 mM – 2,600 mM. Both the natural cough threshold (NCT) 
and suppressed cough threshold (SCT) were evaluated. The study revealed that the majority of 
participants (92% and 70% respectively) triggered an NCT and SCT by 0.8 mol/L (i.e. 800 
mM). While this is within the range of citric acid concentrations recommended by the ERS (i.e. 
1.95 – 3,000 mM), the authors note that 5% of healthy individuals failed to trigger a C2 response 
in the NCT condition, and 22% failed to trigger a C2 response in the SCT condition (Morice et 
al., 2007), suggesting a ceiling effect of the test. No rationale is provided for the range or 
increments of citric acid concentrations used by Monroe and colleagues (2014), or the use of 
molar (mol/L), as opposed to millimolar (mM) units of concentration. It’s also unclear why the 
authors did not test up to 3 mol/L (i.e. 3,000 mM), as recommended by the ERS. This would 
have extended the testing time, but may have reduced the percentage of non-responders 
observed in the study. Consistency in the units of concentrations of citric acid solutions would 
greatly facilitate comparison and interpretation of cough sensitivity data across studies.  
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4.3.1 Preparation of Citric Acid Solutions 
The way in which citric acid solutions are made is a further consideration. The ERS guidelines 
recommend that 0.9% saline solution should be used to dilute citric acid solutions (Morice et 
al., 2007). However, the rationale for this is not specified. In the chemistry field, concentrations 
of citric acid are typically made with distilled water (PubChem Compound database, 2019). 
This may create confusion among researchers and clinicians as to why saline is added to citric 
acid for cough reflex testing. Careful analysis of previously published literature reveals that the 
absence of chloride ions (which are present in saline solution) has a pro-tussive effect on citric 
acid aerosols (Boggs & Bartlett, 1982; Eschenbacher, Boushey, & Sheppard, 1984; Lowry et 
al., 1988). This suggests that citric acid solutions diluted with or without saline will have 
different tussigenic properties (Lowry et al., 1988). Disparity in the solvent used to dilute citric 
acid solutions is likely to have crucial implications for the use of the citric acid CRT for clinical 
and research purposes and suggests that caution is warranted in comparing citric acid cough 
thresholds across studies where different solvents are used. For the dysphagia researcher and 
clinician, the validity of the citric acid CRT in identifying patients at risk of silent aspiration 
may be comprised if different solvents are used.  
 
4.4 Nebulizer Characteristics  
4.4.1 Nebulizer Output 
According to the ERS guidelines, the nebulizer output (i.e. flow rate and/or dose of citric acid 
per inhalation) should be determined prior to CRT (Morice et al., 2007). However, the optimal 
nebulizer output or dose of citric acid per inhalation is unspecified. This offers little guidance 
to researchers and clinicians in determining methods of citric acid CRT for research and clinical 
practices. The nebulizer output may have important implications on the rate at which the pH of 
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the respiratory tract is reduced, by providing a greater volume of acid per inhalation. In this 
respect, it may influence the airway afferents that are targeted by citric acid inhalations.  
 
The ERS guidelines recommend the use of a compressed air driven nebulizer, specifically the 
DeVilbiss 646 model (Morice et al., 2007). Previous studies have demonstrated significant 
variability in nebulizer output both across and within nebulizers of this make and model 
(Hollie, Malone, Skufca, & Nelson, 1991). These data suggest that, even when the ERS 
recommended nebulizer is used, under the same testing conditions, it is possible that the 
nebulizer output will vary substantially. This may have implications on the use of citric acid 
CRT as an outcome measure in cough research. The effects of the nebulizer output on citric 
acid cough thresholds has been evaluated in one previously published study in healthy 
individuals. Using the same order, increments and concentrations of citric acid, significantly 
lower cough thresholds were found with a higher nebulizer output (Barber et al., 2005). In this 
case, there was a 10-fold difference in nebulizer output (i.e. 8.4 µL to 0.8 µL per inhalation). 
These data suggest that caution must be made in comparing cough sensitivity data across 
studies where nebulizer outputs differ. These data also highlight that the nebulizer output, and 
the reliability of the nebulizer output, should be pre-determined, and monitored to ensure 
stability, as it may influence interpretation of study outcomes and the reliability of the test. 
 
4.4.2 Particle Size 
The produced nebulizer particle size may also account for discrepancies in cough thresholds 
(Barber et al., 2005). Jet nebulizers typically have a typical particle size of 2-3 µm, while 
ultrasonic nebulizers theoretically have a larger particle size, of 5-7 µm (Cohen et al., 2011). 
From the respiratory-physiology literature, it is well known that particle size influences the 
mechanisms of aerosol transport and deposition in the respiratory tract (Cheng, 2014; Heyder, 
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2004). The extra-thoracic region of the respiratory tract (mouth, pharynx, larynx), can be 
targeted with larger particle sizes (6 - 10 µm) (Bates, Fish, Hatch, Mercer, & Morrow, 1966; 
Cheng, 2014; Heyder, 2004). This is because the particles are heavier and more susceptible to 
gravitational forces (Cohen et al., 2011; Heyder, 2004). While particles of < 5 µm are typically 
deposited in the lungs (Bates et al., 1966; Cheng, 2014; Heyder, 2004). No study has evaluated 
the effects of particle size, or different nebulizer types (e.g. jet versus ultrasonic) on citric acid 
cough thresholds. For capsaicin CRT, differences in cough thresholds have been seen when 
comparing larger and smaller particle sizes (Hansson, Wollmer, Dahlback, & Karlsson, 1992). 
These data suggest that particle size and nebulizer type (i.e. jet versus ultrasonic) may be an 
important factor in comparing and interpreting cough sensitivity data across studies. 
 
4.5 Methods of Citric Acid Administration 
4.5.1 Single-Dose versus Dose-Response 
A number of different methods of citric acid administration are reported in the ERS guidelines. 
These methods are outlined in Figure 5. A single-dose method involves inhalation of one 
concentration of citric acid only, and observing for a cough response (e.g. C2 , C5, or cough 
frequency) (Morice et al., 2007). A dose-response method involves inhalations of increasing 
concentrations of citric acid until a cough response is achieved (Morice et al., 2007). The 
concentration at which an individual responds is referred to as the cough threshold. In the 
dysphagia literature, a single-dose method is often used as a clinical test to evaluate risk of 
silent aspiration (Lee, Kim, Seo, & Kang, 2014; Perry, Miles, Fink, & Huckabee, 2019; Sato 
et al., 2012; Wakasugi et al., 2008; Wakasugi et al., 2014). This is likely due to the clinical 
feasibility of the method. A dose-response method is used in dysphagia research to determine 
the most sensitive and specific citric acid concentrations in predicting a clinical outcome (e.g. 
silent aspiration or aspiration pneumonia) (Miles, Moore, et al., 2013; Nakajoh et al., 2000). A 
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dose-response method is also widely used as an outcome measure of cough sensitivity in 
response to pharmacological or behavioural therapies, where alterations in the citric acid cough 
threshold represents enhanced or diminished cough sensitivity (Faruqi et al., 2011; Janssens, 
Brepoels, Dupont, & Van den Bergh, 2015; Janssens et al., 2014; Smith, Owen, Earis, & 
Woodcock, 2006; Young et al., 2009). Although the ERS guidelines recommend a dose-
response method, it would appear that the choice of method largely depends on the goals of the 
test.  
 
Figure 5: Methods of citric acid administration. Adapted from “Cough challenge in the 
assessment of cough reflex” Morice, A. H., Kastelik, J. A., & Thompson, R. (2001), British 
Journal of Clinical Pharmacology, 52(4), p 367. 
 
4.5.2 Single Breaths versus Fixed-time Inhalations 
Citric acid can be inhaled in a single breath, or for a fixed time. For a single-dose method (i.e. 
one citric acid concentration inhaled), the ERS guidelines provide no recommendations on 
whether a single breath or fixed-time inhalation should be used. For a dose-response method, 
a single-breath, as opposed to a fixed-time inhalation method, is recommended due to the 
accuracy and reproducibility of the dose delivered (Morice et al., 2007). The ERS guidelines 

















inhalation time are likely to cause variation in the amount of aerosol inhaled and the outcome 
of the test across individuals (Morice et al., 2007). However, this hypothesis was not supported 
in a study using capsaicin CRT (Nejla, Fujimura, & Kamio, 2000). The coefficients of 
repeatability of the cough thresholds between the tidal breathing and single-breath methods 
were similar (i.e. 1.89 versus 2.71 doubling concentrations, respectively), suggesting little 
difference in test-retest variability between methods (Nejla et al., 2000). However, it is 
important to note that the volume of capsaicin inhaled in the tidal breathing method by Nejla 
and colleagues (2008) was carefully controlled. Capsaicin was nebulized into a 300-ml volume 
reservoir, connected to the nebulizer, prior to inhalation (Nejla et al., 2000). Thus, these 
findings may not apply to a tidal breathing method in which the dose of the aerosol is not 
controlled across and within participants. In situations where it may be advantageous to control 
the inhaled dose of citric acid across and within tests, a single breath method may be optimal.  
 
4.6 End of Test Criteria  
According to the ERS guidelines, both a C2 and C5 cough response are recommended as end 
of test criteria for citric acid CRT (Morice et al., 2007). There is lack of consensus as to which 
is superior (Morice et al., 2007). For capsaicin CRT, a C5 response was more reproducible in a 
cohort of healthy volunteers in the short-term (i.e. test-retest interval of 14 days) (Dicpinigaitis, 
2003). In this case, reproducibility was defined as a cough threshold within one doubling 
concentration (Dicpinigaitis, 2003). The nature of the variability of the C2 response is unclear. 
The authors hypothesize it may be related to the “startle phenomenon” (Dicpingaitis, 2003, p. 
64). An individual undergoing their first cough challenge may produce a C2 at a low 
concentration of capsaicin, but fail to cough, or cough less, at subsequent higher concentrations 
(Dicpinigaitis, 2003). According to the authors, the C5 response may be less susceptible to this 
potential pitfall (Dicpinigaitis, 2003). However, the approach of using a C2 response on two of 
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three trials of a citric acid or capsaicin may also overcome this pitfall and has been reported in 
numerous studies in the literature (Miles, Moore, et al., 2013; Miles, Zeng, McLauchlan, & 
Huckabee, 2013; Troche, Brandimore, Okun, et al., 2014).  
 
4.6.1 Suppressed Cough Threshold (SCT) 
The use of a SCT is not considered in the ERS guidelines. As previously mentioned, it aims to 
prevent individuals eliciting a volitional cough in response to a sub-threshold tussigenic stimuli 
(Eccles, 2009; Hutchings et al., 1993b; Hutchings et al., 1993a), and is thought to represent the 
point at which an individual can no longer suppress their cough response (Eccles, 2009; 
Monroe et al., 2014). In this sense, it theoretically more closely resembles a cough to aspiration 
(Monroe et al., 2014). On this basis, evaluation of the SCT may hold more appeal for the 
dysphagia researcher and clinician. However, there is limited data on the reliability of the SCT, 
which has implications on its use as an outcome measure in cough research and clinical 
practice. One study reports significant differences in the mean SCT on the first versus second 
CRT (i.e. 0.5 mol/L versus 0.6 mol/L), using a 15 second tidal breathing method (Perry & 
Huckabee, 2017). This order effect was present for females only but suggests lack of test-retest 
reliability of the SCT. Whether this effect is observed between the first and second test only, 
representing a “startle phenomenon” (Dicpingaitis, 2003, p. 64), or with every repeated test, is 
unclear. Previously studies have also demonstrated that 21 – 32% of healthy individuals may 
not achieve a C2 response in a SCT condition, using a 15 second tidal breathing method via 
facemask (Mills, Jones, & Huckabee, 2017; Monroe et al., 2014; Perry & Huckabee, 2017). 
This may result in undetermined cough thresholds and missing data in a research setting. In the 
clinical setting, it makes it difficult to determine if the capacity to suppress reflects impaired 
cough sensitivity, or a normal response. It is possible that the concentrations of citric acid, or 
nebulizer output was too low in these studies, resulting in a ceiling effect of the test. Whether 
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altering the methods of citric acid CRT could minimize this ceiling effect is an important 
avenue for future research that may improve the use of SCT as an outcome measure in cough 
research and clinical practice.  
 
4.6.2 Urge to Cough 
Urge to cough is a measure of the intensity of perceived sensations elicited by tussigenic 
stimuli, and gives insight into the cognitive motivation to cough (Davenport, 2008). Given that 
coughing is recognized as a cortically modulated behaviour (Eccles, 2009; Mazzone et al., 
2011; Mazzone et al., 2007), there is increasing attention in UTC as an outcome measure in 
cough research. Most research on UTC has been completed with capsaicin CRT (Davenport, 
2008; Dicpinigaitis, Rhoton, Bhat, & Negassa, 2012). There are few studies characterising 
citric acid induced UTC. A small number of exploratory studies have evaluated citric acid 
induced UTC in healthy individuals in cross-sectional studies to evaluate the effects of 
mindfulness (Young et al., 2009), cough suppression (Young et al., 2009) and gender (Gui et 
al., 2010). Young and colleagues (2009) found that UTC ratings at C5 cough thresholds were 
unchanged following cough suppression and a mindfulness intervention, compared to baseline 
(i.e. a natural cough threshold), despite the fact that cough thresholds increased (Young et al., 
2009). These data suggest that UTC ratings at cough threshold may not be sensitive to changes 
in cough sensitivity. Gui and colleagues (2010) found that the dose of citric acid that induced 
an UTC of one (i.e. which they defined as the UTC threshold) was not significantly different 
between males and females, despite the fact that cough thresholds were.  
 
Preliminary evidence suggests UTC is an important clinical outcome for patients with 
dysphagia. Yamanda and colleagues (2008) evaluated UTC in a cohort of elderly individuals 
with and without a history of aspiration pneumonia. The study revealed that there was no 
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difference in UTC at cough threshold (C2) in patients with a history of aspiration pneumonia, 
when compared with aged-matched healthy controls. However, when they compared sub-
threshold concentrations of citric acid (i.e. UTC at half the C2 value), the patient group had 
significantly blunted UTC compared to the control group (Yamanda et al., 2008). This finding 
suggests that UTC at sub-threshold concentrations of citric acid may be more susceptible to 
blunting in patients at risk of airway protective deficits. Similar findings are reported by Troche 
and colleagues (2014) using capsaicin induced UTC in a cohort of patients with PD. Increasing 
levels of dysphagia severity (defined as a higher PAS score) resulted in significantly attenuated 
median UTC ratings at 200 µm capsaicin (Troche, Brandimore, Okun, et al., 2014). These 
studies suggest that sub-threshold UTC may be an important clinical outcome for patients with 
dysphagia and dystussia. However, the clinical significance of these findings remains 
uncertain. Yamanda and colleagues (2008) found a mean difference of only one point on the 
UTC rating scale between patients with a history of aspiration pneumonia and healthy controls 
(i.e. 0.3 (SD = 0.7) versus 1.2 (SD = 0.8) points). It’s also important to note that only eight 
patients were included in this study. One was excluded from the UTC analysis as they were an 
outlier (i.e. substantially higher UTC rating than the other seven). For the use of citric acid 
induced UTC as an outcome measure in cough research and clinical practice, important 
questions remain regarding the reliability of citric acid induced UTC across days.  
 
4.7 Test-retest variability  
4.7.1 Methods of citric acid CRT to optimize reproducibility  
A number of recommendations are provided in the ERS guidelines to optimize repeatability of 
the CRT. Firstly, the ERS guidelines recommend the use of a dosimeter, which is a device that 
connects to the nebulizer, and ensures dose-to-dose reproducibility of the aerosol output across 
and within tests (Morice et al., 2007; Wright, Jackson, Thompson, & Morice, 2010). A further 
 50 
addition is an inspiratory flow regulator valve (Morice et al., 2007). The valve is attached to 
the nebulizer and ensures the inspiratory flow is limited to 0.5 L/s despite excessive inspiratory 
force (Morice et al., 2007). However, it doesn’t control inspiratory flow for individuals with 
an inspiratory flow rate lower than 0.5 L/s. It is also recommended that the same nebulizer – 
or a nebulizer with confirmed identical output - is used across and within participants if 
comparisons of cough sensitivity data are to be made (Morice et al., 2007). This is due to the 
known variation in nebulizer output, even in nebulizers of the same make/model (Hollie et al., 
1991). The extent to which these recommendations are adhered to across studies are unknown. 
It’s likely that these recommendations are more applicable to research settings, as increasing 
the complexity of the instrumentation for citric acid CRT may be prohibitive to clinical 
application. However, this creates a risk of introducing test-retest variability across and within 
tests, with implications on the reliability of the results.   
 
4.7.2 Test re-test reliability 
According to the ERS, large variation in cough thresholds exists across individuals, which 
diminishes the intrinsic significance of CRT outcomes (Morice et al., 2007). The nature of this 
variability is unknown, and is attributed to large variations in cough sensitivity in healthy 
individuals (Morice et al., 2007). No studies have explored the nature of this variation. It may 
relate to a number of physiological or psychosocial factors that are not controlled for in current 
methods of CRT. Test-retest reproducibility of citric acid CRT within individuals has been 
demonstrated by a number of studies using different methods of citric acid CRT (Morice et al., 
2007). This facilitates the use of citric acid CRT as a measure of cough sensitivity in 
longitudinal cough research. A summary of these studies is provided in Table 4, at the end of 
this chapter. Of note, different instrumentation, methods of citric acid inhalation, test-retest 
 51 
intervals and estimates of repeatability are used across these studies. Thus, it remains unclear 
how much variability in citric acid cough thresholds can be expected from repeating the test.  
 
A number of other fundamental limitations also preclud the use of these data into research and 
clinical practices. For example, by report, it appears a somewhat biased sample of participants 
is used in some of the studies referenced by the ERS guidelines. Some early studies use 
“trained” individuals - who were known to demonstrate a fairly consistent response to citric 
acid CRT - to examine reliability (Bickerman & Barach, 1954, p. 157; Bickerman, German, 
Cohen, & Itkin, 1957, p. 192). Others report that only subjects with repeatable cough threshold 
were accepted into the study (Grattan, Marshall, Higgins, & Morice, 1995; Rostami-Hodjegan, 
Abdul-Manap, Wright, Tucker, & Morice, 2001), without comment on the number of 
participants excluded due to variable responses to citric acid CRT. These data will likely 
underestimate the test-retest variability that would be expected in populations with no prior 
experience of citric acid CRT. Many studies allude to a “learning effect” or “startle effect” 
(Bickerman et al., 1954, p. 157 Morice et al., 2007, p. 1260), in which cough thresholds or 
cough frequency is significantly higher on the first test, versus the second. However, 
quantification of this effect is not reported in previously published literature. These data are 
important for the use of citric acid CRT as an outcome measure in cough research to evaluate 
whether changes in cough thresholds can be attributed to true changes in cough sensitivity, 
compared to the artefact of repeating the test. 
 
One study by Wright and colleagues (2010) evaluates test-retest variability of the ERS 
recommended method of CRT, referred to as the “KoKo Digidoser method” (Wright et al., 
2010, p. 2). They compare this method to a commonly used “Mefar Dosimeter Cough 
Challenge Method” in a cohort of healthy volunteers (Wright et al., 2010, p. 2). Both methods 
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differ in terms of the instrumentation and protocol used (see Table 3). Intra-day (1, 2 4 hours 
post baseline) and inter-day (2 weeks post baseline) repeatability for both methods was 
evaluated. The results of the study demonstrated no difference in C2 cough thresholds for the 
KoKo Digidoser method. In contrast, significant differences in C2 cough thresholds were 
reported for the Mefar Dosimeter method. The nature of the poor repeatability for the Mefar 
Dosimeter method is unexplained by the authors. It cannot be attributed to the test-retest 
interval, suggesting that methods of citric acid CRT may have implications on test-retest 
variability. The authors speculate whether a single inhalation may be more repeatable than 
multiple inhalations, or whether a larger particle size, as seen with the Mefar dosimeter method, 
may contribute to greater downregulation of coughing with repeated tests. However, there is 
no empirical evidence to support or refute their speculations. These data suggest that the KoKo 
Digidiser method of CRT may serve as a more viable outcome measure in cough research. 
However, a notable limitation of incorporating these data into future research and clinical 
practices is the way in which test-retest variability of citric acid cough thresholds are reported. 
The authors log transform their data and report geometric mean cough thresholds. For example, 
an inter-day geometric mean difference of – 0.05 log mM is reported for the KoKo Digidoser 
method (Wright et al., 2010). From this data, it remains unclear how much variation one could 
expect upon repeating the test, or how this relates to their original citric acid cough thresholds. 
According to Feng et al. (2014), log transformation has the advantage of dealing with skewed 
data. However, the results of statistical tests performed on log-transformed data are difficult to 
relate back to the original non-log transformed data (Feng et al., 2014). This precludes 




Table 3: Summary of the citric acid CRT protocols used by Wright et al. (2010) 
 KoKo Digidoser Method Mefar Dosimeter Method 
Instrumentation 
DeVilbiss 646 nebulizer 
controlled by a KoKo Digidoser 
Mefar MB3 dosimeter 
Citric acid 
concentrations 
7.8, 15.6, 31.2, 62.5, 125, 250, 
500, 1000 mM 
1, 3, 10, 30, 100, 300, 1000 
mM 
Nebulizer output (ml/s) 0.89 0.1 
Particle Size (MMAD) <5 µm 5.4 µm 
Number of inhalations 1 4 
Duration of inhalations 1.2 s 1 s 
End of test Criteria C2 C2 
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Table 4: Studies reporting reproducibility of citric acid CRT, as referenced by the ERS guidelines (Morice et al., 2007) 
Study (first author, year) 
Protocol of citric acid 
inhalation 
Test Interval Estimate of Repeatability 
Bickerman (1954) 
 
Five successive inhalations of 5% 




periods of 2-9 
months. 
The mean number of coughs per test was 7.4 
(range: 2-19). Within-participant standard 
deviations ranged between 0.6 - 4.5 coughs per 
test. 
Bickerman (1957) 
Five inhalations of predetermined 




The placebo drugs showed no significant mean 
percentage change in cough frequency. Estimate 
of reproducibility is not provided. 
Schmidt (1997) 
One inhalation from residual 
volume to total lung capacity of 
doubling concentrations of citric 
acid (0.625 – 320 mg/ml) were 
inhaled every 3 minutes. 




“The mean (SD) difference between both 
challenges was 0.04 +/- 0.47 doubling 
concentrations (log transformed) of citric acid. 
Therefore, reproducibility was given within about 
0.94 doubling concentrations” (p. 386). 
Barber (2005) 
Four single inhalations, separated 
by a 60 s interval of incremental 
doses of citric acid (0, 10, 30, 
300, 1,000, 2,000, 3,000 mM). 
Same time of day 
on consecutive 
days. 
The standard deviation of the difference between 
the paired cough thresholds was 0.20 log mM, 
therefore the coefficient of repeatability was 0.40 
log mM. 
Correlation coefficient r = 0.96 (95% CI = 0.84 – 
0.99). 
91% of cough thresholds were repeatable within 
one incremental dose. 
Grattan (1995) 
Five 1s inhalations of 5% citric 
acid. 
60 s between each inhalation. 
6 consecutive 
days. 
“There was no significant difference between 
baseline cough response on each of the study 
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Coughs were counted for 1 
minute. 
days” (p 262). Estimate of reproducibility is not 
provided. 
Morice (1994) 
Five 1s inhalations of 33 µmol 
citric acid. 
60 s between each inhalation. 
Coughs were counted for 1 
minute. 
5 tests. 
1 hour intervals. 
Placebo treatments (pine oil and air inhalations) 
showed no significant reduction in cough 
frequency to citric acid. Estimate of 
reproducibility is not provided. 
Rostami-Hodjegan (2001) 
Five 1 s inhalations of 10% (w/v) 
citric acid at 1 minute intervals, 
over 5 minutes. 
1 minute 
intervals, over 5 
minutes. 
The cough response in the placebo and untreated 
condition was best characterized by a decrease in 
cough frequency, to a maximum of 1.6 (a 
decrease to 8.9 coughs from the baseline value of 
10.5 coughs) at 4–4.5 h (tmax), followed by a 




Single inhalations of citric acid 
(7.8, 15.6, 31.2, 62.5, 125, 250, 
500, 1,000 mM) until C2 
response was achieved. 
 
Inter-day: 







Intra-day: geometric mean C2 at baseline, and 1, 
2 and 4 hours were not significantly different (F = 
602, p = 0.61). Mean change from baseline was 
1.57%, 3.15% and 2.08% respectively. 
Inter-day: geometric mean difference in C2 was -
0.05 log mM (95% CI, 0.05 to -0.15). ICC = 0.70 
Mefar Method 
Four inhalations of citric acid (1, 
3, 10, 30, 100, 300, 1,000 mM) 
until C2 response was achieved. 
 
Mefar Method 
Intra-day: geometric mean C2 showed a 
significant increase from baseline at 1, 2 and 4 
hours (F = 8.91, p < 0.001). Mean change from 
baseline was 9.79%, 10.70% and 11.69% 
respectively. 
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Inter-day: geometric mean difference in C2 was 
0.127 log mM (95% CI, 0.25 to 0.0001). ICC = 
0.41. 
Morice (1992) 
Citric acid (0.68% in 0.79% 
saline) were inhaled for 1 minute 




One week apart. 
 
 
On the second test day (one week after the first), 
the number of coughs in the first 10 seconds was 
3.1 (range 0-7) and in the last 10 seconds was 0 
(range 0). The response to citric acid challenge on 
the first test was significantly greater than the 
second test (p < 0.02). 
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4.8 Gaps in the Literature 
Despite publication of the ERS guidelines in 2007, there has been little progress in the last 
decade on standardization of methods of citric acid CRT. Methodological aspects of citric acid 
CRT are known to influence the outcome of the test. Thus, they are an important consideration 
in interpreting study outcomes. No study has systematically reviewed and compared methods 
of citric acid CRT reported in published literature. This information would facilitate 
comparison of citric acid cough thresholds across studies, and enhance interpretation of study 
outcomes.  
 
Test-retest variability of citric acid CRT remains uncertain. This has implications on the use of 
citric acid CRT as an outcome measure in cough research. Test-retest variability of citric acid 
CRT across a multiple days has never been evaluated. Additionally, test-retest variability of 
suppressed cough thresholds and citric acid induced UTC are unknown, but are becoming 
increasingly important outcomes in longitudinal cough research.  
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CHAPTER 5: Methods Matter - Systematic Review of 
Methods of Citric Acid Cough Reflex Testing  
 
5.1 Study Aims and Rationale 
There are no accepted methodological standards for citric acid cough reflex testing (CRT). This 
precludes comparison and interpretation of cough sensitivity data across studies (Morice et al., 
2007). Furthermore, lack of standardization results in an inability to provide cohesive practice 
recommendations to clinicians (Watts et al., 2016). The primary objective of this systematic 
literature review was to summarize and appraise methods of citric acid CRT used in published 
literature across disciplines. Data across studies were translated to standardized units of 
measurement to streamline comparison across studies. It is anticipated that this study will 
contribute towards the development of standards of methods of citric acid CRT, and highlight 
the potential implications of methods of citric acid CRT on the outcome of the test for 
researchers and clinicians.  
 
5.2 Methods 
This study was prospectively registered in the international prospective register of systematic 
review (PROSPERO), on 11th February 2018 (Registration number: CRD42017079055). For 
reporting, guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) were followed.  
 
 59 
5.2.1 Eligibility Criteria 
Publications reporting a method of citric acid CRT in human participants (adults and paediatric 
populations) were included in the review. Eligibility for inclusion was restricted to publications 
in English and Spanish, due to availability of native speakers of these languages. Publications 
other than peer reviewed journal articles, such as conference abstracts, letters to the editor, 
review articles and guidelines were excluded. Full methods of CRT were required for this 
review, and the word limit of conference papers and abstracts often precluded this. 
Furthermore, by including peer reviewed journal articles only, it was expected that the methods 
of citric acid CRT would be of adequate standard for publication. There were no constraints 
regarding publication year.   
 
5.2.2 Search Strategy 
The complete search strategy is provided in Appendix 3. The term cough (including chronic 
cough, experimental coughing, or irritative coughing) as a medical subject heading (MeSH) 
and key word, was combined with the term citric acid as a medical subject heading (MeSH) 
and key word. The following databases were searched up to February 2018: MEDLINE, 
EMBASE, CINAHL, PsychINFO, Scopus.  
 
5.2.3 Selection Procedures 
Two researchers independently assessed the relevance of the studies retrieved from searching 
the electronic databases. The titles and abstracts were independently screened by both 
researchers for keywords: cough(ing) and citric acid. Any disagreement between the two 
researchers was resolved by consensus. The full texts of all included studies were retrieved and 
examined against the inclusion/exclusion criteria (detailed below). The reference list of all 
studies included in the qualitative synthesis were manually checked for further relevant or 
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missed studies using keywords: cough(ing) and citric acid. Figure 6 depicts the selection 
procedure.  
 
Figure 6: Flow Diagram of Study Selection Procedures. Adapted from “ Preferred reporting 
items for systematic reviews and meta-analyses: the PRISMA statement”, Moher, D., Liberati, 
A., Tetzlaff, J., & Altman, D. G. (2009). PLoS Med, 6(7), p. 3. CC BY-NC-ND. 
 
 
  From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097 
 
For more information, visit www.prisma-statement.org. 
 
PRISMA 2009 Flow Diagram 
 
Records identified through 
database searching 





















n  Additional records identified 
through other sources 
(n = 0) 
Total Number of Identified Records 
 (n = 807) 
Total records screened 
(n = 807) 
Records excluded, for reasons 
such as duplicates and records 
in languages other than English 
or Spanish, conference 
abstracts, book chapters, 
letters to the editor.  
(n = 557) 
Full-text articles assessed 
for eligibility 
(n = 250) 
Full-text articles excluded, for 
reasons such as animal studies, 
language (i.e. abstract in 
English), review articles, 
guidelines 
(n = 121) Studies included in 
qualitative synthesis 
(n = 129) 
 
Total number of citric 
acid CRT protocols 
included 
(n = 136)  
 
 
7 studies include two citric 
acid CRT protocols 
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5.3 Data Extraction and Analysis 
Data was extracted and imported into an excel file, under two main headings:  
1.  Instrumentation: including nebulizer model (i.e. brand), nebulizer type (i.e. ultrasonic, 
jet, mesh), dosimeter use and model, nebulizer output, nebulizer output testing and 
nebulizer particle size. 
2. CRT Protocol: including methods of citric acid preparation, citric acid concentrations 
administered, methods of citric acid administration (i.e. single inhalations versus fixed-
time inhalations), termination criteria for cough challenge and cough type investigated.  
 
All data were independently extracted by two investigators from all studies that fulfilled the 
inclusion criteria. In total, four reviewers were involved in data collection. Agreement between 
raters was achieved by comparing data with the other investigator. Any disagreement between 
the two researchers was resolved by consensus, or by a third investigator. To streamline 
comparison across studies, the nebulizer flow rate and citric acid concentrations were 





A total of 807 studies were retrieved from the electronic databases. On the basis of the inclusion 
criteria, 129 studies were retained. Seven studies (Barber et al., 2005; Hull et al., 2002; 
Karttunen, 1988b; Monroe et al., 2014; Morice et al., 1992; Winther, 1970; Wright et al., 2010) 
included two citric acid CRT protocols. Thus, a total of 136 citric acid CRT protocols are 
reported in the qualitative synthesis. Articles were published from 1954 to 2017. All articles 
were in English. Figure 7 shows the populations for which citric acid CRT is used across the 
retrieved studies.  
 










































































































































































































5.4.1 Instrumentation  
5.4.1.1 Nebulizer 
The nebulizer model was not reported in 47% of citric acid CRT protocols. Of the 72 protocols 
reporting nebulizer model, 25 different models were reported. Eleven (44%) were jet, eight 
(32%) were ultrasonic, one (4%) was vibrating mesh, and two (8%) were of unknown type 
(Table 5). 
 
Table 5: Nebulizer model and type used across studies. 
Nebulizer Model Nebulizer Type Studies (first author, year) 
Micro Mist A7003 Jet Leow, 2012 
Acorn/Acorn 22 Jet 
Barros, 1990, Barros, 1991, 
Kenia, 2008 
CR 60 System 22 Jet Vilardell, 2017 
ATOMIZER NL11DÒ,  
La Diffusion Technique 
Jet Gayat, 2007 
“ATOMIZER” 
La Diffusion Technique 
Jet Winther, 1970 
DeVilbiss 646 Jet 
Wright, 2010, Marsden, 2008, 
Katsumata, 1991, Lavorini, 
2014, Schmidt, 1997, Faruqi, 
2011, Di Franco, 2001 
Pari Turboboy Jet Kondo, 1998, Rietveld, 2000 
Salter Labs Jet Lin, 1999 
Ganshorn ProvoJet Jet Pecova, 2007 
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Cross, 1976, Poundsford, 
1985, Vianna, 1988, Riordan, 
1994, Thompson, 1979, 
Costello, 1985, Dilworth, 
1990, Empey, 1979, 
Stockwell, 1993, Winning, 
1988, Winning, 1985 
Hudson (MicroMist Nebulizer Model) Jet 
Rees, 1983, D’Souza, 1988, 
Cox, 1984, Belcher, 1986, 
Perry, 2017 
DeVilbiss 35B Ultrasonic Behera, 1995 
DeVilbiss 65 Ultrasonic Morice, 1987, Morice, 1992 
DeVilbiss 40 Ultrasonic 
Barber, 2005, Karttunen, 
1988, Karttunen, 1987, 
Karttunen, 1988b, Empey, 
1976 
Medix Easimist Ultrasonic Barry, 1997 
Mistogen EN143 Ultrasonic Van Meerhaeghe, 1986 
Omron NE-U17 Ultrasonic 
Gui, 2014, Sato, 2016, 
Kashiwazaki, 2013, Guillen-
Sola, 2015, Wakasugi, 2008, 
Gui, 2012 
Omron NE-UL1B Ultrasonic Ogihara, 1991 
Omron MicroAir Ultrasonic Mincheva, 2014 
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Sharp MU-32 Ultrasonic 
Gui, 2010, Yanamda, 2008, 
Kanezaki, 2010, Ebihara, 
2011, Wantando, 2004, 
Ebihara, 2003 
Soniz 200 Ultrasonic 
Thompson, 2009, Mason, 
1999, Mason, 2009 
Soniclizer 305 Ultrasonic Nishino, 2008 
Omron NE-U22 Vibrating Mesh 
Lee, 2014, Wakasugi, 2014, 
Sato, 2012 
DeVilbiss (unknown model) Unknown Lavietes, 1988 
Bird (asmastick, micro-nebulizer) Unknown Taylor, 1988, Midgren, 1992 
 
5.4.1.2 Dosimeter  
The use of a dosimeter was not reported in 72% of protocols. Of the 26% of studies reporting 
the use of a dosimeter, 17% did not specify the model. Table 6 outlines the dosimeter model 
used in the protocols in which it was reported.  
 
Table 6: Dosimeter model used for citric acid CRT. 
Dosimeter Brand Studies (first author, year) 
KoKo Digidoser 
Young, 2009, Wright, 2010, Smith, 2010, Marsden, 2008, 
Faruqi, 2011, Kelsall, 2009, Smith, 2017 
Mefar 
Morice, 2007, Wright, 2010, Kastelik, 2002, Wong, 1999, 
Barber, 2005, Fahim, 2009, Gordon, 1997, Abdul Manap, 
1999, Laude, 1993, Morice, 1992, Grattan, 1995, 
Rostami-Hodjegan, 2001, Morice, 1994, Smith, 2006, 
Smith, 2006, Decalmer, 2007, Wong, 2007 
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ATOMISER NL11DÒ,  
La Diffusion Technique  
Gayat, 2007 
*reported as a nebulizer dosimeter 
Jaeger APS Jassens, 2014, Ziora, 2005, Jassens, 2015 
Medipron FDC 88 Guglielminotti, 2005, Guglielminotti, 2007 
 
5.4.1.3 Nebulizer output testing 
Only five studies (4%) reported testing their nebulizer output prior to its use in citric acid CRT. 
Of those five, only two studies (Barber et al., 2005; Empey, Laitinen, Jacobs, Gold, & Nadel, 
1976) described how the nebulizer output was tested. Barber et al. (2005) report that the 
nebulizers were “calibrated by weight loss”, which was “checked by a more accurate fluoride 
tracer method” (Barber et al., 2005, p. 178). Empey et al. (1976) report the nebulizer output 
was determined “by filling it with solution and weighing it before and after allowing air to flow 
through it (for 1 minute)” (Empey et al., 1976, p. 132). 
 
5.4.1.4 Nebulizer Output 
The nebulizer output was not reported in 68% of protocols. Nebulizer output was reported as 
the flow rate (i.e. the volume of citric acid omitted form the nebulizer per unit time), or the 
nebulizer output per breath/ actuation, across studies. To streamline comparison across studies, 
nebulizer flow rate and output per breath were converted to mL/s and ml/breath, respectively 




Table 7: Flow Rate (mL/s) and Nebulizer Output (per breath/ actuation). Reported in ascending 
order. 
Flow Rate (mL/s) Studies (first author, year) 
0.002 Auffarth (1991a), Auffarth (1991b) 
0.0025 Katsumata (1991) 
0.003 Lee (2013), Bossi (1988) 
0.004 Wakasugi (2014) 
0.005 Barros (1990) 
0.0058 Lin (1999) 
0.008 Midgren (1992) 
0.011 Lavietes (1998) 
0.015 Ziora (2005) 
0.0225 Ogihara (1991) 
0.0295 Stockwell (1995) 
0.036 
Gui (2010), Yamanda (2008), Kanezaki (2010), Watando 
(2004), Ebihara (2003) 
0.033 Grattan (1995) 
0.05 Guillen-Sola (2015), Wakasugi (2008) 
0.1 
Wright (2010) (Mefar protocol), Morice (1992) (Short term 
tachyphylaxis protocol), Nishino (2008), Wong (1999) 
0.5 Empey (1976) 
0.59 Karttunen (1987) 
0.89 Wright (2010) (KoKo protocol) 
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133.3* 
Monroe (2014), Kelly (2016) 
*This is reported as the nebulizer flow rate, but actually refers 
to the compressor.  
167* 
Poundsford (1985), Empey (1979) 
*This is reported as the flow rate the nebulizer was driven at, 
thus likely refers to the compressor. 
0.0008 ml/breath Barber (2005) (Yan Style Challenge) 
0.008 ml/breath Guglielminotti (2007), Gayat (2007) 
0.0084 ml/breath Barber (2005) (Mefar challenge) 
0.012 ml/breath West (2012), Smith (2006) 
0.125 ml/breath 
Kastelik (2002), Laude (1993), Morice (1992) (Long term 
tachyphylaxis protocol), Morice (1994) 
0.1 ml/breath Smith (2017) 
2.5 mg/breath$ 
Griffin (1982) 
$ cannot convert to ml as density of solutions are not known.  
8 mg/breath$ 
Guglielminotti (2005) 
$ cannot convert to ml as density of solutions are not known. 
 
5.4.1.5 Particle Size of nebulizer output 
Particle size was not reported in 82% of studies. The particle size reported in 18% of studies is 
listed in Table 8. 
 
Table 8: Particle sizes reported across studies 
Particle Size (µm) Studies (first author, year) 
1.6 (+/- 0.5) D’Souza, 1988 
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2.5 Katsumata, 1991; Bickerman, 1956; 1954; Noel, 1962; Packman, 1977 
2.65 Riordan, 1994 
3 Calesnick 1967; Midgren, 1992 
4 Van Meerhaeghe, 1986 
5 Wakasugi, 2014; Sato, 2012; Auffarath, 1991a, 1991b 
5.4 Yamanda 2008; Gui, 2010, Kanezaki, 2010; Watando 2004; Ebihara, 2004 
5.6 (+/- 1.8) Enright, 1980 
1-5 Winther, 1970 
0.5 - 5 Lin, 1999 
1-8 Guillen-Sola, 2015; Wakasugi, 2008 
 
5.4.2 Protocol of citric acid CRT used across studies 
5.4.2.1 Methods of citric acid preparation reported across studies 
Citric acid solutions were made with different solvents across studies. The solvents used to 
dilute citric acid are summarized in Table 9, with over half (53%) of the studies failing to report 
this methodological parameter. 
 
Table 9: Solvent used to dilute citric acid solutions 
Solvent Percentage of Studies (%) 
0.9% saline 3% 
0.79% saline 1% 
Saline (concentration not specified) 42% 
Distilled water 1% 
Not reported 53% 
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5.4.2.2 Citric acid concentrations used across studies  
The citric acid concentrations were not reported in 6% of studies. A wide range of 
concentrations are used across the remaining studies. The studies were classified below into 
those that use single concentrations of citric acid, and those that use ranges of citric acid 
concentrations (i.e. dose-response method).  
 
5.4.2.2.1 Single Concentrations of Citric Acid  
Thirty percent of protocols used a single concentration of citric acid. A total of thirteen different 
single concentrations of citric acid are used, ranging from 0.04 mol/L - 1.3 mol/L. The most 
common single concentrations of citric acid were 0.5 mol/L, used in 26% of the protocols, and 
0.3 mol/L, used in 15% of the protocols (see Appendix 4 for full list of single concentrations 
of citric acid used across studies).  
 
5.4.2.2.2 Range of Citric Acid Concentrations (i.e. dose-response method): 
Sixty-four percent of protocols used a dose-response method of citric acid CRT. Various 
increments were reported across studies: doubling, log incremental, incremental, 0.1 mol/L, 
multiples of 1.5, stepwise (0, 2, 4, 10, 20, 35, 50g per 100 ml), half log, quarter log, linear, 
percentage increments, or random increments. The range of citric acid concentrations varied 
widely across studies - with a total of 54 different reported ranges. The most common range of 
citric acid concentrations was doubling doses of 0.003 mol/L - 1.9 mol/L (reported as 0.7 - 360 
g/L), used in 10% of the protocols (see appendix 4 for full list of the range of citric acid 
concentrations used across studies).  
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5.4.2.3 Methods of Citric Acid Administration  
The method of citric acid administration was not reported in 12% protocols. Methods of citric 
acid administration were classified into those that reported the number of breaths per citric acid 
concentration, and those that reported a fixed-time of citric acid inhalation.  
 
5.4.2.3.1 Number of breaths  
Sixty-percent of protocols reported the number of breaths per citric acid concentration. This 
ranged from 1-16 across studies, with the majority of these protocols (52%) using a single 
inhalation method. The use of three inhalations, and five inhalations per citric acid 
concentration were the next most common methods, reported in 11% and 18% of studies, 
respectively. 
 
5.4.2.3.2 Fixed-time inhalation method 
Twenty-eight percent of protocols used a tidal breathing method and reported the duration of 
the citric acid inhalation. Of those using a fixed-time inhalation method, the durations of tidal 
breathing, and the percentage of protocols in which they are reported in brackets were: 15 
seconds (28%), 20 seconds (3%), 30 seconds (4%) and 60 seconds (59%). The duration of tidal 
breathing was not reported in 6% of studies that use a tidal breathing method.  
 
5.4.2.4 Termination of the citric acid CRT 
The end of test criteria was defined differently across studies. Twenty-seven (20%) studies 
used a C1 cough threshold. Twenty-seven (20%) studies used a C2 cough threshold (2 of these 
also include a C1 cough threshold). Eighteen studies (13%) used a C2 and C5 cough threshold. 
Three studies (2%) used a C3 cough threshold. Fourteen (10%) studies use a C4 or C5 cough 
threshold. Twenty-nine percent of studies recorded cough frequency (i.e. number of coughs 
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elicited) following inhalation of a single concentration of citric acid (i.e. single inhalations 
and/or fixed dose methods) or in response to multiple doses (i.e. dose-response method). Seven 
(6%) studies did not report their end of test criteria. These studies measured the latency of the 
cough response, respiratory muscle EMG during cough, and spirometry.  
 
5.4.2.5 Cough type  
Ninety percent of protocols did not specify the cough type (i.e. natural cough threshold, 
suppressed cough threshold, laryngeal cough reflex) they evaluated in the study. The cough 
type is reported in 14 (10%) citric acid protocols. Four studies evaluated the NCT. Four studies 
evaluated the SCT. Five studies evaluated both NCT and SCT. One study evaluates the 
laryngeal cough reflex (LCR). 
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5.5 Discussion 
Two important findings are derived from this study. This study provides the first empirical 
evidence of lack of standardization of methods of citric acid CRT across disciplines. This is 
evidenced by the wide range of instrumentation and protocols reported. Secondly, the study 
identifies that reporting methods of citric acid CRT is substandard in published literature. Many 
authors omit crucial elements of their citric acid CRT methods from their manuscripts. These 
findings, and the implications of these findings, are discussed in detail below.  
 
5.5.1 Lack of standardization  
There was lack of consensus in the instrumentation used across studies for citric acid CRT. For 
example, of the 72 protocols reporting nebulizer model, 25 different models were reported. The 
two most commonly reported nebulizers - the Wright nebulizer, and De Vilbiss 646 nebulizer 
- are both jet nebulizers. The following three most common - the Omron NE-U17, the Sharp-
MU32, and the DeVilbiss 40 - are ultrasonic nebulizers. As outlined in Chapter 4, jet and 
ultrasonic nebulizers differ in terms of the particle size of aerosol they emit (Cohen et al., 2011). 
While the effects of particle size on citric acid cough thresholds have not been evaluated, 
previous studies using capsaicin CRT have demonstrated differences in cough thresholds with 
aerosols of different particle sizes (Hansson et al., 1992). This may be related to differences in 
the site of deposition in the respiratory tract with aerosols of different particle sizes, or the rate 
at which the pH in the extracellular fluid surrounding the airway afferents is reduced (i.e. larger 
particles, more rapid reduction). These findings suggest that caution may be warranted in 
comparing citric acid cough thresholds between studies using different types of nebulizers.  
 
Few studies (28%) report using a dosimeter despite being a recommendation by the ERS 
guidelines (Morice et al., 2007), suggesting lack of compliance with ERS standards. All studies 
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that use a dosimeter are from the respiratory physiology literature, where citric acid CRT is 
used as an outcome measure to evaluate a cough therapy or antitussive medication. No studies 
from the dysphagia literature report using a dosimeter for citric acid CRT. The use of a 
dosimeter may be a prohibitive factor in the clinical application of methods of citric acid CRT. 
However, it is important to acknowledge that variability in the dose of citric acid delivered 
across and within tests may arise in the absence of a dosimeter (Morice et al., 2007). This is 
likely to be a crucial factor in studies using citric acid CRT as an outcome measure to evaluate 
the effects of cough therapies or antitussive medications, where dose-to-dose reproducibility is 
essential.  
 
There was wide disparity in the output of nebulizers used across studies. Twenty-eight different 
nebulizer outputs are reported. Flow rates range from 0.002 ml/s to 0.89 ml/s, while nebulizer 
outputs per breath ranged from 0.0008 ml/breath to 0.1 ml/breath. The nebulizer output may 
have important implications for the rate at which citric acid is delivered to the respiratory tract, 
and, as a result, may influence the underlying mechanisms of cough induction. Rapid reduction 
of the pH in the respiratory tract – which may be achieved more readily by higher nebulizer 
outputs - activates nodose A-d fibres, and jugular C-fibres (Kollarik & Undem, 2002). Whereas 
gradual reduction - which may be more readily achieved by lower nebulizer outputs - activates 
jugular C-fibres only (Kollarik & Undem, 2002). The capacity of alterations in the nebulizer 
output to induce differential activation of laryngeal afferents in humans is unknown. This is an 
important area for future investigations to clarify the optimal output for different populations. 
The optimal nebulizer output, and thus the rate at which citric acid is delivered to the airway, 
may differ for patients with chronic cough compared to patients with dysphagia, due to 
hypothesized differences in underlying cough pathophysiology. Thus, investigations specific 
to dystussia associated with dysphagia may improve the diagnostic accuracy of the test for 
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specific patient populations. However, differential activation of laryngeal afferents by citric 
acid CRT is also likely to be dependent on the citric acid concentrations and methods of citric 
acid administration. For example, single breaths to total lung capacity, and higher 
concentrations of citric acid, may be more effective at inducing rapid reduction in pH of the 
respiratory tract, compared to tidal breathing or lower citric acid concentrations. It is apparent 
that methodological factors, such as nebulizer output, method of administration and citric acid 
concentration cannot be considered mutually exclusive in determining the speed at which the 
pH of the airway is altered. However, it is important to acknowledge that these preconceptions 
lack empirical evidence. Further research is necessary to determine the capacity for different 
methods of citric acid CRT to target differential laryngeal afferents.  
 
The results of the study revealed a wide range of citric acid concentrations and methods of 
citric acid inhalation reported across studies. A total of thirteen different single concentrations 
(for single-dose method), and fifty-four different ranges (for a dose-response method) of citric 
acid concentrations are reported. Only two studies (Vilardell et al., 2017; Wright et al., 2010) 
use the ERS recommended concentrations of citric acid, suggesting lack of compliance to these 
standards. This disparity makes it difficult to decide the optimal citric acid concentrations to 
use for clinical and research practices. Standardizing units of concentrations of citric acid to 
mol/L revealed a 40-fold difference in the highest and lowest single concentration of citric acid 
used across studies, i.e. 0.04 mol/L (Morice, Brown, Lowry, & Higenbottam, 1987; Morice et 
al., 1992; Ogihara, Mikami, Katahira, & Otsuka, 1991), versus 1.6 mol/L (Nishino, Isono, 
Shinozuka, & Ishikawa, 2008). Furthermore, there was a 1,000-fold difference between the 
highest and lowest ranges of concentrations of citric acid used across studies, i.e. 0.00001 – 
0.0033 mol/L (Barros, Zammattio, & Rees, 1990; Barros, Zammattio, & Rees, 1991), versus 
0.01 – 3.3 mol/L (Gayat et al., 2007; Guglielminotti et al., 2005; Guglielminotti et al., 2007). 
 76 
The basis of this disparity is unclear. It is acknowledged that the populations across these 
studies differ. However, it is unlikely that a forty, or thousand-fold difference in the 
concentrations of citric acid to evoke coughing across these populations would be required.  
 
Careful analysis of the methods across these studies suggest that the solvent used to dilute the 
citric acid may, in part, explain the nature of this disparity. For example, two of the three studies 
that use the lowest concentration of citric acid (i.e. 0.04 mol/L, single-dose method), dilute 
their citric acid with 0.79% saline (Morice et al., 1987; Morice et al., 1992). The solvent used 
to dilute citric acid is not reported in the third study (Ogihara et al., 1991). Previous studies 
suggest that solutions that are low or absent in chloride ions have a greater tussigenic potency 
(Lowry et al., 1988). It is possible that citric acid solutions made with 0.79% saline may have 
a greater tussigenic potency than studies using the ERS recommended 0.9% saline, due to the 
lower concentration of chloride ions. Although it appears that this is a small difference in saline 
(and thus, chloride ion) concentration, it is possible that airway afferents are sensitive to such 
small differences. Further research is required to clarify how the solvent used to dilute citric 
acid influences citric acid cough thresholds. This may have crucial clinical implications on the 
sensitivity and specificity of the citric acid CRT in predicting patients at risk of silent aspiration 
(Miles, Moore, et al., 2013; Wakasugi et al., 2008). For example, lower or absent concentration 
of chloride ions in citric acid solutions may be more likely to evoke a C2 cough response in 
patients with laryngeal sensory deficits who are at risk of silent aspiration, diminishing the 
sensitivity of the test. Those preparing citric acid solutions for clinical use should be aware of 
the potential implications of using different solvents or different concentrations of solvents.  
 
Methods of citric acid administration differed across studies. The majority of the studies used 
a fixed number of breaths, as recommended by the ERS (Morice et al., 2007), with one, three 
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and five inhalations being most commonly reported. No rationale is provided for the use of 
multiple inhalations over a single inhalation in any study. Twenty-eight percent of studies use 
a fixed-time inhalation method, which is discouraged by the ERS guidelines, due to lack of 
reproducibility of the dose delivered across tests (Morice et al., 2007). There is lack of 
consensus in the length of the inhalation. Most studies (59%) used a 1-minute inhalation time. 
However, others use 15 s, 20 s or 30 s. No rationale for these inhalation duration times is 
provided in any study. A shorter inhalation time may be advantageous to minimize the effects 
of tachyphylaxis (i.e. a rapidly diminishing cough response to citric acid in response to 
prolonged inhalation), which is reported over one-minute inhalations of citric acid (Morice et 
al., 1992).  
 
5.5.2 Substandard reporting of methods of citric acid CRT 
Many crucial components of the citric acid CRT protocol are omitted from a large proportion 
of published studies. This prevents full replication of CRT protocols. For example, the 
nebulizer model is not reported in almost half (47%) of CRT of protocols, and the nebulizer 
output is not reported in over half (68%) of protocols. It was noted that almost a third (27%) of 
studies who do not report the nebulizer output report the output of the compressor. The 
compressor is used to drive gas through the nebulizer chamber (Boe et al., 2001; O'Callaghan 
& Barry, 1997). However, nebulizer chambers have a resistance to flow (O'Callaghan & Barry, 
1997). Thus, the flow rate of the compressor will not equate to the flow rate of the nebulizer 
once the compressed air has passed through its chamber (O’Callaghan & Barry, 1997). 
Furthermore, different nebulizing chambers will have different resistance (O'Callaghan & 
Barry, 1997). As a result, the use of the same compressor and compressor flow rate with 
different nebulizing chambers may result in variation in nebulizer output across these studies. 
It is suggested that the flow rate should be measured at the outlet of the nebulizer, rather than 
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from the compressor, to avoid over-estimating the aerosol available for inhalation (O'Callaghan 
& Barry, 1997). This would permit different nebulizers, of known output, to be used 
interchangeably (O'Callaghan & Barry, 1997), and facilitate universal replication of methods 
of citric acid CRT.  
 
Few studies (5%) report testing their nebulizer output, or the reliability of their nebulizer 
output. Previous studies have demonstrated large variability in nebulizer outputs across and 
within nebulizers of the same make and model (Hollie et al., 1991; Ryan et al., 1981), 
suggesting that testing the nebulizer output is essential to ensure dose-to-dose reproducibility 
of the citric acid aerosol delivered across and within tests. Only one study (Young et al., 2009) 
alludes to testing the reliability of the nebulizer output. The authors report that the nebulizer 
was “re-calibrated at regular intervals” to ensure consistency across tests (Young et al., 2009, 
p. 995). However, the methods used to calibrate the nebulizer output were not reported in the 
study. In the ERS guidelines for bronchial challenge testing, it is recommended that the output 
of nebulizers used for bronchial challenge testing in clinical use have a test-retest coefficient 
of variation of less than 10% (Coates et al., 2017). This may be a useful standard to incorporate 
into future citric acid CRT guidelines. It is recommended that researchers evaluate their 
nebulizer output and the reliability of the output, in studies where this may be crucial to the 
outcome of the study, for example, when using across or within-subject repeated measures of 
citric acid CRT.  
 
5.5.3 The nature and implications of these findings 
It is important to consider the factors that may be precluding lack of standardization and 
inadequate reporting of methods of citric acid CRT. A possible explanation for the findings of 
this review may arise from the lack of a strong evidence base on which methods of citric acid 
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CRT are based. The first published protocol on citric acid CRT was over sixty years ago 
(Bickerman & Barach, 1954). However, there is still limited scientific understanding of the 
underlying neurophysiological mechanisms of citric acid CRT, and the parameters that 
influence citric acid cough thresholds. There is a paucity of methodological studies on citric 
acid CRT, and a number of fundamental questions remain regarding the effect of flow rate, 
particle size, inspiratory flow rate, preparation of citric acid solutions and methods of citric 
acid administration on citric acid cough thresholds in healthy and patient populations. Without 
a clear understanding of how these factors influence citric acid cough thresholds, interpretation 
of study outcomes and comparison of cough sensitivity data across studies is challenging. 
Furthermore, researchers and clinicians are forced to use methods of citric acid CRT without 
empirically-based rationale. To overcome these shortcomings, it is recommended that 
researchers and clinicians make themselves aware of methodological limitations that may have 
implications on the outcome of the test, and secondly, evaluate their method of citric acid CRT 
prior to its use to ensure reliability. 
 
There is lack of consensus in the terminology used across studies. This hinders comparison of 
methods and results across studies. More importantly, it creates confusion, and may lead to 
misinterpretation of methods of citric acid CRT. An example of such confusion is evidenced 
in a recent study from the dysphagia literature. In describing methods of citric acid CRT, 
Holmes and colleagues (2016) report that according to a study by Monroe and colleagues, 
“92.5% of the normal population trigger a cough on 0.8 mmol of citric acid” (Holmes, 2016, 
p. 192). They also report that “0.6 mmol” of citric acid optimized sensitivity and specificity in 
detecting silent aspiration on VFSS in a study by Miles and colleagues (2013) (Holmes, 2016, 
p. 192). In reality, 0.6 mol/L (i.e. 600 mmol) and 0.8 mol/L (i.e. 800 mmol) were used in the 
above studies. This is an example of how lack of standardization in units of concentration 
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creates confusion among clinicians and researchers, which may have crucial implications on 
patient care and clinical decision making.  
 
5.5.4 Potential biases in the review process  
The search was limited to peer-reviewed, scientific studies, in English and Spanish only. This 
may have created a language bias (Higgins & Green, 2011) and resulted in some methods of 
citric acid CRT being omitted from the current review. Citation tracking was not completed, as 
reference checking yielded no addition studies, suggesting that all studies that met the inclusion 
criteria had been identified by the search. Lastly, there were no constraints regarding 
publication year in the current study. The results identify all methods of citric acid CRT used 
in published literature from 1954 to 2017. The ERS guidelines for CRT were developed in 
2007. Thus, it is possible that less variability and better reporting of methods of citric acid CRT 
may have been observed if studies published prior to 2007 were excluded. However, as outlined 
above, few studies adhere to the ERS guidelines, suggesting that similar conclusions would be 
made for studies published after 2007.  
 
5.5.5 Conclusions  
This is the first study to evaluate methods of citric acid CRT in published literature. The results 
highlight lack of standardization and substandard reporting of methods of citric acid CRT. 
These findings suggest that caution is warranted in comparing citric acid cough thresholds 
across studies. Full replication of previously published methods of citric acid CRT may be 
limited due to crucial elements of the citric acid CRT protocol being omitted from the majority 
of published manuscripts. Further methodological studies on citric acid CRT are necessary to 
enhance understanding of factors that influence the outcome of the test.  
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CHAPTER 6: Quantifying Test-Retest Variability of the 
Citric Acid Cough Reflex Test 
 
6.1 Study Aims and Rationale 
Quantification of test-retest variability of citric acid CRT is poorly reported in the literature. 
Furthermore, no previous studies have quantified test-retest variability of citric acid suppressed 
cough thresholds (SCT) and urge to cough (UTC) ratings. These data are important for the use 
of citric acid CRT as a viable outcome measure in longitudinal cough research, as they enable 
the effects of an intervention to be compared to the artefact of repeating the test. The aims of 
this study were (1) to quantify test-retest variability of citric acid cough thresholds - both 
natural cough thresholds (NCTs) and suppressed cough thresholds (SCTs) - when citric acid 
CRT is repeated on three alternate days (i.e. Monday, Wednesday and Friday), and (2) to 
quantify test-retest variability of UTC at NCT, SCT, and at a sub-threshold citric acid 
concentration (0.05 mol/L), when citric acid CRT is repeated on three alternate days.  
 
It was hypothesized that citric acid cough thresholds (NCT and SCT) would not change across 
the three alternate days, as methods of citric acid CRT used in the current study were chosen 
to optimize reproducibility of the test (Morice et al., 2007). Secondly, it was hypothesized that 
UTC at NCT, SCT and sub-threshold citric acid concentration would not change across days. 
It was expected that the perceived intensity of the same tussigenic stimulus would remain 
consistent with repeated tests.  
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6.2 Materials and Methods 
6.2.1 Study Design 
This was a prospective observational study. Participants citric acid cough thresholds were 
evaluated on three alternate days. Ethical approval was obtained by the local institutional 




Sixteen healthy participants (7 males, 9 females) over the age of 18 years (mean 24 years, range 
19-48 years) gave informed written consent prior to commencement of data collection. One 
participant (male, 21 years) withdrew from the study after Day 1 due to unforeseen university 
commitments that preventing him from returning to the research laboratory on Day 3 and 5. 
All participants were identified by self-report to be healthy. Participants were excluded from 
participating in the study if they had a history of any neurogenic disorder, a clinically 
significant respiratory disease (e.g. asthma, COPD, chronic bronchitis, emphysema), gastro-
esophageal reflux, were taking ACE inhibitor or codeine-based drugs, were current, or previous 
smokers, or had a recent (< 2 weeks) acute upper respiratory tract infection (URTI), as these 
are factors that are known to influence cough sensitivity (Morice et al., 1987; Schmidt et al., 
1997; Wong & Morice, 1999; Ziora et al., 2005). 
 
6.2.3 Instrumentation & Materials 
As recommended by the ERS Guidelines (Morice et al., 2007), citric acid was delivered using 
a compressed air-driven nebulizer (DeVilbiss 646; DeVilbiss Health Care, Inc.), controlled by 
a breath-activated dosimeter (KoKo Digidoser, nSpire health Inc.), connected to a compressor 
 83 
(Pulmomate Compressor, model 46501). Compressed air was delivered at 40 psi, which was 
confirmed on the dosimeter at the start of each test. The nebulizer was modified with an 
inspiratory flow regulator valve (RIFR, nSpire health Inc.), which limited inspiratory flow rates 
to 0.5 L/s (Morice et al., 2007). Patients inhaled citric acid via a mouthpiece while wearing a 
nose clip. Citric acid, diluted in 0.9% sodium chloride, was prepared at 8 different 
concentrations: 0.01, 0.05, 0.1, 0.2, 0.4, 0.8, 1.6, 3.2 mol/L. 
 





6.2.3.1.1 Nebulizer Output Testing 
In order to ensure consistency and reproducibility of the dose of citric acid delivered across 
and within tests, the nebulizer output and the reliability of the nebulizer output was confirmed 
prior to data collection using a weigh-reweigh method (Tandon, Smaldone, & McPeck, 1997). 
The nebulizer was filled with saline and weighed before and after a series of ten actuations of 
1.2 s duration each (the same duration used in the CRT). The nebulizer was triggered using a 
3 L calibration syringe to ensure consistency of the volume of air pulled from the nebulizer 
across actuations. This process was repeated five times (i.e. five sets of ten actuations). Only 
one nebulizer was tested as the same nebulizer and instrumentation was used for all 
participants, across all tests, as per ERS guidelines (Morice et al., 2007). Adequate reliability 
of the nebulizer output was defined as a < 10% coefficient of variation across the five sets of 
ten actuations. This was based on the ERS guidelines for bronchial challenge testing (Coates 
et al., 2017).  
 
6.2.4 Citric Acid Cough Threshold Testing 
On each day, participants inhaled three successive 1.2 sec doses of incrementally increasing 
concentrations of citric acid, until C2 cough thresholds (defined as two consecutive coughs 
within 3 seconds, on the same concentration of citric acid on two successive trials) were 
achieved. These criteria were based on the premise that the cough response to citric acid is 
immediate and brief (Dicpinigaitis, 2003; Morice et al., 2007). A C2 response was required on 
the same concentration of citric acid on two trials to mitigate the “startle phenomenon” where 
individuals cough at a particular concentration of tussigenic aerosol, but then fail to cough at 
the same, or higher subsequent presentations of citric acid (Dicpinigaitis, 2003; Morice et al., 
2007, p. 1260). Citric acid concentrations were administered in incrementally increasing order. 
This was because administration of a higher concentration of citric acid may influence the 
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response to a lower concentration of citric acid (Morice et al., 2007). Participants were blinded 
to the concentrations of citric acid they were inhaling. Saline placebos were randomly 
interspersed throughout the test to reduce the effects of participants anticipating progressively 
higher concentrations of citric acid (Morice et al., 2007). Participants’ NCT and SCT were 
examined. In the NCT condition, participants were asked to “breathe in and out through your 
mouth and cough if you need to”. Once the NCT was reached, participants were told to “breathe 
in and out through your mouth and try not to cough” to evaluate their SCT. Instructions were 
provided prior to each citric acid presentation. In the SCT condition, the concentration of citric 
acid immediately below the NCT was used as the starting point. This was based on prior 
research showing the SCT is always higher than the NCT (Leow, Beckert, Anderson, & 
Huckabee, 2012; Monroe et al., 2014), and therefore avoided unnecessarily extending the 
testing time.  
 
6.2.4.1 Rationale for Methods of Citric Acid Cough Threshold Testing 
The citric acid concentrations (i.e. 0.01, 0.05, 0.1, 0.2, 0.4, 0.8, 1.6, 3.2 mol/L) and the number 
of inhalations (i.e. three inhalations per concentration) used in the current study were based on 
the outcome of a previous, unpublished study, that aimed to determine whether the dose (i.e. 
concentration and volume) of citric acid was appropriate to eliminate potential floor and ceiling 
effects in healthy individuals (Wallace, Ang, Guiu-Hernandez, & Macrae, in prep). In the 
study, a single inhalation of each concentration of citric acid was used. The use of a single 
inhalation was based on the KoKo Digidoser method of citric acid CRT used by Wright and 
colleagues (2010) and recommended by the ERS guidelines (Morice et al., 2007). The results 
of the study revealed that no participant produced a sensorimotor cough response at 0.01 mol/L. 
However, these data showed that a large number of healthy participants could suppress 
coughing up to 3.2 mol/L citric acid with a single inhalation (1.2 sec) of citric acid. This was 
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unanticipated given that 3 mol/L is the maximum dose of citric acid that is recommend by the 
ERS (Morice et al., 2007), but suggested that the volume of citric acid per inhalation may be 
too low to induce action potential discharge in the laryngeal afferents. To overcome this ceiling 
effect, three successive inhalations (3 x 1.2 sec) of increasing concentrations of citric acid were 
performed in the current study.  
 
6.2.5 UTC Ratings 
Participants were asked to rate their UTC following all citric acid inhalations, using a modified 
Borg Scale from 1-10, one representing no need to cough, and ten representing a maximum 
urge to cough (Hegland, Pitts, Bolser, & Davenport, 2011). No specific instructions were 
provided to participants on how to rate their UTC, but each number was accompanied by a 




Table 10: Urge-to-Cough Scale (Hegland et al., 2011) 
1 No need to cough 
1.5 Just noticeable urge to cough 
2 Slight urge to cough 
3 Slight-to-moderate urge to cough 
4 Moderate urge to cough 
5 Moderate-to-strong urge to cough 
6 Strong urge to cough 
7 Strong-to-severe urge to cough 
8 Severe urge to cough 
9 Severe-to-maximum urge to cough 
10 Maximum urge to cough 
 
6.2.6 Sterilization of the Equipment 
The nebulizer and component parts were sterilized between each subject as per local hospital 
and ERS guidelines (Morice et al., 2007). The nebulizer was washed in Medizyme ® (6 ml per 
1 L of cold water), a specialist enzymatic detergent solution, for 3 minutes. Afterwards, the 
nebulizer was placed in hospital grade disinfectant solution (Milton ®, anti-bacterial tablets, 1 
tablet per 1 L of water) for 15 minutes. The nebulizer and component parts were allowed to air 
dry. A marker was placed on the base of the nebulizer bowl, to ensure consistency in the 
placement of the straw and baffle, as this is known to influence the nebulizer output (Morice 
et al., 2007).  
 
6.3 Data Analysis 
6.3.1 Nebulizer Output  
The nebulizer weight (in grams), before and after five sets of ten actuations, was manually 
entered into Excel (version 16.16.7). The weight loss for each of the five sets of ten actuations 
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was calculated by subtracting the pre- and post-nebulizer weight. The mean and standard 
deviation of the nebulizer weight loss across the five sets of ten actuations was calculated. The 
reliability of the nebulizer output was determined by calculating the coefficient of variation of 
the nebulizer weight loss across the five sets of ten actuations.  
 
6.3.2 Test Rest Variability of CRT 
Test-retest variability of citric acid CRT is expressed in different ways. This was based on the 
recommendations by Barber et al. (2005), who advocate for expressing estimates of test-retest 
repeatability of citric acid CRT in a number of different ways to facilitate interpretation and 
comparison of cough sensitivity data across studies. For statistical analyses, citric acid cough 
thresholds were re-coded from 1-7, one representing 0.05 mol/L and seven representing 3.2 
mol/L. No participant had a cough threshold at 0.01 mol/L. Participants who did not respond 
at the highest concentration of citric acid were coded as missing data so that variability was not 
skewed by assigning a false value. Linear mixed effects models were used to quantify (1) the 
effect of day, and the within-participant variability of citric acid cough thresholds (both NCT 
and SCT conditions) when citric acid CRT was repeated on three alternate days and (2) the 
effect of day on UTC ratings at NCT, SCT and at a subthreshold citric acid concentration (0.05 
mol/L) when citric acid CRT was repeated on three alternate days. Data were analysed using 
R statistical package (version 3.5.2) (R Core Team, 2012) and a linear mixed effects models 
statistical package, lme4 (Bates, Mächler, Bolker, & Walker, 2015). Day was entered as a fixed 
effect, and intercepts for each subject were entered as random effects. A p-value of 0.05 was 




6.4 Results  
6.4.1 Nebuliser Output  
Mean (SD) nebulizer output was 0.08 (0.004) ml per ten actuations (i.e. 0.008 ml per actuation). 
Based on these data, the volume of aerosol delivered per concentration of citric acid (i.e. 3 
inhalations) was calculated as 0.024 ml (i.e. 0.008 ml x 3). The coefficient of variation of the 
nebulizer output across the five sets of ten actuations was 5.48%. This meets the ERS 
guidelines of < 10% coefficient of variation in nebulizer output for bronchial challenge testing 
(Coates et al., 2017).  
 
6.4.2 Percentage of responders 
The percentage of responders at each citric acid concentration on day 1-3 for NCT and SCT 
conditions are shown in Figures 9-11. Inhalation of citric acid concentrations (0.01 - 3.2 mol/L) 
induced a sensorimotor cough response in all participants (100%) in the NCT condition. In the 
SCT condition, two participants (8%) suppressed all citric acid concentrations on at least one 
day.  
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Figure 9: The percentage of responders at each citric acid concentrations for NCT and SCT on 
Day 1. Data is reported cumulatively, meaning that those who responded at 0.05 mol/L were 
assumed to respond at all higher concentrations. 
 
Figure 10: The percentage of responders (cumulative) at each citric acid concentrations for 
NCT and SCT on Day 2. 
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Figure 11: The percentage of responders (cumulative) at each citric acid concentrations for 
NCT and SCT on Day 3. 
 
6.4.3 Reproducibility of citric acid cough thresholds  
Table 11 shows the reproducibility of citric acid cough thresholds within one, two, or more 
than two doubling concentrations across the three days. In the NCT condition, one participant’s 
cough threshold varied by more than two doubling concentrations. In the SCT condition, two 
participants did not respond to any concentration of citric acid on at least one day of testing. 
Thus, reproducibility across the three days was unable to be determined for these participants.  
 










More than two 
doubling 
concentrations 
NCT 1/15 (7%) 7/15 (46%) 6/15 (40%) 1/15 (7%) 
SCT 1/15 (7%) 7/15 (46%) 5/15 (33%) 2/15 (14%)* 
*both participants were non-responders.  
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6.4.4 Quantification of Test-retest Variability of Citric Acid Cough Thresholds 
Table 12 shows the mean, standard deviation and range of NCT and SCT across days. Table 
13 shows the estimated effects of day on NCT and SCT, and the variability of cough thresholds 
(NCT and SCT), expressed as the standard deviation, across day and participant.  
 
Table 12: Mean, standard deviation (SD) and range of citric acid cough thresholds (citric acid 
concentrations recoded 1-7). 






1 NCT 2.9 1.4 0.05 – 3.2 
3 NCT 3.7 1.6 0.05 – 3.2 
5 NCT 3.7 1.5 0.05 – 3.2 
1 SCT 3.9 1.5 0.05 – 3.2 
3 SCT 4.4 1.5 0.1 – 3.2 
5 SCT 4.6 1.8 0.1 – 3.2 
 
Table 13: Estimated day effects for NCT and SCT and variability across days. 









NCT 0.43 0.16, 0.71 0.01* 0.78 0.58, 0.96 
SCT 0.32 0.04, 0.59 0.04* 0.77 0.55, 0.98 
*statistically significant  
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6.4.5 Quantification of Test-retest Variability of UTC  
6.4.5.1 UTC at NCT and SCT 
Table 14 shows the mean, standard deviation and range of UTC ratings at citric acid cough 
threshold (NCT and SCT) across individuals. There was no evidence of an effect of day in 
UTC ratings at participants’ NCT (p = 0.34) or SCT (p = 0.46). (Note: NCT and SCT were not 
always the same for participants across days).  
 
Table 14: Mean, standard deviation (SD) and range of UTC ratings at citric acid cough 
thresholds (NCT and SCT). 
Day Cough Type Mean UTC SD Range 
1 NCT 5.67 2.16 3-9 
3 NCT 6.20 2.46 3-10 
5 NCT 5.53 2.56 3-10 
1 SCT 7.36 2.17 4-10 
3 SCT 7.50 1.91 4-10 
5 SCT 6.71 2.33 3-10 
 
6.4.5.2 UTC at Subthreshold Concentration  
Two participants were removed from the analysis of UTC at a subthreshold citric acid 
concentration, as their cough thresholds were 0.05 mol/L, thus, it did not represent a sub-
threshold concentration. Table 15 shows the mean, standard deviation and range of UTC ratings 
at sub-threshold citric acid concentration (0.05 mol/L) across individuals. There were 
differences in UTC ratings at a subthreshold citric acid concentration (0.05 mol/L), between 
day 1 and 3 (1.4 UTC, 95% CI [0.5, 2.3], p = 0.013) and between day 1 and 5 (1.7, 95% CI 
[0.77, 2.63] p = 0.003), but not between day 3 and day 5. 
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Table 15: Mean, standard deviation (SD) and range of UTC ratings at sub-threshold citric acid 
concentration (0.05 mol/L). 
Day Cough Type Mean UTC SD Range 
1 Subthreshold 3.19 1.87 1-7 
3 Subthreshold 1.78 0.99 1-4 




6.5 Discussion  
6.5.1 Test-retest variability of NCT and SCT 
The results of this study demonstrate that both NCT and SCT increase when citric acid CRT is 
repeated on alternate days, resembling a habituation effect to citric acid CRT over repeated 
testing. Estimated increases of 0.43 and 0.32 doubling concentrations per day are reported for 
NCT and SCT, respectively. These data are important for the use of citric acid CRT as an 
outcome measure in longitudinal cough research. They facilitate interpretation of whether 
changes in citric acid cough thresholds reflect true changes in cough sensitivity, rather than an 
artefact of repeating the test.  
 
Unlike previously published literature (Barber et al., 2005; Schmidt et al., 1997; Wright et al., 
2010), data in the current study are not log transformed, and thus, may be more easily 
interpreted and applied to future research practices (Feng et al., 2014). However, a recognized 
limitation of reporting test-retest variability in doubling concentrations of citric acid is that the 
increments between the citric acid concentrations are not equal. For example, there is a 0.05 
mol/L difference between cough thresholds of 0.05 and 0.1 mol/L. Whereas, there is a 1.6 
mol/L difference in cough thresholds of 1.6 and 3.2 mol/L. Caution must be made in assuming 
the test-retest variability of a doubling concentration equates to the same change in mol/L 
across individuals.  
 
Statistical data are supported by descriptive results to facilitate interpretation and comparisons 
of results across studies (Barber et al., 2005). The results revealed that 93% and 86% of 
individuals’ NCT and SCT were reproducible within two doubling concentrations (or two 
incremental doses) of citric acid, across the three days. Barber and colleagues report their data 
in a similar way and found that 91% of cough thresholds were reproducible within one 
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incremental dose. However, in this case, an incremental dose refers to a half-log (i.e. 3.16-fold) 
increments of citric acid, across two consecutive days. Thus, caution must be made in 
comparing these findings to studies using different increments and test-retest intervals.  
 
As outlined in Chapter 4, the reproducibility of a similar method of citric acid CRT (i.e. the 
KoKo Digidoser method) was evaluated by Wright and colleagues (2010). In contrast to the 
findings of the current study, Wright and colleagues (2010) report no significant difference in 
citric acid cough thresholds from repeating the test with the KoKo Digidoser method. Different 
concentrations of citric acid, number of inhalations, and dose of citric acid per concentration 
are used in the current study, compared to the KoKo Digidoser method by Wright and 
colleagues (2010). For example, Wright and colleagues use doubling doses ranging from 7.8 
to 1,000 mM (i.e. 0.0078 – 1 mol/L) citric acid. They use one, as opposed to three inhalations 
of citric acid, and the difference in the total dose per trial was 1.1 ml (Wright et al., 2010) 
versus 0.024 ml (current study). However, given these factors are kept consistent across tests, 
one might assume that test-retest variability would be similar. These discrepancies cannot be 
attributed to differences in test-retest intervals, as Wright and colleagues (2010) report 
significant differences in citric acid cough thresholds using the Mefar inhalation method over 
the same test-retest interval.  
 
These findings raise questions regarding the parameters of citric acid CRT that are necessary 
to optimize reproducibility of the test, and whether disparity in the underlying mechanisms of 
cough induction may account for differences in test-retest variability. According to the 
nebulizer output documented by Wright and colleagues (2010), their participants received a 
greater dose of citric acid (i.e. 1.1 ml) over a single inhalation, compared to the current study 
(0.024 ml) over three inhalations. Electrophysiological studies in animal models demonstrate 
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that differences in how rapidly the pH of the airway afferents is reduced influences the afferents 
that are targeted by citric acid (Kollarik & Undem, 2002). Rapid reduction of the pH of airway 
afferents evokes action potential discharge in nodose A-! fibres, whereas graduation reduction 
of the pH evokes action potential discharge in jugular C-fibres (Kollarik & Undem, 2002). The 
optimal stimulation parameters to target differential afferents during citric acid CRT in humans 
remains unknown. However, it is possible that differences in the rate at which the pH of the 
airway afferents is reduced (and thus, the underlying mechanisms of cough induction), may 
account for the discrepancy in test-retest variability across these methods.  
 
Future studies should explore whether a single inhalation of citric acid or using a greater 
nebulizer output per breath (all other variables remaining the same), would reduce test-retest 
variability of the current method. It is hypothesized that these methods may be more suitable 
to targeting nodose A-! fibres (or cough receptors) (Canning et al., 2004), that are processed 
by viscero-sensory cough pathways in the central nervous system (McGovern, Driessen, et al., 
2015) and assumed to play a greater role in airway protective coughing (Canning et al., 2004; 
Mazzone & Undem, 2016). This mechanism of cough induction may be less susceptible to 
variability than that evoked by jugular C-fibres, which are processed by somatosensory central 
neural pathways (McGovern, Driessen, et al., 2015), and are more likely to evoke cortically 
mediated coughing. However, further research is needed to substantiate this hypothesis. 
 
It is also important to note that despite using the same nebulizer (i.e. DeVilbiss 646), dosimeter 
(i.e. KoKo Digidoser) and inhalation duration (i.e. 1.2 s) as Wright and colleagues, the 
nebulizer output in the current study was over 100 times lower than that reported by Wright 
and colleagues (i.e. 1.1 ml versus 0.008 ml). The reason for the lower nebulizer output in the 
current study is unclear. This finding highlights the variability in nebulizer output of the same 
 98 
make and model, under similar testing conditions. It is hypothesized that the disparity in 
nebulizer output between the two studies may be attributed to the flow rate of the compressor, 
which is known to affect the nebulizer output (Smith, Denyer, & Kendrick, 1995). The 
compressor pressure, make or model is not reported by Wright and colleagues (2010) making 
it difficult to draw definitive conclusions on the nature of the disparity. This highlights the 
importance of documenting methods of citric acid CRT in order to fully replicate and make 
valid comparisons of citric acid cough thresholds across studies. In addition, it highlights the 
importance of determining and documenting the nebulizer output.  
 
6.5.2 Test-retest variability of UTC 
This the first study to characterize test-retest variability of citric acid induced UTC. 
Interestingly, the results of the study revealed that UTC at NCT and SCT did not change across 
days, despite the fact that the natural and suppressed cough thresholds themselves changed. 
These data suggest that the perceived intensity of a tussigenic stimulus that evokes a 
sensorimotor cough response remains stable across days, within participants. In other words, 
there is a reliable relationship between individuals’ UTC and motor cough threshold, regardless 
of what concentration elicits that threshold. 
 
There was a wide range of UTC ratings at NCT and SCT across participants. It is interesting 
that some participants rated their urge to cough at cough threshold as a three or four, while 
others rated it as a ten. This disparity may reflect the methods which were used to test UTC in 
the current study. Participants were not given any instructions on how to rate their UTC. Thus, 
it is unclear what sensory perceptions participants were rating, and whether these were the same 
across individuals. Gui et al. (2010) asked participants to rate the intensity of their UTC, but to 
ignore other sensations such as dyspnoea, burning, irritation and choking. This may facilitate 
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standardization of the sensations associated with an urge to cough rating. It is also possible that 
the wide range of UTC ratings may simply reflect the known variation in cough sensitivity 
across individuals (Morice et al., 2007). It is possible that despite eliciting a C2 response, there 
are individual differences in the perceived intensity of that tussigenic stimulus. Regardless, 
these data provide insight into test-retest variability of UTC that can be used to interpret the 
outcomes of longitudinal cough studies, when UTC is used as an outcome measure.  
 
UTC at a sub-threshold stimulus (i.e. 0.05 mol/L) behaved differently to UTC at cough 
threshold. The results of the current study revealed that UTC was higher on day one, compared 
to days three and five by 1.4 and 1.7 UTC increments, respectively. These data imply that 
individuals may “recalibrate” their UTC ratings of sub-threshold stimuli upon repeated 
presentations, based on their experience of CRT on day one. While progressing through 
concentrations on day one, participants had no prior experience on which to base their UTC 
ratings. However, after day one, participants had experienced the full range of citric acid 
concentrations (up to their cough threshold), and thus had something on which to base future 
UTC ratings. As the results show a reduction in UTC rating on days three and five, it is likely 
that the perception of irritation of 0.05 mol/L was less, after the maximum concentration had 
been experienced on day one. In the psychology literature, previous experiences are known to 
shape the perception of different sensory stimuli, such as tactile, visual and auditory stimuli 
(Snyder, Schwiedrzik, Vitela, & Melloni, 2015). These are known as “temporal contextual 
effects” in which prior experience of a stimulus can alter or stabilize the perception of a 
proceeding stimulus (Snyder et al., 2015). This may explain the difference in UTC ratings 
between day one and day three and five observed in the current study at 0.05 mol/L. However, 
it is important to note that whether the same pattern would be seen with all sub-threshold citric 
acid concentrations is unclear. As 0.05 mol/L is the second concentration that is presented to 
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participants, it may be more susceptible to modulation on consecutive testing. Given that this 
is the first study to evaluate test-retest variability of UTC in healthy individuals, further studies 
are necessary to validate or dispute these findings.  
 
6.5.3 Within-participant variability  
The use of linear mixed effects models to analyse the data revealed sources of within participant 
variability in NCT and SCT that are not explained by day. Table 13 shows that across the three 
alternate days, NCT and SCT varied by 0.78 and 0.77 doubling concentrations. This was an 
unexpected finding, and it is unclear what factors contribute to this within participant 
variability in NCT and SCT. In interpreting this finding, it is important to consider the 
underlying mechanisms of citric acid induced coughing, and how it may be influenced by day-
to-day variability within participants. The pH of citric acid plays an important role in mediating 
coughing (Canning et al., 2004; Kollarik & Undem, 2002; Lowry et al., 1988; Rai et al., 2018; 
Wong et al., 1999). Thus, it is possible that day-to-day changes in the pH of the internal 
environment (i.e. the respiratory tract) in which the acid is inhaled may account for day-to-day 
variability within individuals. Salivary pH can be lowered by consumption of sugary 
beverages, coffee or acid reflux (Hans, Thomas, Garla, Dagli, & Hans, 2016; Loke, Lee, 
Sander, Mei, & Farella, 2016), an effect that can be sustained for up to 20 minutes (Johansson 
et al., 2004). Similarly, salivary volume can be altered by a number of variables such as degree 
of hydration, body position (i.e. seated versus standing), and circadian rhythms (Dawes, 1987). 
Increased salivary volume is known to alter the rate of swallowing, and thus, clearing and 
diluting acid in the mouth more effectively (Loke et al., 2016). Given the importance of pH as 
the primary mechanisms by which coughing is evoked by citric acid (Canning et al., 2004; 
Kollarik & Undem, 2002; Lowry et al., 1988; Rai et al., 2018; Wong et al., 1999), it is possible 
that alterations in salivary pH and volume may account for the unexplained variability in citric 
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acid cough thresholds within participants. In the current study, patients with acid reflux were 
excluded due to known differences in citric acid cough thresholds in individuals with acid 
reflux (Ziora et al., 2005). However, other factors that may influence the pH of the upper 
respiratory tract - such as prior consumption of sugary beverages, tea or coffee, or degree of 
hydration - were not controlled. It is possible that these factors may explain the observed within 
participant variability in the current study.  
 
It is also possible that an imbalance in the pH of saliva or airway surface fluids may alter the 
response to citric acid CRT in disease populations. There is some evidence to suggest a 
relationship between oral bacteria levels and citric acid cough thresholds in elderly individuals 
(Watando et al., 2004). Wantando et al. (2002) found that citric acid cough thresholds were 
significantly decreased (i.e. increased sensitivity) following an intensive oral hygiene program. 
However, the nature of this relationship was unknown. From the dentistry literature, it is well 
known that bacteria in the oral cavity contribute to acidification, which is the main cause of 
dental caries (Forbes, Latimer, Sreenivasan, & McBain, 2016). Whether a relationship between 
intra oral pH and cough thresholds explain the findings by Wantando and colleagues (2002) 
requires further investigation.  
 
Salivary or airway surface fluid pH may also account for the large variability across 
participants documented for citric acid CRT (Morice et al., 2007). Large inter-individual 
variability of citric acid cough thresholds prevents the development of parameters to accurately 
define hyper- or hypo- cough sensitivity (Morice et al., 2007). In line with previous findings in 
the literature (Monroe et al., 2014; Morice et al., 2007), the current study revealed a wide range 
of citric acid cough thresholds across healthy individuals, extending from 0.05 or 0.1 mol/L to 
3.2 mol/L on all days of testing. To date, the nature of this variability across individuals is 
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unexplained in the respiratory physiology literature (Morice et al., 2007). It is possible that 
inter-individual variation in saliva pH or volume may explain this variation. Further research 
should explore whether monitoring intra-oral pH across and within individuals, prior to citric 
acid CRT, may explain the nature of test-retest variability across and within participations.  
 
6.5.4 Limitations  
It is acknowledged that the method of citric acid CRT used in the current study may not be 
suitable for clinical use due to the complexity of the instrumentation (i.e. compressor, 
dosimeter, nebulizer) and sterilization of the nebulizer that is required between individuals. 
The method of citric acid CRT used in the current study was designed to serve as a viable 
outcome measure to monitor changes in cough sensitivity in response to an intervention in 
Chapter 7. Thus, the desire to optimize test-retest reproducibility was prioritized at the expense 
of the clinical applicability of the method.  
 
Secondly, the methods of citric acid CRT used in the current study were based on the ERS 
guidelines (Morice et al., 2007). However, there is lack empirical evidence to support many of 
these recommendations. As recommended by the ERS guidelines, the nebulizer in the current 
study was adapted with an inspiratory flow valve (RIFR, nSpire health Inc.) to limit inspiratory 
flow rate to 0.5 L/s (Morice et al., 2007). However, there is still lack of consensus regarding 
the optimal inspiratory flow rate for laryngeal deposition of an aerosol (Barros et al., 1990). It 
is also acknowledged that this valve would not standardize inspiratory flow rates for individuals 
who may inhale slower than this.  
 
Lastly, the most appropriate end of test criterion for NCT and SCT remains unclear and may 
be dependent on the study population for which the test is used. Both non-responders in the 
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current study demonstrated a range of airway clearance behaviours such as single coughs, 
throat clearing and exhalations (Troche, Brandimore, Godoy, et al., 2014), in response to 1.6 
and 3.2 mol/L citric acid. These behaviours are considered sensorimotor airway clearance 
mechanisms (Troche, Brandimore, Godoy, et al., 2014), but are considered failed responses to 
citric acid CRT under the current end of test criterion (i.e. a C2 cough response). This end of 
test criterion was chosen due to the need for an outcome measure that is objective and 
reproducible. However, it is important to acknowledge that it is not known whether a C2 
response is the most likely response to aspiration – which in this context, the test is trying to 
replicate. Further research is required to determine the most appropriate end of test criteria. In 
the interim, clinicians and researchers should record all cough and non-cough behaviours (e.g. 
throat clears, expirations) in response to citric acid CRT during testing protocols in order to 




SECTION III. MODULATION OF THE 




CHAPTER 7: Sensory Stimulation to Modulate Cough 
Sensitivity - A Protocol Safety Study 
 
7.1 Introduction 
Silent aspiration is defined as aspiration without a sensorimotor cough response, or other overt 
signs of distress (Ramsay et al., 2008). Patients who silently aspirate are amongst the most 
vulnerable dysphagic patients. They are without vital means of airway protection and airway 
clearance mechanisms during swallowing, leaving them vulnerable to aspiration pneumonia 
and mortality (Nakashima et al., 2018; Nakazawa et al., 1993). The pathophysiology of silent 
aspiration can be attributed to reduced or absent laryngeal afferent input, or impaired central 
neural processing of laryngeal afferent input, from central and/or peripheral neurological 
damage (Garon et al., 2009; Holas et al., 1994; Horner & Massey, 1988). Damage to the 
brainstem, which houses the coughing and swallowing CPGs (Bianchi & Gestreau, 2009; 
Bonham, Sekizawa, & Joad, 2004; Haji et al., 2013), results in a high incidence of silent 
aspiration (Garon et al., 2009). A high incidence is also reported in patients following cortical 
stroke (Garon et al., 2009), reinforcing the role of the cerebral cortex in coughing to aspiration 
(Eccles, 2009; Hegland et al., 2012; Mazzone et al., 2011; Mazzone et al., 2007), which was 
historically considered reflexive in nature.  
 
One of the greatest clinical challenges in assessing patients with dysphagia is that silent 
aspiration can occur in the absence of clinical signs of distress. The traditional clinical 
swallowing evaluation is inadequate for detecting silent aspiration (Ramsey et al., 2003; 
Smithard et al., 1998; Splaingard, Hutchins, Sulton, & Chaudhuri, 1988). Studies have shown 
that approximately 50% of patients who silently aspirate go undetected from CSE alone 
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(Smithard et al., 1998; Splaingard et al., 1988). This is likely due to the limited information 
available from asking patients to volitionally cough, or observing a lack of coughing on oral 
intake. Volitional coughing does not provide information about the sensorimotor cough 
response to aspiration, due to the disparity in the underlying neurophysiology of both cough 
types (Magni, Chellini, Lavorini, Fontana, & Widdicombe, 2011; Widdicombe et al., 2011). 
An absent cough during swallowing does not reliably indicate absence of aspiration, as 
aspiration may be silent.  
 
The addition of the citric acid cough reflex test (CRT) to the clinical swallowing evaluation 
has provided a substantial contribution to the diagnosis of silent aspiration. When used 
alongside the clinical swallowing evaluation, the outcome of the CRT can be used to support 
clinical decision making and informed decisions about referral for instrumental assessment, 
and safety for oral intake. In a recently published clinical management protocol based on CRT 
outcomes, patients who passed the CRT proceeded to assessment of oral trials, and the clinical 
swallowing evaluation was used to guide further management decisions (Perry et al., 2019). 
This is based on the premise that these patients were at low risk of silent aspiration (Miles, 
Moore, et al., 2013) and would likely demonstrate overt signs of aspiration in response to 
misdirected food or fluid into the airway that can inform further management decisions. 
Patients who failed the CRT were considered at high risk of silent aspiration (Perry et al., 2019). 
These patients were recommended nil per orem (NPO) and referred for instrumental 
assessment (i.e. VFSS or FEES). Patients with confirmed silent aspiration on instrumental 
assessment remained NPO, and alternative nutrition/hydration was recommended (e.g. via 
nasogastric intubation) until spontaneous recovery of the sensorimotor cough response, or 
resolution of aspiration was confirmed. In theory, this mitigates the risk of pulmonary sequelae 
by negating the need for swallowing (and potential aspiration), while maintaining adequate 
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nutrition and hydration. Although, studies suggest that patients on NG tube feeding may not 
have better outcomes against aspiration pneumonia than those who eat orally (Finucane & 
Bynum, 1996; Gomes, Pisani, Macedo, & Campos, 2003; Mamun & Lim, 2005).  
 
There are no alternative recommendations in the literature for management of patients who fail 
to make spontaneous recovery and demonstrate long-term silent aspiration. Long-term use of 
non-oral methods of feeding (e.g. percutaneous endoscopic gastrostomy) in patients with 
severe dysphagia is associated with mortality, aspiration pneumonia and long-term swallowing 
impairment (James, Kapur, & Hawthorne, 1998). A number of management options, such as 
manipulation of bolus texture (Garcia & Chambers, 2010; Leonard, White, McKenzie, & 
Belafsky, 2014), thermal tactile stimulation (Regan, Walshe, & Tobin, 2010; Teismann et al., 
2009), and/or postural changes (Ra, Hyun, Ko, & Lee, 2014; Saconato, Chiari, Lederman, & 
Gonçalves, 2015) are designed to prevent aspiration during swallowing. However, evidence 
for these treatments provides mixed results. There are no clear recommendations as to which 
swallowing deficits are best suited to their application, and there is lack of evidence to suggest 
that these treatments contribute to better long term clinical outcomes, such as reducing rates of 
aspiration pneumonia (O'Keeffe, 2018). Thermal-tactile stimulation and modification of bolus 
texture could be considered sensory-based treatments. However, they do not target specific 
sensory deficits, and are designed to enhance the general sensory experience during 
swallowing. This highlights the need for rehabilitation approaches that target specific laryngeal 
sensory deficits associated with silent aspiration. 
 
7.1.1 Framework for Sensory Rehabilitation 
Research in the limb literature suggests that sensory enhancement can occur, at a neural and 
behavioural level, in response to repetitive, passive exposure to sensory stimulation, without 
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the need for active attention from the subject (Beste & Dinse, 2013; Dinse & Tegenthoff, 2015; 
Godde, Spengler, & Dinse, 1996; Godde, Stauffenberg, Spengler, & Dinse, 2000; Pleger et al., 
2001; Pleger et al., 2003). This passive approach challenges our traditional understanding and 
assumptions of learning and rehabilitation that is driven by intense training and active 
participation by the patient (Kleim & Jones, 2008; Robbins et al., 2008). The term “training 
independent sensory learning” (TISL) refers to learning induced by passive sensory stimulation 
that has the intention of changing perception and sensorimotor behaviours (Dinse & 
Tegenthoff, 2015, p.11). The advantage of not requiring active participation or attention by the 
participant, is that patients who are at risk of low cognitive functioning, receptive language 
impairments or fatigue may still benefit from such interventions (Dinse & Tegenthoff, 2015).  
 
Dinse and Tegenthoff (2015) propose a conceptual framework outlining the factors that control 
learning as a result of passive sensory stimulation. According to their model, sensory learning 
occurs when sensory input passes a “learning threshold” (Dinse & Tegenthoff, 2015, p. 18). 
For TISL, “high frequency” or “burst-like features”, as well as heavy schedules of sensory 
stimulation must be present to drive learning past the learning threshold (Dinse & Tegenthoff, 
2015, p 18). This aligns with the motor learning principals of “repetition matters” and “intensity 
matters” (Kleim & Jones, 2008, p. 227), and suggests that sufficient repetition and intensity are 
important components of both sensory and motor rehabilitation regimes.  
 
7.1.2 The Efficacy of TISL in the limb literature 
The efficacy of TISL for neural plasticity and enhanced sensory acuity in the limbs has been 
demonstrated in a number of studies (Godde et al., 1996; Godde et al., 2000; Pleger et al., 2001; 
Pleger et al., 2003). Enhanced sensory acuity and cortical reorganization following a tactile 
stimulation TISL protocol for the hand was reported by Pleger and colleagues (2001). Sensory 
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acuity was measured by a two-point discrimination task, in which participants had to decide if 
they felt the sensation of one or two needle tips on the index finger (Pleger et al., 2001). This 
was measured at the index finger of the right hand (test finger, that would be stimulated with 
TISL) and the index finger of the left hand (control finger). Cortical reorganization was 
measured by somatosensory evoked potential (SSEP) mapping of the digit representation in 
the primary somatosensory cortex, before and after the TISL protocol (Pleger et al., 2001). 
Tactile (electrical) stimulation involved a train of eight 1 Hz pulses, applied to the index finger, 
followed by a 15 second break (Godde et al., 1996; Pleger et al., 2001). After three trains of 
stimulation, there was a pause of 1 minute to minimize adaption and habituation to the stimulus 
(Godde et al., 1996; Pleger et al., 2001). The duration of the sensory stimulation was 3 hours, 
and was delivered during one session only (Pleger et al., 2001). The authors report enhanced 
sensory acuity and cortical reorganization following the TISL protocol (Pleger et al., 2001). 
However, the effects were short-lived and participants returned to baseline with 24 hours. 
Interestingly, sensory acuity enhancement was variable across participants, and was predicted 
by the extent of cortical reorganization (Pleger et al., 2001). Participants who demonstrated 
little gain in spatial discrimination showed small changes in the stimulated digit representation 
in the primary somatosensory cortex, suggesting that behavioural changes may align with 
cortical reorganization. The largest cortical reorganization and sensory acuity enhancement 
was observed for individuals with the lowest sensory acuity threshold (Pleger et al., 2001), 
suggesting that those with better sensory acuity at baseline yield the greatest benefit from TISL. 
It is possible that those with inferior sensory acuity may have required greater intensity or 
longer exposure (i.e. more than one session) of the TISL protocol to enhance sensory acuity. 
 
The efficacy of TISL in enhancing sensorimotor performance has also been demonstrated in 
patient populations following stroke. Kattenstroth, Kalisch, Peters, Tegenthoff, and Dinse 
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(2012) conducted a series of case studies to examine the effects of a long term tactile TISL 
protocol in chronic (> 10 years) stroke patients with severe sensory deficits in the hand (n =3). 
The stimulation sequence was more intense than that used for healthy individuals in Pleger and 
colleagues’ study (2001), and consisted of 45 minutes of sensory stimulation per day on the 
paretic hand of the patients, for eight (n = 1), thirty-six (n = 1), and seventy-six weeks (n = 1). 
Stimulation intensity was delivered at the highest threshold each individual could tolerate, and 
differed for each subject. Beneficial effects were observed on tactile tasks (touch threshold, 
and two-point discrimination tasks) and sensorimotor behaviours (e.g. execution of fine motor 
movement) as well as functional tasks (such as moving and manipulating heavy, light and small 
objects). The impact of TISL on cortical activity in response to sensory stimulation was 
investigated in one patient, who received 36 weeks of sensory stimulation. No SEP was 
detectable prior to intervention. However, there were clear cortical SEP components (i.e. P50, 
N80 and P200) in response to sensory (pneumatic) stimulation following TISL treatment at 36 
weeks (Kattenstroth et al., 2012), suggesting a partial restoration of processing of tactile 
information in the somatosensory cortex.  
 
While the findings of this study are limited due to the small sample size, they were recently 
replicated in a randomized control trial in a cohort of sub-acute stroke patients (n – 46) using 
the same stimulation parameters and protocol as above (Kattenstroth et al., 2018). These 
patients had less severe sensory deficits than the previous study. After two weeks of 
intervention, patients in the group receiving standard therapy with TISL (n = 23) showed 
significant improvement in sensory, motor, proprioceptive and everyday tasks, compared to 
those receiving standard therapy alone (n = 23). The greatest measurable gains following the 
TISL protocol were in the sensory domain (i.e. touch threshold and two-point discrimination). 
However, the authors note large inter-individual variability, as demonstrated by large standard 
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deviations in pre- and post- test scores, which the authors attribute to the small sample size. In 
addition, patients with more severe sensory impairments were not included in the study, 
suggesting the positive effects of passive sensory stimulation may be limited to patients with 
less severe sensory deficits.  
 
7.1.3 Sensory Stimulation of the Larynx 
An issue of substantial relevance to the current research is the extent to which the principals of 
passive sensory stimulation of the skin could be applied to the larynx to enhance the sensitivity 
of the sensorimotor cough response. The sense of touch from the skin has distinct neural control 
to visceral senses arising from internal organs. However, comparisons have been made in the 
literature between central neural processing of chronic cough and chronic pain (Ando et al., 
2016). This suggests that similar sensory neural mechanisms may underlie somatic and visceral 
sensations, and raises the possibility that passive sensory stimulation to the larynx may have 
the potential to enhance the sensorimotor cough response under the correct conditions. Based 
on the above studies, important factors of a sensory stimulation protocol include the repetitive 
nature of passive sensory stimulation (Kattenstroth et al., 2018; Pleger et al., 2001; Pleger et 
al., 2003), and preventing adaption to the stimulus (Godde et al., 1996).  
 
7.1.4 Sensory Stimuli 
From the principals of neurorehabilitation (Kleim & Jones, 2008), we know that the specificity 
of stimulation is an important factor for dictating the nature of the plasticity. Tussigenic 
aerosols (such as citric acid, capsaicin and distilled water) offer a means of activating afferents 
and central neural pathways involved in coughing (Morice et al., 1992), with relatively non-
invasive methods. Thus, they offer an appealing possibility for enhancing the sensorimotor 
cough response. Previous studies have shown that citric acid, distilled water and capsaicin can 
 112 
modulate coughing (Morice et al., 1992). For example, significant attenuation of the 
sensorimotor cough response has been demonstrated in response to prolonged (1 minute) 
inhalations of citric acid, capsaicin and distilled water aerosols - a phenomenon known as 
tachyphylaxis (Morice et al., 1992). Interestingly, both citric acid and distilled water induced 
rapid and substantial attenuation of the sensorimotor cough response (i.e. 84 – 100% reduction 
in cough frequency), compared to the more modest effects of capsaicin (i.e. 37-49% reduction 
in cough frequency) (Morice et al., 1992). The difference in modulation of the sensorimotor 
cough response was attributed to the distinct underlying afferents activated by each stimulus 
(Morice et al., 1992). Citric acid and distilled water are likely acting through the same neuronal 
pathway (i.e. laryngeal nodose A-d fibres, or cough receptors), which is characterized by a 
rapidly adapting response (Canning et al., 2004; Mazzone & Undem, 2016; Morice et al., 
1992). This is supported by studies demonstrating the nodose A-d fibres are highly responsive 
to rapid alterations in pH, and hypotonic solutions (i.e. distilled water) (Anderson, 
Sant'Ambrogio, Mathew, & Sant'Ambrogio, 1990; Boushey, Richardson, Widdicombe, & 
Wise, 1974; Lee, Macglashan, & Undem, 2005; Mazzone & McGovern, 2006; Mazzone & 
Undem, 2016; Storey, 1968). In contrast, capsaicin-induced coughing is mediated through C-
fibre activation, which is more slowly adapting (Canning et al., 2004; Mazzone & Undem, 
2016; Morice et al., 1992). Given their underlying mechanisms of cough induction (i.e. via 
laryngeal nodose A-d fibres), both citric acid and distilled water may target a greater number 
of afferents and central neural pathways involved in coughing to aspiration, compared with 
capsaicin.  
 
7.1.5 Citric Acid as a Sensory Stimulus 
Citric acid has been widely used in the literature for assessment of coughing without reported 
adverse effects (Miles, Moore, et al., 2013; Miles, Zeng, et al., 2013; Sato et al., 2012; Vilardell, 
 113 
Rofes, & Clave, 2015; Wakasugi et al., 2008). However, this typically involves short 
inhalations of small quantities of citric acid. The safety of inhalations of citric acid in larger 
quantities and over a number of days – as required with a sensory stimulation protocol – must 
be carefully considered.   
 
Acid induced bronchoconstriction is widely recognized in the literature (Ricciardolo, 2001). In 
animal models, an increase in respiratory resistance in response to citric acid inhalations was 
dose-dependent (Ricciardolo et al., 1999), suggesting the dose of citric acid is an important 
predictor of the development of bronchoconstriction. This finding is supported in a more recent 
study in humans. Wright and colleagues (2010) report a significant increase in respiratory 
resistance (as measured by impulse oscillometry), in healthy individuals in response to the 
KoKo Digidoser method of citric acid CRT (i.e. single inhalation of citric acid), but not on the 
Mefar method (i.e. four single inhalations of citric acid). The total volume of citric acid inhaled 
per concentration in the KoKo Digidoser method was much higher than that in the Mefar 
method (1.1 ml in one inhalation, versus 0.4 ml in four inhalations), suggesting that inhalations 
of larger quantities of citric acid may account for the development of bronchoconstriction in 
healthy individuals.  
 
In the original studies by Bickerman and colleagues (1954), no signs of bronchoconstriction 
were reported in healthy individuals. However, the authors report a “slight degree of 
bronchospasm” in response to 10% citric acid aerosols (five successive inhalations) in 
asthmatic participants (Bickerman & Barach, 1954). It is not reported how this was evaluated 
or managed in the study. Other studies report no evidence of bronchoconstriction in asthmatics 
using 1-minute inhalations of citric acid (Auffarth, de Monchy, van der Mark, Postma, & 
Koeter, 1991a). However, the nebulizer output is not reported in either study, making it difficult 
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to determine whether the dose of citric acid inhaled may have accounted for the presence or 
absence of bronchoconstriction.  
 
Prolonged inhalations of acidic aerosols are known to have adverse effects on the respiratory 
system (Folinsbee, 1989; Utell, 1985; Wyzga & Folinsbee, 1995). This has been studied 
specifically with airborne pollutants. For example, Spektor and colleagues (1989) 
demonstrated that inhalations of low concentrations of sulfuric acid aerosols (100 µg/M3 = ~ 1 
x 10-11 mol/L) for 1 hours and 2 hours on separate occasions, separated by one week, markedly 
reduced the rate of mucociliary clearance in a cohort of healthy adults. This may lead to 
enhanced bacterial colonization and upper respiratory tract infections (Antunes & Cohen, 
2007). The longer the exposure to the acidic aerosol, the greater the prolongation of mucociliary 
clearance mechanisms (Spektor, Yen, & Lippmann, 1989), suggesting prolonged inhalations 
of acidic stimuli should be avoided. Holma and colleagues (1989) also suggested that 
prolonged inhalations of acidic aerosols may have adverse effects on the mucus in the 
respiratory tract. When mucus becomes acid-saturated (due to an excess of H+ ions), these ions 
can access the surrounding tissues and gain access to tissues and cause intra and inter-cellular 
oedema and acid induced airway resistance (Holma, 1989). The authors suggest that the amount 
of acid an individual can tolerate is dependent on their buffer capacity and protein content of 
their mucus. Those with acidic mucus or mucus with a low protein concentration would be at 
higher risk of adverse effects from prolonged acid inhalation (Holma, 1989). These findings 
raise potential problems for repeated inhalations of citric acid as part of a sensory stimulation 
protocol.  
 
Repeated ingestion of acidic substances is also associated with adverse health effects. In a 
published report for chemical and biosafety of citric acid (OECD, 2001), gastrointestinal 
 115 
disturbances, such as diarrhoea, indigestion and nausea are reported following repeated 
ingestion of citric acid. Limited details are provided on the dose of citric acid that was ingested. 
However, this is an important consideration for repeated inhalations of citric acid, which would 
result in deposition of acid on the pharyngeal wall, that may be swallowed causing potential 
gastrointestinal disturbances. Overall, these risks preclude the use of citric acid as a potential 
stimulus to modify the sensorimotor cough response over prolonged durations.  
 
7.1.6 Distilled Water as a Sensory Stimulus 
There are numerous advantages of using distilled water. Distilled water is a relatively 
innocuous stimulus. It is purified by the process of distillation that removes salts and other 
compounds (Daintith, 2008) and is safe for ingestion. Distilled water can induce coughing 
when inhaled as an aerosol from an ultrasonic nebulizer, and has been used as a tussigenic 
stimulus in numerous studies for cough assessment in patients and healthy individuals, without 
reported adverse effects (Fontana, Pantaleo, Lavorini, Benvenuti, & Gangemi, 1998; Fontana, 
Pantaleo, Lavorini, Boddi, & Panuccio, 1997; Fontana et al., 1999; Hegland et al., 2016; Morice 
et al., 1992).  
 
The safety of prolonged inhalations of distilled water in healthy individuals, without respiratory 
diseases, has been demonstrated in numerous studies that are described in detail below. 
However, these studies demonstrate that distilled water inhalation is associated with 
bronchoconstriction in asthmatics (Allegra & Bianco, 1980; Anderson, Schoeffel, & Finney, 
1983; Chadha, Birch, Allegra, & Sackner, 1984; Cheney & Butler, 1968; Schoeffel, Anderson, 
& Altounyan, 1981). This observation gave rise to the original use of distilled water inhalations 
as a bronchial challenge test, to assess for bronchial hyperresponsiveness in asthmatics, and 
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warrants some caution in the use of distilled water inhalations as part of a sensory stimulation 
protocol.  
 
Cheny and Butler (1968) were among the first to document a relationship between distilled 
water inhalations and bronchoconstriction. Ten healthy individuals and ten patients with 
pulmonary disease (asthma and bronchitis) inhaled distilled water for 15 minutes (nebulizer 
flow rate of 3.5 ml/min). Severe coughing was reported in all participants during distilled water 
inhalations. Bronchoconstriction (as measured by whole body plethysmography) was not 
evident in any of the healthy individuals. However, all patients with pulmonary disease 
experienced bronchoconstriction following distilled water inhalations (Cheney & Butler, 
1968). These findings align with those by Chada, Birch, Allegra and Sackner (1984). Healthy 
individuals were exposed to 30 s, 1 minute, 2 minutes, 4 minutes and 8 minutes of distilled 
water, administered in 15-minute intervals, while the exposure times for asthmatics were 15 s, 
30 s, 1 minute, 2 minutes, 4 minutes (nebulizer flow rate: 6 ml/min). The authors report that all 
participants experienced laryngeal irritation and coughing during distilled water inhalations, 
which increased in intensity with longer exposures to distilled water (Chadha et al., 1984). 
Interestingly, this contradicts the findings of Morice and colleagues (1992) above, who report 
less coughing with longer exposures of distilled water within one-minute. The reported 
nebulizer flow rates are the same in both studies (i.e. 6 ml/min). It is possible that initial 
exposure and adaption to distilled water, as reported by Morice and colleagues (1992), is 
mediated through rapidly adapting airway afferents (i.e. nodose A-!). While subsequent 
increases in coughing to prolonged (> 1 minute) exposure to distilled water may be mediated 
through C-fibre activation, which are slowly adapting. In healthy participants, no signs of 
bronchoconstriction were reported during any of the inhalations (Chadha et al., 1984). Patients 
with asthma produced no changes in respiratory resistance or breathing patterns at 15 and 30 s 
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of distilled water inhalations. However, longer exposures (1, 2, and 4 minutes) produced a 
stepwise significant increase in mean respiratory resistance, suggesting a dose-response 
relationship between the dose of distilled water and bronchoconstriction in asthmatics (Chadha 
et al., 1984). A similar dose-response effect has also been demonstrated in subsequent studies, 
suggesting the volume of distilled water that is inhaled has important implications for the 
development of respiratory resistance. Schoeffel, Anderson and Altounyan (1981) examined 
bronchial hyper-responsiveness in asthmatics and healthy controls in response to distilled water 
inhalations. The authors evaluated the total ventilation (i.e. volume of air inhaled and exhaled 
from the lungs) required to induce a 20% fall in FEV1. Distilled water was administered in total 
ventilation volumes of 10, 20, 40, 80, 80, 80 L. Of note, tidal volume is approximately 500 
ml/breath for a healthy adult (Landers, Barker, Wallentine, McWhorter, & Peel, 2003), 
suggesting that approximately 20, 40, 80, 160, 160, 160 inhalations of distilled water were 
administered. All healthy subjects inhaled all increments of distilled water, without registering 
a 20% fall in FEV1. All patients with asthma registered a > 20% fall in FEV1 in response to 
inhalations of distilled water. However, there was wide variation in total ventilation of distilled 
water that registered this response in the patients with asthma (ranging from a total ventilation 
of 1.3 L to 180 L) which is likely to reflect varying degrees of asthma severity. The output of 
the nebulizer is not reported by the authors, which is a limitation in applying theses data to 
future studies. 
 
In the above studies, all cases of bronchoconstriction induced by distilled water were reversed 
with a bronchodilator (Allegra & Bianco, 1980; Anderson et al., 1983; Chadha et al., 1984; 
Cheney & Butler, 1968; Schoeffel et al., 1981). However, one isolated case-study by Saetta et 
al. (1995) reports a fatal asthma attack following distilled water inhalation. In this case, a 22-
year old man, who was reported to be taking regular treatment with inhaled steroids and B-
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agonists to control his asthma, was referred for a distilled water inhalation challenge, as an 
alternative to a hypertonic saline bronchial challenge test. The dose or flow rate of distilled 
water inhalations was not reported in the study. The authors only reported that the patient was 
inhaling distilled water for one minute prior to his fatal asthma attack (Saetta et al., 1995). It is 
stated in the study that the patient’s asthma was “well-controlled” (Saetta et al., 1995, p. 1285). 
However, evident oedema in the trachea and infiltration of mast cells and eosinophils in the 
peripheral airways observed during post mortem was suggestive of chronic inflammation 
(Murdoch & Lloyd, 2010), and potentially poorly controlled asthma. Although these findings 
have not been repeated in any additional studies in patients with asthma or healthy individuals, 
they highlight the importance of confirming the safety of distilled water inhalations.  
 
7.1.7 Gaps in Knowledge 
There are a number of gaps in knowledge that have potential safety implications in using 
inhalations of distilled water as part of a sensory stimulation protocol to enhance cough 
sensitivity. Firstly, the effect of distilled water inhalations over multiple days on the 
development of bronchoconstriction is not known. Longer exposures, or larger volumes of 
distilled water are known to increase risk of bronchoconstriction in patients with asthma 
(Chadha et al., 1984; Schoeffel et al., 1981). Thus, it is possible that repeated exposure to 
distilled water, over a number of days, may enhance the risk of developing bronchoconstriction.  
 
Additionally, no previous studies have evaluated the effects of repeated, short inhalations of 
distilled water on the development of bronchoconstriction in healthy individuals. Repeated 
short inhalations of distilled water may activate different laryngeal afferents in the upper 
airway, than prolonged inhalations. Whether this method of inhalation would make individuals 
more or less susceptible to bronchoconstriction requires further investigation.  
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In previously published literature, prolonged (1-minute) inhalations of distilled water 
inhalations have been shown to attenuate the sensorimotor cough response (Morice et al., 
1992). This is contrary to the objectives for patients with laryngeal sensory deficits and silent 
aspiration. Whether repeated, short inhalations of distilled water could enhance the 
sensorimotor cough response is not known. Given the risk of attenuating the sensorimotor 
cough response, the effects of a distilled water inhalation protocol on cough sensitivity should 
be first evaluated in healthy, non-dysphagic individuals.  
 
 The effects of different flow rates of distilled water on cough sensitivity modulation has never 
been evaluated. In the motor rehabilitation literature, different neuromuscular electrical 
stimulation frequencies have differential effects of either enhancing or inhibiting corticobulbar 
projections to muscles in the upper respiratory tract (e.g. muscles underlying the pharyngeal 
mucosa, faucial pillars, and submental muscles) (Doeltgen, Dalrymple-Alford, Ridding, & 
Huckabee, 2010; Fraser et al., 2002; Power et al., 2004). Thus, whether high versus low 
intensity distilled water inhalations have a differential effect on modulating cough sensitivity 
warrants investigation.  
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7.2 Study Aims and Hypothesis 
7.2.1 Safety 
The primary objective of this study was to evaluate the safety of a sensory stimulation protocol 
involving distilled water inhalations on pulmonary function in a cohort of healthy, non-
asthmatic, adults. The percentage change in FEV1 following distilled water inhalations was 
evaluated for each participant enrolled in the study. It was hypothesized that no participant 
would demonstrate bronchoconstriction (as defined by a > 20% fall in FEV1 as measured on 
spirometry) in response to distilled water inhalations across four days.  
 
7.2.2 Effects of Citric Acid Cough Thresholds 
As a secondary objective, this study aimed to evaluate the effects of a high and low intensity 
distilled water inhalation protocol on citric acid cough thresholds, in a cohort of healthy adults, 
across days. Specifically, the study aimed to evaluate the effects of a high and low intensity 
distilled water inhalation protocol on the natural cough threshold (NCT) and the suppressed 
cough threshold (SCT) to citric acid, compared to control (0.9% saline inhalations). It was 
hypothesized that changes in NCT and SCT in the distilled water inhalation groups would differ 
to those in the control group. It was hypothesized that changes in the distilled water inhalation 
groups would be characterized by a decrease in citric acid cough thresholds, whereas changes 
in the control group would be characterized by an increase in citric acid cough thresholds.  
 
As a further secondary objective, the study aimed to evaluate how potential changes in cough 
thresholds were reflected at a perceptual level. The study aimed to evaluate the effect of day 
and group on urge-to-cough (UTC) at NCT, SCT and subthreshold citric acid concentration 
(0.05 mol/L). It was hypothesized that changes in UTC in response to high and low intensity 
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distilled water inhalations would significantly differ to those in the control group receiving 
0.9% saline inhalations.  
 
7.3 Methods  
This study was prospectively registered on the Australian New Zealand registry of clinical trials 
(ANZCRT) ON THE 28th October 2016 (Trial Id: ACTRN 12616001495415).  
 
7.3.1 Participants 
Twenty-eight healthy participants were recruited for the study. Participants were initially 
identified as healthy by self-report. A pre-participation medical questionnaire was then 
completed (Appendix 2). Participants were excluded from the study if they had a history of 
asthma (or any prior use of an inhaler), a clinically significant respiratory disease (e.g. COPD, 
cystic fibrosis, bronchitis) a history of neurogenic disorders, gastro-esophageal reflux, 
currently taking ACE inhibitor or codeine based drugs, current or prior smokers, individuals 
with a recent (< 2 weeks) upper respiratory tract infection (URTI), or abnormal baseline 
spirometry measures (based on the Global Lung Function Initiative (GLI) reference values) 
(Quanjer et al., 2013). Ethical approval was obtained from the New Zealand Health and 
Disability Ethics Committee (HDEC) (Reference number: 17/STH/2) and the local institutional 
review board. Informed, written consent was obtained from all participants, prior to the 
commencement of data collection.  
 
7.3.2 Study Design 
This study was a prospective quasi-randomized control trial. Participants were randomized into 
one of three groups, (1) high intensity distilled water inhalations, (2) low intensity distilled 
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water inhalations and (3) control (0.9% saline inhalation), using a computer-generated program 
(Urbaniak & Plous, 2013). Participants were blinded to their group assignment until after the 
treatment protocol. Each of the three groups underwent the same inhalation protocol (differing 
by the intensity and stimuli they were inhaling), completed over five days (Table 16). Citric 
acid cough threshold testing was performed at a research lab, and the distilled water inhalation 
protocols and spirometry were completed at a respiratory physiology laboratory at a local acute 
hospital. This was to ensure immediate access to trained respiratory physiologists and medical 
personnel in the event of any adverse respiratory events associated with the distilled water 
inhalations.  
 
Table 16: Outline of the study design. 




























































7.3.3 Sensory Stimulation Protocol  
Distilled water and saline aerosols were delivered using an ultrasonic nebulizer (Micro 801 U 
Suchatzki Ultrasonic Nebulizer) (see Figure 12). Distilled water inhalations were designed to 
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be below cough threshold to avoid participants expelling the aerosol during the sensory 
stimulation protocol. The high-intensity group received distilled water inhalations at the 
maximum flow rate of the nebulizer (1.6 ml/min). Based on prior research, this was not 
expected to induce coughing (Hegland et al., 2016; Lavorini et al., 2007). The low-intensity 
group received distilled water inhalations at the minimum flow rate of the nebulizer (0.5 
ml/min). The control group received high-intensity 0.9% saline inhalations (1.6 ml/min). Saline 
was chosen as the control stimulus, as it does not evoke coughing or excite sensory receptors 
in the airway (Storey, 1968). The nebulizer outputs were confirmed prior to completing the 
study based on a weigh-reweigh method. An outline of the sensory stimulation protocol is 
provided in Figure 13. All groups underwent the same stimulation protocol, differing only by 
the solution, and flow rate of the inhalations. Participants completed a total of 300 inhalations 
of distilled water (at a flow rate of 1.6 or 0.5 ml/min) or saline (at a flow rate of 1.6 ml/min). 
Inhalations were divided into twelve cycles. Each cycle comprised twenty-five inhalations (5 
inhalations, 10 seconds break, x 5). Spirometry was completed at baseline, and following every 
three cycles of distilled water inhalation. Participants received a one-minute break in between 
each cycle. The sensory stimulation protocol was designed based on previously described TISL 
protocols, which involved a high number of exposures to passive sensory stimuli, but 
incorporated short breaks into the stimulation cycles to avoid adaption and habituation to the 
stimulation (Godde et al., 1996; Godde et al., 2000; Pleger et al., 2001). 
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7.3.4 Outcome Measure 1 - Spirometry 
Baseline spirometry was completed prior to the sensory stimulation protocol in all three groups, 
on days 2-5. All spirometry met the criteria for acceptable quality spirometry, as outlined by 
the ERS, and the American Thoracic Society (ATS) (Miller et al., 2005). On day two, baseline 
spirometry was compared to GLI reference values, which takes participants’ weight, height, 
sex and ethnicity in account (Quanjer et al., 2012). Only participants with normal baseline 
spirometry (defined as > 80% of predicted values) were allowed to continue to the sensory 
stimulation protocol. Spirometry was performed throughout the sensory stimulation protocol, 
after every four stimulation cycles, to monitor for any signs of bronchoconstriction. 
Bronchoconstriction was defined as a > 20% fall in FEV1, as per ERS guidelines for 
methacholine challenge testing (Coates et al., 2017). In the event any participant showed signs 
of bronchoconstriction, immediate treatment with a bronchodilator (i.e. 2 inhalations of 
salbutamol), under the guidance of a designated respiratory physician, was available for 
administration, with the a priori criteria to exclude any such participant from the remainder of 
the study. As per ERS recommendation for bronchial challenge testing, a bronchodilator and 
oxygen were available in the immediate vicinity (Joos & Connor, 2003). Medical 
help/resuscitation was available within two minutes, and an oximeter was available for 
monitoring oxygen saturation (Joos & Connor, 2003).  
 
7.3.5 Outcome Measure 2 - Citric Acid Cough Threshold Testing  
Citric acid cough threshold testing was completed as described in Chapter 6 (Section 6.2.4), 
using the same instrumentation. Citric acid was delivered using a compressed air-driven 
nebulizer (DeVilbiss 646; DeVilbiss Health Care), controlled by a breath-activated dosimeter 
(KoKo Digidoser, nSpire health Inc.), connected to a compressor (Pulmomate Compressor, 
model 46501). Compressed air was delivered at 40 psi, as measured on the dosimeter. The 
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nebulizer was modified with an inspiratory flow regulator valve (RIFR, nSpire health Inc.). 
Patients inhaled citric acid via a mouthpiece, wearing a nose clip. Citric acid, diluted in 0.9% 
sodium chloride, was prepared at 8 different concentrations: 0.01, 0.05, 0.1, 0.2, 0.4, 0.8, 1.6, 
3.2 mol/L. On each day, participants inhaled three successive 1.2 sec doses of each 
concentration of citric acid in ascending order until C2 cough thresholds (defined as two 
consecutive coughs within 3 seconds, on the same concentration of citric acid on two 
successive trials) were achieved. Participants were examined in a natural cough threshold 
(NCT) condition and a suppressed cough threshold (SCT) condition. In the NCT condition, 
participants were asked to “breathe in and out through your mouth and cough if you need to”. 
Once the NCT was reached, participants were told to “breathe in and out through your mouth 
and try not to cough” to evaluate their SCT. Instructions were provided prior to each citric acid 
presentation. In the SCT condition, the concentration of citric acid immediately below the NCT 
was used as the starting point. This was based on prior research showing the SCT is always 
higher than the NCT (Leow et al., 2012; Monroe et al., 2014), and therefore avoided 
unnecessarily extending the testing time. Saline placebos were randomly interspersed 
throughout the test to reduce the effects of participants anticipating progressively higher 
concentrations of citric acid (Morice et al., 2007). 
 
7.3.6 Outcome Measure 3: Urge-to-cough Ratings  
Following each citric acid inhalation, participants were asked to rate their urge to cough (UTC) 
according to methods reported by Hegland, Pitts, Bolser & Davenport (2012). For this, a 
modified Borg Scale from one to ten was used, with one representing no need to cough and ten 
representing a maximum urge to cough (Figure 17). No specific instructions were provided to 
participants on how to rate their UTC, but the scale was visually available throughout all 
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inhalations, with each number including a written description (e.g. 3 - slight to moderate urge 
to cough).  
 
Table 17: Urge-to-Cough Scale (Hegland et al., 2011). 
1 No need to cough 
1.5 Just noticeable urge to cough 
2 Slight urge to cough 
3 Slight-to-moderate urge to cough 
4 Moderate urge to cough 
5 Moderate-to-strong urge to cough 
6 Strong urge to cough 
7 Strong-to-severe urge to cough 
8 Severe urge to cough 
9 Severe-to-maximum urge to cough 





7.4 Data Analysis  
7.4.1 Safety Data 
FEV1 was analysed for all participants throughout the sensory stimulation protocol, and 
dictated whether the stimulation protocol was continued or ceased. The maximum, range and 
mean change in FEV1 across all participants and tests is reported below. Statistical analysis was 
not completed for the safety data as it was not intended to compare safety data across groups. 
Rather, safety data was evaluated on an individual basis for all participants.  
 
7.4.2 Citric Acid Cough Thresholds and Urge-to-Cough 
Citric acid cough thresholds were re-coded from 1-7, one representing 0.05 mol/L and seven 
representing 3.2 mol/L. No participants’ cough threshold was 0.01 mol/L. Participants who did 
not respond at the highest concentration of citric acid were coded as missing data, so that 
variability was not skewed by assigning a false value. Linear mixed effects models were used 
to estimate the interaction effect between day and group on NCT and SCT. In the linear mixed-
effects analysis, the interaction between day and group was entered as a fixed effect into the 
model and intercepts for each participant were included as a random effect. The inclusion of 
the interaction effect was firstly evaluated by comparing the model with and without the 
interaction effect using a likelihood ratio test. If the likelihood ratio test was significant (i.e. p-
value <0.05) the analysis was continued and the coefficient estimates, 95% confidence intervals 
and p-values of the model coefficients are reported. If the likelihood ratio test was non-
significant (i.e. p-value >0.05) no further analyses were completed.  
 
For UTC data, linear mixed effects models were used to estimate the interaction effect between 
day and group on UTC at NCT, SCT and subthreshold citric acid concentration (i.e. 0.05 
mol/L). The interaction between day and group was entered as a fixed effect into the model, 
 130 
and intercepts for each participant were included as a random effect. As above, the inclusion 
of the interaction effect was firstly evaluated by comparing the model with and without the 
interaction effect using a likelihood ratio test. If the likelihood ratio test was significant (i.e. p-
value <0.05) the analysis was continued and the coefficient estimates, 95% confidence intervals 
and p-values of the model coefficients are reported. If the likelihood ratio test was non-
significant (i.e. p-value >0.05) no further analyses were completed. Data were analysed using 
R statistical package (R Core Team, 2017) and a linear mixed effects models statistical 
package, lme4 (Bates et al., 2015). A p-value of 0.05, or less, was considered statistically 
significant.
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7.5  Results 
7.5.1 Participants 
A total of 28 healthy individuals (6 males, mean age, 30 years, range 19-74) were recruited for 
the study. Data from four participants were excluded. Three participants were excluded from 
the sensory stimulation protocol on day two, based on their baseline spirometry data. One 
participant (male, 24 years) was unable to perform acceptable quality spirometry, as per ERS, 
and ATS guidelines (Miller et al., 2005). Two participants had obstructive spirometric patterns 
at baseline (1 female, 22 years, 1 male, 24 years), and were excluded from continuing to the 
sensory stimulation protocol. These participants were offered a consultation by the respiratory 
physician on the research team, and were provided with a copy of their spirometry report for 
their GP.  
 
One participant (female, 56 years) could not tolerate the high intensity distilled water 
inhalations without coughing. Despite continuous coughing, this participant showed no signs 
of bronchoconstriction when spirometry was completed after the first cycle of distilled water 
inhalations. As the sensory stimulation protocol was designed to be sub-threshold, it was 
decided to continue with distilled water inhalations inhalation at a lower flow rate that did not 
evoke coughing in the participant, with the primary aim of evaluating the safety of the distilled 
water inhalations. A flow rate of approximately 1 ml/min, based on a weight, re-weigh method, 
was provided. The participant demonstrated no signs of bronchoconstriction on spirometry 
throughout the distilled water inhalation protocol. The maximum change in FEV1 for this 
participant was -6% across all tests (range: +4% to -6%). This participant’s data was excluded 




A total of 24 healthy individuals were included in the final analysis. A summary of the 
participants included in each group is provided below (Table 18).  
 
Table 18: Participant demographics across groups 
 
High Intensity 
(n = 8) 
Low Intensity 
(n = 8) 
Control 
(n = 8) 
Gender 
(females) 




(19 – 30) 
38 
(21 – 74) 
28 
(19 – 70) 
 
7.5.2 Outcome Measure 1 – Spirometry 
There were no adverse events during the study. All spirometry met acceptability and 
repeatability criteria as per ERS and ATS guidelines (Moore, 2012). All baseline spirometry 
was within normal limits, as per GLI reference standards, for all participants who received the 
sensory stimulation protocol (Quanjer et al., 2012). No participant demonstrated a > 20% fall 
in FEV1 in response to distilled water inhalations. The maximum fall in FEV1 in response to 
distilled water inhalation across all participants and days was 8%. Changes in FEV1 across 
participants ranged from +4% to -8%. The mean change across all tests was -2%.  
 
7.5.3 Outcome Measure 2 - Citric Acid Cough Thresholds 
7.5.3.1 NCT 
Descriptive statistics for NCT across days and groups is provided in Table 19. There was no 
significant interaction effect between day and group on NCT (X2 (4) = 9.14, p = 0.058). 
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 1 3.43 0.98 0.1 – 0.4 
Control Group 3 3.63 1.41 0.1 – 0.8 
 5 4.00 1.07 0.1 – 0.8 
 1 3.38 1.51 0.05 – 1.6 
High Intensity 3 2.88 1.13 0.1 – 0.8 
 5 4.00 1.00 0.1 – 0.8 
 1 3.86 1.46 0.1 – 1.6 
Low Intensity 3 3.13 1.55 0.1 – 1.6 
 5 3.83 1.17 0.2 – 0.8 
 
7.5.3.2 SCT 
Descriptive statistics for SCT across days and groups are provided in Table 20. There was an 
interaction effect between day and group on SCT (X2 (4) = 11.32, p = 0.023). At baseline, there 
was no significant difference in SCT between the control group and high intensity group (p = 
0.54) and the control group and low intensity group (p = 0.52). There were no significant 
difference in SCT in the high intensity group, or low intensity group across days (p > 0.05). 
No significant difference in SCT was revealed in the control group between day 1 and day 3 
(p = 0.11). In contrast, SCT was higher on day 5 compared to baseline in the control group 
(1.2, 95% CI [2.0, 0.4], p = 0.008). The estimated differences in the change in SCT between 
day 1 and 3 and 1 and 5, comparing high and low intensity groups to the control group, are 
provided in table 21. The change in SCT was different across days 1-3 and 1-5 in the high 
intensity group compared to the control group. SCT changed differently across days 1-5 in the 
low intensity group compared to the control group (Table 21 and Figure 14). 
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Table 20: Descriptive statistics of SCT (recoded) across the days and groups. 





 1 3.83 1.72 0.05 - 1.6 
Control Group 3 4.50 1.38 0.2 - 1.6 
 5 5.00 1.27 0.2 -1.6 
 1 4.38 1.41 0.1 - 1.6 
High Intensity 3 3.88 1.25 0.1 - 1.6 
 5 3.71 1.25 0.1 - 0.8 
 1 3.67 1.63 0.1 - 1.6 
Low Intensity 3 4.25 1.75 0.1 - 1.6 
Group 5 4.25 2.19 0.05 - 3.2 
 
Table 21: Estimated differences of the change in SCT for the high intensity and low intensity 




change in SCT 
(doubling 
concentrations) 
95% CI p value 
1-3 High vs. Control -1.2 -2.26, -0.14 0.04* 
1-5 High vs. Control -1.8 -2.88, -0.72 0.01* 
1-3 Low vs Control -0.8 -1.98, 0.38 0.16 
1-5 Low vs Control -1.3 -2.4, -0.2 0.03* 
* significant at p = <0.05 
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Figure 14: Estimated effects of day and group on SCT (error bars reflect the confidence 




7.5.4 Outcome Measure 3 – Urge to Cough 
7.5.4.1 NCT  
Descriptive statistics for UTC in the NCT condition across days and groups are provided in 
Table 22. There was no significant interaction effect between day and group on UTC in the 
NCT condition (X2 (4) = 8.68, p = 0.07). 
 
  
  Control   High Intensity   Low Intensity 
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Table 22: Descriptive statistics for UTC in the NCT condition across the days and groups. 
Day Group Mean UTC SD Max UTC Min UTC 
1 Control 6.43 2.47 9 1.5 
3 Control 6.63 1.60 9 5 
5 Control 6.13 1.46 8 4 
1 High 8.13 1.72 10 5 
3 High 6.25 2.38 10 3 
5 High 8.14 2.34 10 4 
1 Low 6.63 2.93 10 3 
3 Low 5.75 2.71 10 2 
5 Low 6.13 2.10 9 3 
 
7.5.4.2 SCT 
Descriptive statistics for UTC in the SCT condition across days and groups are provided in 
Table 23. There was no significant interaction effect between day and group on UTC in the 
SCT condition (X2 (4) = 3.57, p = 0.47). 
 
Table 23: Descriptive statistics for UTC in the SCT condition across the days and groups. 
Day Group Mean UTC SD Max UTC Min UTC 
1 Control 6.83 1.72 9 4 
3 Control 6.33 0.82 7 5 
5 Control 7.33 1.37 9 6 
1 High 8.38 1.72 10 2 
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3 High 7.38 2.45 10 3 
5 High 7.86 2.80 10 3 
1 Low 7.00 2.37 10 3 
3 Low 7.25 2.49 10 3 
5 Low 7.38 2.13 10 4 
 
7.5.4.3 UTC at subthreshold (0.05 mol/L) 
Descriptive statistics for UTC at subthreshold (0.05 mol/L) condition across days and groups 
are provided in Table 24. There was no significant interaction effect between day and group 
for UTC at 0.05 mol/L (X2 (4) = 7.39, p = 0.117). 
 
Table 24: Descriptive statistics for UTC at 0.05 mol/L across the days and groups. 
Day Group Mean UTC SD Max UTC Min UTC 
1 Control 2.4 1.4 5 1 
3 Control 1.9 0.6 3 1 
5 Control 1.7 0.6 3 1 
1 High 4.5 2.8 8 1.5 
3 High 3.4 2.5 9 1.5 
5 High 3.6 2.8 7 1.7 
1 Low 1.46 0.4 2 1 
3 Low 3.0 3.0 10 1 




In this study, the safety of a proposed sensory stimulation protocol to modulate citric acid 
cough thresholds was evaluated in healthy individuals. The results of the study revealed that 
distilled water inhalations did not induce bronchoconstriction (defined as a > 20% fall in FEV1) 
in any participant enrolled in the study across the five days. These data suggest that the distilled 
water inhalation protocol utilized in this study is safe in healthy, non-asthmatic adults.  
 
The results also revealed that SCTs changed differently in the distilled water inhalation groups, 
compared to the control group. In evaluating the changes in SCT in the stimulation and control 
groups, it is apparent that while SCTs increased across days in the control group, SCTs did not 
change across days in the high or low intensity distilled water inhalation groups. It is important 
to reflect on the variability of CRT as an outcome measure, when considering the implications 
of this result. Chapter 6 demonstrated that citric acid cough thresholds significantly increased 
across three alternate days in healthy individuals in the absence of sensory stimulation, 
resembling a habituation effect to repeated exposure to CRT. In light of this, the current data 
suggests that the observed increase in SCT across days in the control group may be attributed 
to the artefact of repeating the citric acid CRT. In contrast, the lack of change in SCT in the 
high and low intensity distilled water inhalations suggest that the distilled water inhalation 
protocol may inhibit the expected increase in citric acid cough thresholds associated with this 
habituation. It is therefore possible that cough sensitivity is enhanced by the distilled water 
inhalation protocols, but this effect is masked, or diminished, by the use of citric acid CRT as 
an outcome measure. This is a notable limitation of using citric acid CRT as an outcome 
measure to observe for decreases in cough sensitivity.  
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There are few alternative valid methods for evaluating cough or laryngeal sensitivity. One 
possibility is the use of laryngeal air puff stimulation, which has been used in a recent study to 
detect cough thresholds (i.e. the minimum air pulse intensity that elicited a cough response) in 
patients with and without dysphagia (Giraldo-Cadavid et al., 2017). The instrumentation 
included an endoscopic laser range finder, to overcome some of the known limitations in the 
reliability of laryngeal air puff stimulation that arise from inconsistencies in the distance and 
angle of the tip of the endoscope in the upper airway across tests (Cunningham, Halum, Butler, 
& Postma, 2007; Giraldo-Cadavid et al., 2017). The authors reported excellent intra- and 
interrater agreement when cough thresholds were determined eight times by an experienced 
and novice clinician (i.e. four times each), during the same endoscopic procedure. However, 
quantification of test-retest variability of air puff cough thresholds across repeated tests is not 
reported in the study. It is possible that individuals would also habituate to air puff stimulation 
following repeated tests, similar to citric acid cough threshold testing.  
 
Interestingly, SCTs in the control group increased by an estimated 1.2 doubling concentrations 
on day five compared to baseline. This is almost double the estimated increase in SCT across 
three alternate days with no intermittent sensory stimulation, as reported in Chapter 6 (i.e. 0.32 
doubling concentrations per day, x 2 days = 0.64 doubling concentrations). This suggests that 
while habituation to CRT may somewhat explain the increase in thresholds seen in the control 
group, it is likely that saline inhalations enhanced the effect of increased thresholds across days. 
Saline does not evoke cough or activate airway afferents (Storey, 1968). However, it is possible 
that a tactile stimulation effect from repeated inhalations of an aerosol contributed to the 
observed increase in citric acid cough thresholds. These findings raise the question of whether 
saline inhalations may be beneficial for patients with cough hypersensitivity, where it would 
be advantageous to increase their cough sensitivity. However, as this study has identified this 
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effect in only a small number of healthy individuals, more thorough investigations in patient 
populations are required prior to any clinical conclusions being drawn about saline stimulation 
for hypersensitive airway afferents. 
 
It is possible that the high intensity distilled water inhalation protocol used in the current study 
was not of adequate intensity to induce a significant reduction in SCT across days. A sub-
threshold flow rate was chosen to avoid excessive coughing, which would result in expelling 
the aerosol during the sensory stimulation protocol, and possibly contribute to lowered 
participant tolerance. As this is the first study to use distilled water in an attempt to modulate 
sensitivity of airway afferents, the protocol parameters were the first to be investigated for such 
purposes. It is possible that alternative durations or number of inhalation cycles could increase 
the differences between the groups. It is also important to acknowledge that the distilled water 
inhalation protocol was not tailored to the sensory threshold of each individual. The results of 
the current study, and previous studies in the literature, suggest that cough thresholds differ 
widely across individuals (Monroe et al., 2014; Morice et al., 2007). As a result, the high and 
low intensity distilled water inhalation protocols may have represented different intensities for 
different participants. An individual with a low cough threshold may have experienced more 
laryngeal irritation and urge to cough during the distilled water inhalations than that of an 
individual with a high cough threshold. This may have contributed to different magnitudes of 
change in SCT across days, as demonstrated by the wide confidence intervals in the estimates 
of change in SCT across days and groups (Table 20).  
 
Sensory stimulation of the hand in sub-acute and chronic stroke patients was administered at 
an intensity that was individualized for each patient (Kattenstroth et al., 2012). This was found 
to enhance tactile tasks, sensorimotor behaviours, functional tasks and cortical activity from 
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baseline (Kattenstroth et al., 2012). Originally, it was intended to determine participants’ 
distilled water cough threshold - defined in the literature as the flow rate of distilled water 
evoking a cough response during two distinct cough challenges separated by 30 minutes 
(Fontana et al., 1998; Fontana et al., 1997; Fontana et al., 1999) - and administer distilled water 
at flow rates of minus one increment (high intensity stimulation) and minus three increments 
(low intensity stimulation) below that threshold. However, it was anticipated that this may 
cause problems for potential future application of the distilled water inhalation protocol for 
patients with silent aspiration, where baseline cough thresholds may be impossible to determine 
due to laryngeal sensory deficits. Monitoring urge to cough during the distilled water inhalation 
protocol in future studies may provide an opportunity to gauge, and regulate, the intensity of 
the distilled water inhalations across participants, although this measure was characterised by 
large variation across participants in Chapter 6.  
 
It is of interest that differential changes in cough thresholds between the stimulation groups 
and the control group was only identified in the SCT condition, and not in the NCT condition. 
There are a number of possible explanations for this observation. Brain imaging studies in 
humans have demonstrated distinct central neural networks involved in natural and suppressed 
coughing to capsaicin (Mazzone et al., 2011). Although capsaicin has distinct neural networks 
to citric acid, these data imply that NCT and SCT conditions may reflect distinct cough types 
and neural pathways. The current results, and those of previous studies (Monroe et al., 2014) 
highlight that SCTs are elicited at higher citric acid concentrations than NCTs. Higher 
concentrations of citric acid may evoke rapid reduction of pH in the respiratory tract. This has 
been shown to evoke action potential discharge in nodose A-d fibres (Kollarik & Undem, 
2002), which mediate coughing through viscero-sensory cough pathways in animal models 
(McGovern, Davis-Poynter, et al., 2015; McGovern, Driessen, et al., 2015). Distilled water is 
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known to activate nodose A-d fibres (Canning et al., 2004; Mazzone & Undem, 2016). Thus, 
it is possible that the distilled water inhalation protocol has a greater effect on the suppressed 
cough pathway.  
 
It also bears mentioning that in the NCT condition, mean NCTs in the high and low intensity 
groups non-significantly decreased on day 5 compared to baseline, and mean NCTs in the 
control group non-significantly increased on day 5 compared to baseline. Thus, NCTs were 
observed to change differently in the stimulation groups compared to the control group. This 
differential change did not reach statistical significance (although it approached significance, 
p = 0.058). It is possible that the sample size in the current study was too low to accurately 
characterize this effect. Given that this is the first study to evaluate the effects of the distilled 
water inhalation protocol on citric acid cough thresholds, further studies, with large sample 
sizes, are necessary to validate or refute these findings. 
 
7.6.1 Implications for rehabilitation of silent aspiration 
The finding that the distilled water inhalation protocol was safe in healthy adults provides the 
basis to evaluate the safety and potential efficacy of the protocol in patients with laryngeal 
sensory deficits following neurological injury. The extent to which these findings would be 
replicated in patients with silent aspiration is unknown. Patients with silent aspiration 
secondary to stroke would differ to those in the current study. They would be expected to have 
relatively high baseline citric acid cough thresholds, given that an absent C2 cough response to 
0.6 mol/L citric acid had high sensitivity and specificity for detecting silent aspirators using a 
15 second tidal-breathing method (Miles, Moore, et al., 2013). In the limb literature, Pleger 
and colleagues (2003) report that the largest cortical reorganization and sensory enhancement 
following TISL was observed in healthy individuals with the lowest sensory acuity threshold 
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(i.e. better sensory discrimination abilities) (Pleger et al. 2001). This suggests that those with 
better sensory acuity at baseline yield the greatest benefit from TISL. This questions whether 
the observed inhibition of habituation to CRT in the current study is limited to healthy 
individuals with adequate sensory perception. However, using a similar, but more intense (i.e. 
45 minutes per day for two weeks) stimulation protocol for patients with reduced sensation in 
the hand following cortical stroke, Kattenstroth and colleagues (2018) reported greatest 
enhancement of sensorimotor performances in patients with more severe sensory deficits. 
These data imply that patients with reduced cough sensitivity may require a longer, more 
intense sensory stimulation protocol than that used in the current study. Further research is 
required to explore these hypotheses. Longer (1-minute) inhalations of distilled water have 
been shown to decrease cough sensitivity, as demonstrated by a significant reduction in cough 
frequency over the one-minute inhalation (Morice et al., 1992). This suggests that different 
distilled water stimulation parameters may have different effects on cough sensitivity, with 
longer inhalations potentially decreasing cough sensitivity. This should be carefully considered 
before altering the current stimulation parameters for patients with silent aspiration.  
 
A greater estimated differential change in SCT across the five days was demonstrated for the 
high intensity group versus the low intensity group, when compared to the control group (i.e. -
1.8, [95% CI, -2.88, -0.72] versus -1.3, [95% CI, -2.88, -0.2] respectively). This suggests that 
a greater flow rate and output of distilled water may be more effective at changing SCTs 
compared to the control group, across days. This aligns with recommendations of “high 
frequency” and “heavy schedules” of sensory stimulation as part of a TISL protocol (Dinse & 
Tegenthoff, 2015, p. 18), as well as the motor learning principal of “intensity matters” (Kleim 
& Jones, 2008, p. 227). This observation suggests that the high intensity distilled water 
inhalation protocol may be the most appropriate sensory stimulation protocol to evaluate in 
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further studies for patients with laryngeal sensory deficits and subsequent impairment of airway 
clearance mechanisms.  
 
7.6.2 Limitations  
It is acknowledged that the findings of the current study must be interpreted with caution due 
to the small sample size. Furthermore, the participants recruited in the current study were 
predominantly female. Females are known to be at higher risk of chronic cough than males 
(Kavalcikova-Bogdanova, Buday, Plevkova, & Song, 2016), which raises the question of 
whether females are more susceptible to cough sensitivity modulation. It is possible that a 
predominantly male cohort may be less likely to demonstrate the observed differential changes 
in cough sensitivity across days. Additionally, the age range in the high intensity groups was 
less than that in the low intensity and control groups. Age is known to have implications on 
SCTs, which younger individuals demonstrating a greater capacity for suppression (i.e. higher 
SCTs) than older individuals (Leow et al., 2012; Monroe et al., 2014). However, the mean age 
across the groups was similar, and baseline citric acid cough thresholds were not significantly 
different across groups.  
 
There was no assessment of maintenance of effects in the current study design. Thus, it remains 
to be seen whether the differential changes in SCT between the groups would be maintained 
over time. The dynamic nature of cough sensitivity has been demonstrated in previous studies 
(Dicpinigaitis et al., 2006; Morice et al., 1992). For example, tachyphylaxis resolves 3.5 hours 
following exposure to tussigenic aerosols (Morice et al., 1992). Therefore, it is possible that 
the effects of the sensory stimulation protocol may be short-lived. Citric acid cough reflex 
testing was completed within one hour of the sensory stimulation protocol on days 3 and five. 
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The longer-term effects of the sensory stimulation protocol should be explored in future 
research.  
 
It is also important to acknowledge that patients with respiratory diseases and asthma were 
excluded from the current investigation. However, there is a high prevalence of respiratory 
diseases, such as COPD and asthma in patients with stroke (Lekoubou & Ovbiagele, 2016; 
Wen et al., 2016), who are at high risk of laryngeal sensory deficits. If this sensory stimulation 
protocol is to be evaluated in patients with laryngeal sensory deficits following neurological 
injury, these patients should be excluded, or carefully monitored for risk of 
bronchoconstriction. Previous studies have demonstrated that the underlying mechanisms of 
coughing and bronchoconstriction induced by distilled water are distinct (Eschenbacher et al., 
1984; Lavorini et al., 2001; Sheppard, Rizk, Boushey, & Bethel, 1983). It was hypothesized 
that pre-treatment with a bronchodilator may mitigate risk of bronchoconstriction in 
individuals with respiratory diseases, while enabling them to derive potential benefits from the 
sensory stimulation. However, further studies may be necessary to determine the efficacy of 
the sensory stimulation protocol in patients with laryngeal sensory deficits without respiratory 
diseases, before warranting the risk associated with evaluating this hypothesis in patients with 
respiratory diseases.  
 
In conclusion, this study evaluates the safety and efficacy of a novel sensory stimulation 
protocol, that aimed to enhance cough sensitivity in a cohort of heathy adults. Results indicate 
that the sensory stimulation protocol is safe, evidenced by no signs of bronchoconstriction 
following distilled water inhalations in any participant. Secondly, evidence of no change in 
citric acid cough thresholds in the high and low intensity groups suggests that the sensory 
stimulation protocol mitigates the habituation effect of repeating the citric acid CRT across 
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alternate days, implying a sensitization effect. These data provide the basis to evaluate the 
safety and efficacy of the sensory stimulation protocol in patients with laryngeal sensory 





SECTION IV. COUGH STRENGTH STUDIES 
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CHAPTER 8: Introduction to Cough Strength Studies 
 
8.1 What is cough strength? 
Coughing is considered as the mechanism by which the airways are cleared of secretions and/or 
foreign materials (Gauld, 2009; Laciuga, Brandimore, Troche, & Hegland, 2016; Watts et al., 
2016). A ‘strong cough’ may be considered as one which effectively expels secretions and/or 
foreign materials from the airway, while a ‘weak cough’ may be considered as one which 
ineffectively expels secretions and/or foreign materials from the airway. Assessment of “cough 
strength” is challenging in dysphagia research and clinical practice. There is lack of agreement 
on what constitutes “cough strength” and the measurement that best reflects this. For example, 
a “strong cough” has been defined as one with a peak flow of > 60 L/min, and has been shown 
to predict successful extubation in patients with tracheostomy (Salam, Tilluckdharry, 
Amoateng-Adjepong, & Manthous, 2004; Smina et al., 2003). A “strong cough” has also been 
defined as a cough volume acceleration of > 46 L/s and has been related to lower penetration-
aspiration scale scores (PASS) in patients with dysphagia (Plowman et al., 2016; Smith 
Hammond et al., 2009). Others report a “strong cough” as voluntary cough peak flow of > 242 
L/min and have linked this to lower risk of developing aspiration pneumonia following stroke 
(Bianchi et al., 2012). This highlights the arbitrary nature of cough strength and the range of 
contexts and methods in which it can be measured. Objective measurement of “cough strength” 
and its relationship to efficacy of clearance of penetration and/or aspiration has never been 
reported in previously published literature. This gap in the literature forms the basis of the 
current research, which attempts to validate the use of acoustic intensity as an objective 
measure of cough strength in patients with dysphagia.  
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8.2 Evaluation of Cough Strength 
There are numerous ways to evaluate effective/ineffective clearance of penetration and 
aspiration from the airway. Subjective evaluation of voluntary and/or reflexive coughing is 
often used by clinicians to guide clinical decision making during the clinical swallowing 
evaluation (CSE) (Laciuga et al., 2016; Mann, 2002; McCullough & Martino, 2013; Smith 
Hammond, 2008; Watts et al., 2016). Subjective evaluation of cough strength is appealing in 
the clinical setting due to its ease of use. However, numerous studies dispute its reliability 
(Laciuga et al., 2016; Miles & Huckabee, 2013; Miles, McFarlane, & Huckabee, 2014). 
Laciuga and colleagues (2016) found lack of agreement among clinicians (i.e. speech-language 
therapists, otolaryngologists and neurologists) on ratings of perceived voluntary cough strength 
(i.e. strong versus weak) in healthy individuals. In addition, coughs rated as ‘strong’ and ‘weak’ 
represented a wide range of aerodynamic measures of coughing (i.e. peak cough flow, 
expiratory phase rise time, cough volume acceleration and compression phase duration) 
(Laciuga et al., 2016). This highlights lack of agreement between subjective ratings and 
objective measures of cough motor output. The nature of this lack of agreement is attributed to 
lack of training and uniform terminology by the authors (Laciuga et al., 2016). Clinicians were 
not provided with a definition of cough strength, or criteria on which to make judgements of 
strong or weak coughing. It’s also important to note that the cough epochs evaluated by 
clinicians in this study were produced by healthy individuals mimicking different types of 
coughing. Thus, it’s unknown how these results translate to reliability in cough ratings from 
patient populations.  
 
Similar to these findings, Miles and colleagues (2013) found fair-to-moderate agreement 
among speech-language therapists’ ratings of perceived strength of citric acid induced 
coughing. In this case, coughing was elicited from patients with dysphagia of heterogeneous 
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aetiology, as well as two non-dysphagic patients. This ensured that cough samples were 
representative of a typical patient population that clinicians may evaluate during CSE. 
Clinicians were given no specific definition of cough strength, and were asked to rate coughs 
as “strong”, “weak” or “absent”. Qualitative analysis of discussions between clinicians during 
the study revealed confusion regarding the definitions of a cough and cough strength. This 
suggests that lack of training and uniform terminology may explain the nature of this poor 
agreement, as hypothesized by Laciuga and colleagues (2016). In a follow up study, clinicians 
were given two hours of training on cough physiology and cough strength judgement (Miles et 
al., 2014). As part of this training, clinicians observed videotaped examples of “strong”, 
“weak” and absent coughs during citric acid CRT. A weak cough was defined by the authors 
as “a cough that does not appear strong enough to clear aspiration and is substantially weaker 
than your own reflexive cough” (Miles et al., 2014, p. 205). However, perceptual 
characteristics of coughing to aid this judgement were not provided by the authors. Regardless 
of training, no improvement in inter-rater agreement of cough strength was found, even among 
experienced clinicians, and qualitative comments still reflected lack of certainty in ratings of 
perceived cough strength. These data suggest that subjective evaluation is not a reliable tool 
for assessing cough strength in patients with dysphagia, regardless of the amount of training 
received by raters.  
 
More recently, attention has shifted to objective evaluation of voluntary and reflexive 
coughing, to overcome the limitations of subjective evaluation (Watts et al., 2016). Numerous 
assessment tools are available for objective measurement of different components of cough 
motor output. These include aerodynamic measures, respiratory muscle activity, intra-
abdominal pressure, and acoustic intensity. The advantages, disadvantages and clinical 
applicability of these measures are discussed below.  
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8.2.1 Aerodynamic Measures  
Aerodynamic measures are the most commonly evaluated parameters of cough motor output 
in patients with dysphagia. They have been shown to predict risk of aspiration and aspiration 
pneumonia in patients with dysphagia with high sensitivity and specificity (Pitts et al., 2008; 
Pitts et al., 2010; Plowman et al., 2016; Silverman et al., 2016; Smith Hammond et al., 2009). 
Smith Hammond and colleagues (2009) were among the first to report cut-off values for 
voluntary coughing for differentiating patients with dysphagia at high risk of aspiration (PAS 
of > 5) versus no aspiration (PAS of < 4) on instrumental assessment following stroke. Cut-off 
values of < 2.9 L/s for peak cough flow (PCF), > 65 ms for expulsive phase rise time (EPRT) 
and < 50 L/s for cough volume acceleration (CVA), had excellent sensitivity (i.e. 91%, 91% 
and 82% respectively) and specificity (81%, 92% and 83% respectively) for predicting risk of 
aspiration on instrumental assessment. The PCF (also referred to as the peak expiratory flow 
rate) is the peak airflow achieved during the expiratory phase of cough (Plowman et al., 2016; 
Tabor-Gray, Gallestagui, Vasilopoulos, & Plowman, 2019). EPRT refers to the duration from 
the beginning of expiration to the greatest peak of the expiratory phase (Plowman et al., 2016; 
Tabor-Gray et al., 2019). CVA is calculated by dividing PCF by EPRT, and provides an index 
of the volume and speed of air expelled from the lungs (Plowman et al., 2016; Tabor-Gray et 
al., 2019).  
 
Similar findings are reported in patients with progressive neurological disorders. Aerodynamic 
measures of voluntary coughing were sensitive to the presence or absence of aspiration in 
patients with Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS) (Pitts et al., 
2008; Pitts et al., 2010; Plowman et al., 2016). A summary of these cut-off values are outlined 
in Table 25. One of the notable limitations of these studies is the cut-off values that are used. 
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Reducing the PAS to a binary variable has limitations, as a higher score is not always indicative 
of greater clinical risk (Steele & Grace-Martin, 2017). For example, a patient who penetrates 
and does not eject the material from the laryngeal vestibule (i.e. PASS = 3) may be at greater 
risk of aspiration pneumonia than a patient who aspirates, but ejects the aspiration from the 
laryngeal vestibule (i.e. PASS = 6). Furthermore, the cut-off values in the above studies are 
only based on depth of airway invasion, but offer little insight into patients’ ability to 
effectively expel aspirate from the airway. This is an important differentiation in the 
management of these patients in clinical practice. It is also important to acknowledge that 
evaluating voluntary coughing provides limited insight into the sensorimotor cough response 
to aspiration (Widdicombe et al., 2011). As a result, caution is warranted in drawing 
conclusions about airway protective mechanisms during swallowing from evaluation of 
voluntary coughing.  
 
Table 25: Summary of cut-off values of aerodynamic measures of voluntary coughing that 
predict aspiration in patients with dysphagia. 




PASS < 4 
versus PASS > 
5 
< 2.9 > 65 < 50 






< 5.24 NA NA 
Pitts et al. (2010) 
Parkinson’s 
Disease 
PASS 1 versus 
PASS 2-8 
< 7.49 NA NA 







< 3.97 > 75 < 45.28 
PASS = Penetration- aspiration scale score. NA = not evaluated in the study. PASS = 
penetration-aspiration scale score. 
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Other authors have evaluated the relationship between aerodynamic measures of coughing and 
risk of pulmonary morbidity. Bianchi et al (2012) measured the PCF of voluntary coughing in 
patients with dysphagia, all of whom had confirmed aspiration on VFSS. PCF was significantly 
lower in patients who developed aspiration pneumonia versus those who did not (3.37 (1.12) 
L/s versus 5.06 (1.35) L/s). Based on these findings, a cut-off value of 4 L/s (242 L/min) for 
voluntary PCF had high sensitivity and specificity (77% ad 83% respectively) for predicting 
pulmonary morbidity (Bianchi et al., 2012). More recently, a cut-off value of PCF for citric 
acid induced coughing to predict aspiration pneumonia was evaluated in a cohort of patients 
with neurological dysphagia (Sohn et al., 2018). A PCF of <0.98 L/s had high sensitivity and 
specificity (81% and 83% respectively) for predicting risk of aspiration pneumonia. 
Interestingly, the lower PCF for citric acid induced coughing, compared to voluntary coughing 
provides an example of the limitations in evaluating voluntary coughing to draw conclusions 
about the sensorimotor cough response. These data also raise a number of questions – do 
patients with higher PCF more effectively expel aspirate from the laryngeal vestibule, 
mitigating their risk of aspiration pneumonia? Or does a higher PCF represent better overall 
pulmonary health, which mitigates the risk of aspiration pneumonia? Bianchi et al. (2012) note 
that silent aspiration was more prevalent in patients who developed aspiration pneumonia than 
those who did not (i.e. 39% versus 19% respectively), suggesting that the absence of a 
sensorimotor cough response to airway invasion is a risk factor for aspiration pneumonia. 
However, no comment is made on the effectiveness of coughing in clearing airway invasion in 
patients with and without aspiration pneumonia. Thus, it’s difficult to directly determine 
whether effective clearance of aspirate from the airway is a protective factor against risk of 
aspiration pneumonia – although, it seems likely that it would be.  
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A number of tools can be used evaluate aerodynamic measures of cough motor output. 
Different tools are used across the aforementioned studies, and are outlined in Table 26. 
Pneumotachographs are highly sensitive and accurate instruments for measuring air flow and 
volume of cough motor output (Mandal, 2006). They have the advantage of being able to 
evaluate numerous aerodynamic measures of coughing simultaneously (see Figure 15) 
(Mandal, 2006; Plowman et al., 2016). This may facilitate differential diagnosis of the nature 
of weak coughing. For example, an impaired compression phase may signal poor glottic 
closure (Britton et al., 2014; Tabor-Gray et al., 2019). While impaired peak cough flow may 
indicate weak expiratory musculature (Plowman et al., 2016; Tabor-Gray et al., 2019).  
 
However, pneumotachographs are expensive, not easily transportable and require training by 
the user for correct operation (Kulnik et al., 2015; Plowman et al., 2016). This renders them 
inaccessible to many clinicians, and unsuitable for measuring cough strength at bedside. 
Portable spirometers and peak flow meters are less expensive and more conveniently applied 
in the clinical setting. These devices have been used to measure the PCF of voluntary (Kimura 
et al., 2013; Kulnik et al., 2016; Silverman et al., 2014) and/or induced coughing (Fujiwara et 
al., 2017; Lee et al., 2013; Sohn et al., 2018). However, poor inter-instrument reliability and 
accuracy of these devices, compared to laboratory based pneumotachographs, have  been 
demonstrated by a number of studies (Brouwer, Roorda, & Brand, 2007; Kulnik et al., 2015; 
Miller, Dickinson, & Hitchings, 1992; Takara et al., 2010). For example, significant differences 
in PCFs across different peak flow meters and portable spirometers have been demonstrated 
(Takara et al., 2010). This would preclude the use of cut-off values of PCF to identify patients 
at risk aspiration pneumonia or ineffective clearance of aspirate, due to variability across 
instrumentation. Coughs with lower PCFs (i.e. between 0.97-3.95 L/s, as measured on the 
pneumotachograph) were not always registered on portable peak flow meters and spirometers 
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(Kulnik et al., 2015). This may be problematic for measuring coughing in patients with 
dysphagia, who are likely to have a lower PCFs (Bianchi et al., 2012; Plowman et al., 2016; 
Sohn et al., 2018). In contrast to these findings, Silverman and colleagues reported concordance 
between digital and analog peak airflow meters and pneumotachograph measures of peak 
cough airflow in healthy individuals and patients with PD. However, correlation analysis of 
peak cough flow measurement between age and gender within groups revealed poor correlation 
in certain groups, such as healthy younger (60-70 years) and older (71-80 years) females (r = 
0.60, 0.56 respectively), and healthy younger males (r = 0.64). Interestingly, correlation 
between cough peak flow measurement was higher in patients with PD compared to healthy 
individuals.  
 
Of relevance to the current research, it is important to note that aerodynamic evaluation of 
coughing requires the use of a facemask or mouthpiece. This would preclude evaluation of 
effective/ineffective clearance of aspiration by coughing during eating and drinking. Fontana 
and colleagues (1997) also highlight that for (citric acid or capsaicin) induced coughing, having 
a pneumotachograph and respiratory valve between the nebulizer and the mouthpiece may 
affect the particle size and or output of the tussigenic aerosol. The complexity of this 
instrumentation is also likely to be prohibitive to clinical application.  
 
Table 26: Instrumentation used to measure voluntary and reflexive cough strength in patients 
with dysphagia. 
Study Cough Type Instrumentation 
Hegland et al (2014) 
Troche et al (2014) 








Pitts et al. (2008) VC Pneumotachograph 
Pitts et al. (2010) VC Pneumotachograph 
Smith-Hammond et al. (2001) VC Pneumotachograph 
Smith-Hammond et al. (2009) VC Pneumotachograph 
Kulnik et al. (2016) VC & RC Pneumotachograph 
Plowman et al. (2016) VC Pneumotachograph 
Fujiwrara et al. (2016) RC Portable Spirometer  
Kimura et al. (2013) 




Peak flow meter & pneumotachograph  
Silverman et al. (2016) VC Peak flow meter 
Bianchi et al. (2012) VC Peak flow meter. 
Sohn et al. (2018) 
Hutcheson et al (2018) 
VC & RC 
VC 
Peak flow meter. 
Peak flow meter 
 
VC = Voluntary coughing, RC = Reflexive coughing 
Figure 15: Schematic of a voluntary cough spirometry waveform depicting the range of 
aerodynamic measures of cough motor output. From “Voluntary Cough Airflow Differentiates 
Safe Versus Unsafe Swallowing in Amyotrophic Lateral Sclerosis”, Plowman et al. (2016), 
Dysphagia, 31(3), p. 387.  
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PEFR (PCF) = peak expiratory flow rate (peak cough flow). PIFR = peak inspiratory flow rate. PEFRT = peak 
expiratory flow rise time. CVA = =PEFR/PEFRT.  
8.2.2 Respiratory Muscle Activation  
Respiratory muscle activity (as measured by surface electromyography of 
abdominal/respiratory muscles) during voluntary and reflexive coughing (Fontana et al., 1997; 
Vovk et al., 2007) has also been evaluated as an objective measure of cough strength. Fontana 
et al. (1997) used surface electromyography (EMG) of abdominal muscles (the obliquus 
external muscles and the transversus muscles) as a measure of cough intensity in response to 
ultrasonically nebulised distilled water (UNDW) in healthy individuals. Cough intensity (as 
measured by EMG of the abdominal muscles) was highly repeatable at each individuals’ cough 
threshold and increased with inhalation of progressively higher ultrasonically nebulised 
distilled water flow rates, suggesting a dose-response relationship (Fontana et al., 1997). Intra-
abdominal muscle EMG has also been used to evaluate cough strength in patients with PD 
compared to healthy controls (Fontana et al., 1998). Patients with PD had lower intra-
abdominal muscle EMG compared to aged-matched healthy controls during volitional and 
UNDW induced coughing (Fontana et al., 1998). The authors attribute this observation to 
impaired central neural mechanisms involved in the recruitment of motor units during coughing 
in patient with PD (Fontana et al., 1998). It is also possible that this weakness may be attributed 
to the peripheral changes in muscles and nerves. Muscle biopsies from patients with PD 
demonstrated changes (i.e. atrophy and hypertrophy) in the muscle fibres in the limbs, resulting 
in weakness and spasticity (Edstrom, 1970; Rossi et al., 1996). This may explain observations 
of reduced intra-abdominal muscle EMG (Fontana et al., 1998). However, studies demonstrate 
that respiratory muscle strength is improved (determined by increased maximum inspiratory 
and expiratory flow-volume curves) following antiparkinsonian meditations (apomorphine) 
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which acts centrally (de Bruin, de Bruin, Lees, & Pride, 1993), suggesting that respiratory 
muscle weakness is likely of central origin.  
 
Vovk et al. (2007) evaluated respiratory muscle activation (as measured by EMG of the rectus 
abdominis, external abdominals obliquus and the 8th intercostal space) as a measure of the 
intensity of the LER and induced coughing to capsaicin. The LER and induced coughing were 
elicited simultaneously (via single inhalations of capsaicin), but were differentiated using the 
airflow tracing by presence or absence of a preceding inspiratory phase (Vovk et al., 2007). 
Similar to Fontana et al. (1997), a dose-response trend between respiratory muscle EMG and 
concentration of capsaicin was found (Vovk et al., 2007). The authors also note that EMG 
activation decreased with each successive expulsive event in the cough epoch (Vovk et al., 
2007), suggesting a decline in ‘cough strength’ with each successive cough.  
 
Abdominal and respiratory muscle EMG may be a valuable tool for measuring cough strength 
in patient populations, as it mitigates the need for a facemask or mouthpiece, enabling coughing 
during eating and drinking to be evaluated. However, numerous limitations are associated with 
measuring surface EMG of respiratory and abdominal muscles in a clinical setting. Lack of 
consistency in the placement of the electrodes across and within participants can account for 
large intra- and inter- participant variability (Vovk et al., 2007). For example, placing EMG 
electrodes in slightly different positions can affect the signal amplitude, due to variation in 
abdominal fat content, skin resistance and muscle size (Vovk et al., 2007). In addition, 
measuring respiratory muscle activity as a surrogate measure of cough strength to aspiration 
may be unsuitable for patients with dysphagia, where deficits at the laryngeal level may not be 
captured (Fontana & Widdicombe, 2007).  
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8.2.3 Intra-Abdominal Pressures 
Cough strength can also be assessed by measuring changes in intra-abdominal pressures using 
rectal or urethral catheters (Addington, Stephens, Phelipa, Widdicombe, & Ockey, 2008). 
Addington et al. (2008) used this method to evaluate voluntary coughing and tartaric induced 
coughing in eleven heterogeneous female patients. Rationale for the use of intra-abdominal 
pressure recordings was based on prior VFSS observations during which coughing was 
observed to increase displacement of the diaphragm (Stephens, Addington, Miller, & 
Anderson, 2003). The authors hypothesized that this diaphragmatic displacement generates the 
expiratory forces that are required for airway clearance, and is synchronized with urethral and 
rectal closure to prevent incontinence during coughing (Addington et al., 2008). The results of 
the study reveal that area under the curve (AUC) pressure was higher for induced versus 
voluntary coughing (Addington et al., 2008). It is important to note that in this case, the entire 
cough epoch is compared, and differences in the number of coughs between voluntary [mean 
= 6 (+/- 0.94)] and induced coughing [mean = 1.8 (+/- 0.28)] are not taken into consideration. 
Interestingly, longer sustained elevated intra-abdominal pressures was noted for induced 
coughing compared to voluntary coughing (Addington et al., 2008). The authors suggest this 
may be an important factor in airway protection, reflecting sustained closure of the glottis 
(Addington et al., 2008). Addington and colleagues conclude that measurement of intra-
abdominal pressure changes during coughing may be a useful clinical tool for determining 
airway protection deficits and quantitative assessment of changes in a patient’s functional 
recovery or decline (Addington et al., 2008). However, the cost and invasive nature of this 
method of cough evaluation is likely to make it poorly accepted by patients, and unsuitable for 
daily clinical application.  
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8.2.4 Acoustic Analysis  
There is growing interest in acoustic analysis of coughing as a measure of cough strength (Lee 
et al., 2017; Umayahara et al., 2018a, 2018b). Measurement of acoustic intensity is non-
invasive, relatively simple and accessible through the use of smartphone technology 
(Umayahara et al., 2018a, 2018b). This makes it an appealing option for clinical application. 
Acoustic analysis of coughing is not a new phenomenon, and has been used for over 60 years 
as a valid measure of cough frequency (Woolf & Rosenberg, 1964). Acoustic analysis of 
coughing is used in a number of automated ambulatory cough monitoring systems, such as the 
Hull Automated Cough Counter, The Leicester Cough Monitor, and The VitaloJAKTM, for 
patients with chronic cough or asthma (Shi, Liu, Wang, Cai, & Xu, 2018; Smith, 2007). These 
systems measure the frequency of coughing as an estimate of cough severity (Smith, 2007).  
 
Numerous studies have also used acoustic analysis to measure the intensity of voluntary and 
induced coughing across patient population and healthy individuals (Lee et al., 2017; Mills et 
al., 2017; Smith Hammond, 2008; Smith Hammond et al., 2001). The cough sound is 
recognised as a function of airflow turbulence in the respiratory tract, and is influenced by the 
magnitude of the expiratory airflow (Sarkar, Madabhavi, Niranjan, & Dogra, 2015; Von & 
Isshiki, 1965). In this sense, it is a logical estimate of cough strength, as airflow turbulence is 
considered the process by which the airway is cleared of secretions and foreign materials 
(Sarkar et al., 2015; Von & Isshiki, 1965). Smith-Hammond and colleagues (2001) were among 
the first to measure acoustic intensity of voluntary coughing - specifically sound pressure levels 
(SPLs) - in patients with dysphagia. Using a calibrated microphone attached to the 
pneumotachograph, the authors found a significant difference in the SPLs between patients 
with severe (i.e. all consistencies administered aspirated) and no aspiration, as seen on VFSS. 
The authors suggest that the loudness of coughing may have limited utility as an indicator of 
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aspiration severity, as there was no difference in the decibels of severe and mild aspirators (i.e. 
think fluids and Ensure drinks aspirated). This may due to the influence of secretions, which 
can affect airflow turbulence in the respiratory tract, and introduce considerable variability 
across participants (Smith Hammond et al., 2001). A notable limitation of this study is that the 
relationship between acoustic intensity and clearance of aspirate on VFSS is not evaluated.  
 
In patients with chronic cough, voluntary cough sounds were repeatable and strongly correlated 
with other physiological measures of coughing (i.e. airflow and esophageal pressures)(Lee et 
al., 2017). Specifically, measurement of the sound power (i.e. the area under the curve of the 
power spectral density) and the peak energy (i.e. the maximum value of the root mean square 
[RMS]) of the expulsive phase of coughing had the strongest and most consistent correlation 
with esophageal pressures [median (IQR) correlation coefficient for sound power and peak 
energy = 0.89 (0.84-0.95), 0.89 (0.82-0.95)] and cough flow [median (IQR) correlation 
coefficient for sound power and peak energy = 0.88 (0.78-0.93), 0.87 (0.78-0.92)] (Lee et al., 
2017). Other parameters (e.g. rise time, duration, bandwidth, and centroid frequency) were 
poorly correlated and had wide inter-individual variations. In contrast to speculation by Smith 
Hammond and colleagues (2001), the influence of secretions in the airway was not identified 
by the authors as a potential factor that may influence the cough sound (Lee et al., 2017). 
However, it is possible that presence of secretions in the respiratory tract may not be an issue 
for patients with chronic cough who were evaluated in this study. Although not specifically 
stated in the study, patients with chronic cough are typically characterized by a non-productive 
cough type (McGarvey et al., 1998). The authors note that the factors influencing cough sounds 
are poorly understood (Lee et al., 2017). Differences in sound power and energy were observed 
between gender, with moderate associations between height (r = 0.4, p = 0.03) and lung 
function, specifically FEV1 (r = 0.4, p = 0.03) (Lee et al., 2017). This may be attributed to 
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differences in airway geometry which influences airflow turbulence (Sarkar et al., 2015). 
However, more research is needed to fully substantiate the influence of these variables. Of 
note, standardization of the position of the microphone relative to the mouth is an important 
consideration for measuring cough sounds, as the power and energy of the acoustic signal can 
fluctuate with varying positions of the microphone (Lee et al., 2017; Subburaj, Parvez, & 
Rajagopalan, 1996).  
 
Mills and colleagues (2016) evaluated acoustic intensity, in addition to measures of flow and 
pressure, of voluntary and citric acid induced coughing in healthy volunteers. This is the first 
study to evaluate the acoustic intensity of coughing during CRT, and specifically suppressed 
coughing. The benefit of using a suppressed cough as opposed to a natural cough is that it aims 
to prevent elicitation of a volitional cough in response to sub-threshold tussigenic stimuli 
(Eccles, 2009; Hutchings et al., 1993a). It is thought to represents the point at which an 
individual can no longer suppress their cough response (Eccles, 2009; Monroe et al., 2014), 
and in this sense, it may more closely resemble a cough to aspiration (Monroe et al., 2014). An 
objective measure of citric acid induced coughing would likely overcome some of the 
limitations of subjective judgements of cough strength that have been documented by Miles 
and colleagues (Miles & Huckabee, 2013; Miles et al., 2014).  
 
The results of the study reveal that acoustic intensity, flow and pressure of voluntary coughing 
were strongly correlated in healthy individuals (Mills et al., 2017). Furthermore, all measures 
were sensitive to differences in volitionally modulated strong and weak coughing (Mills et al., 
2017). In contrast, poor correlations between acoustic intensity, flow and pressure of citric acid 
induced suppressed coughing were found (Mills et al., 2017). There was no dose-response 
relationship between increasing concentrations of citric acid and the magnitude of the cough 
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response (Mills et al., 2017). Based on correlation and effect sizes, the authors note that peak 
flow and AUC pressure appear to provide optimal measurement and the greatest potential for 
clinical application, while acoustic intensity was found to be the least accurate and sensitive 
(Mills et al., 2017). However, there are a number of methodological limitations that must be 
considered in interpreting these findings. Firstly, Mills et al. (2017) use an impedance 
microphone, connected to a stethoscope (i.e. contact microphone) to record acoustic intensity. 
According to Lee et al. (2017) free field microphones are regarded as superior to contact 
microphones, and yield higher correlations with objective measures of cough flow (Lee et al., 
2017). Thus, it’s possible that the use of a free field microphone by Mills and colleagues (2017) 
would have provided better correlation between acoustic intensity and flow for citric acid 
induced coughing.  
 
Secondly, Mills and colleagues evaluate the entire acoustic signal of the cough (i.e. the 
expulsive, compressive and voiced phase). Lee et al. (2017) evaluate the expulsive phase (also 
referred to as the “explosive” phase) (Lee et al., 2017, p. 2) of the cough signal only (see Figure 
16). This is because the expulsive phase of coughing is the most easily identifiable and always 
present on the acoustic waveform in healthy individuals (Lee et al., 2017). The voiced phase is 
not always present, and can make identification of the start and end of the cough signal difficult 
(Lee et al., 2017; Thorpe, Toop, & Dawson, 1992). This may have introduced variability in the 
automated macro applied to the acoustic waveforms to identify the beginning and end of the 
cough activity by Mills and colleagues (2017). These factors may explain the lack of 
correlation between acoustic intensity, flow and pressure for citric acid induced coughing 
observed by Mills et al (2016). It is also important to note that while measures of acoustic 
intensity, flow and pressure for citric acid induced coughing were not found to be correlated 
by Mills and colleagues (2017), their relationship to clearance of aspiration remains unknown. 
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Acoustic analysis of coughing is likely to have the greatest usability in the clinical setting. 
Whether acoustic intensity could differentiate between cough effectiveness (i.e. 
effective/ineffective clearance of aspiration from the airway) is a promising area of further 
investigation.  
 
Figure 16: The expulsive, intermediate and voiced components of coughing. From “Sound: a 
non-invasive measure of cough intensity”, Lee et al (2017), BMJ Open Respiratory Research, 




CHAPTER 9: Objective Measurement of Cough Strength 
for Clearance of Penetration and Aspiration on Video-
fluoroscopy 
 
9.1 Study Aims and Hypothesis 
The aim of this study was to objectively measure the cough strength that is required to expel 
penetrated and aspirated material from the laryngeal vestibule in patients with dysphagia during 
video-fluoroscopic swallowing studies (VFSS). Acoustic intensity was chosen as a measure of 
cough strength, as it represents a non-invasive, inexpensive, clinically applicable means of 
objectively measuring coughing. It was hypothesized that the decibel level of coughing that is 
effective at expelling penetrated and aspirated material form the laryngeal vestibule would be 
significantly higher than the decibel level of coughing that is not effective at expelling 
penetrated and aspirated material from the laryngeal vestibule. Based on these data, cut-off 
values of effective/ineffective coughing for clearance of penetration and aspiration would be 
determined.  
 
9.2 Methods  
9.2.1 Study Design 
A cross-sectional observational study design was used to answer the research question. Data 
were collected across two acute hospital settings. VFSS was conducted by hospital clinicians, 




The study was approved by the New Zealand Health and Disability Ethics Committee (HDEC). 
Locality authorisation of the District Health Board was granted prior to the commencement of 
data collection and all participants gave informed consent. Patients who were referred for VFSS 
during May to November 2016 were invited to participate in the study. Data were included 
from patients who demonstrated airway invasion (i.e. aspiration and/or penetration) and a 
subsequent cough response on VFSS, defined as a forced expulsive manoeuvre, associated with 
a characteristic sound (Morice et al., 2007). From a total of eighty-eight patients recruited, 
twenty-two patients (25%) demonstrated airway invasion and coughing during their VFSS. 
Data from four of the twenty-two patients were excluded, as coughing was not captured 
radiographically (i.e. VFSS was not recording for coughing or patient positioning precluded a 
clear view of the upper airway during coughing). A subsequent five of the twenty-two studies 
were excluded due to VFSS equipment failure during the study, which meant the studies were 
not available for later analysis. A total of 13 patients (mean age: 72 years, range: 29-95, 9 
males) were included in the final analysis. The nature of dysphagia varied across participants; 
neurological (n = 5), head and neck cancer (n= 4), unknown aetiology (n = 4).  
 
9.2.3 Instrumentation and Instrumentation Reliability 
Coughing in response to penetration and aspiration was recorded with a lapel microphone 
(RODE smartLav+), connected to an iPad Mini (iOS 10.3.2) installed with an audio recording 
application (RODE Rec). The reliability of the audio recording instrumentation was confirmed 
prior to data collection. A calibrated sound source (Bruel & Kjaer, model: 4230, 94 dB – 1000 
Hz) - calibrated with a Bruel & Kjaer precision sound level meter (type: 2203) - was used to 
evaluate the reliability of the instrumentation at a consistent placement of the microphone (i.e. 
3 cm from the calibrated sound source). The calibrated sound source was placed on a table and 
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using a ruler, a mark was placed 3 cm from the sound source. The microphone was taped over 
the mark for each recording to ensure consistency of placement. A total of twelve recordings 
were made. Each time, the microphone was removed and re-placed at the 3 cm mark before 
recordings were made. This was to mimic potential variation that may arise in the acoustic 
signal from placement of the microphone across participants in the study. After each recording 
was made, it was exported to a laptop computer and imported into AudacityÒ, a free acoustic 
analysis software, that was also used for the acoustic analyses of the main study. The start and 
end of the acoustic signal was manually selected from the waveform. Two sound parameters - 
the root mean square (RMS) and peak decibel level – were chosen for analysis. The choice of 
these two sound parameters was motivated by clinical feasibility. Both parameters could be 
automatically calculated from a selected acoustic waveform using AudacityÒ (wave-stats 
program). The RMS of the cough signal was also used by Lee and colleagues (2017) and was 
found to strongly correlate with cough flow, esophageal pressure and subjective judgements of 
cough strength. A < 10% coefficient of variation of the two chosen sound parameters was 
deemed acceptable, as described by Lee et al. (2017). The coefficient of variation (% CV) for 
the RMS dBFS was 1.9 % and for the peak dBFS was 4.5%. These data suggest the reliability 
of the two sound parameters, at a consistent microphone placement, is acceptable (Lee et al., 
2017).  
 
It was later hypothesized that, despite placing the microphone at a consistent anatomical 
location across participants, there may be variation in the mouth-to-mic distance across 
participants. In order to estimate this variation, the mouth-to-mic distance across a cohort of 
24 healthy males and females was evaluated. The mic-to-mouth distance was defined as the 
distance in cm between anterior to the tragus of the ear (where the microphone was positioned), 
and the corner of the mouth. The mean (SD) mouth-to-mic distance for males was 11.9 (0.35) 
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cm, and for females 11.0 (0.54) cm. The variance in mouth-to-mic distance across males and 




The microphone was placed anterior to the tragus of participants’ ears, facing towards the 
mouth, and secured with medical tape. The placement of the microphone at the tragus of the 
ear was for hygiene reasons, and ensured it was out of the trajectory of coughing. VFSS were 
conducted by hospital clinicians, as per clinical protocol, in the radiology suite. Participants 
were administered a standard protocol of volumes and consistencies (3 x sip of water, 3 x sip 
of thickened juice, 3 x teaspoons apple puree, 3 x bites of peaches/banana, 3 x bites of white 
bread, 3 x bites of hard cracker, continuous drinking from a cup), mixed with barium contrast 
agent (Liquid Polibar, E-Z paste, E-Z-EM Canada Inc.), which were modified as required for 
patient safety by their treating clinician. Images were recorded in the anteroposterior and lateral 
planes. The researcher observed for spontaneous coughing in response to airway invasion of 
food or fluid during the VFSS study. This was defined as a forced expulsive manoeuvre against 
a closed glottis that was associated with a characteristic cough sound (Morice et al., 2007). 
Throat clearing, forced exhalations, or coughing elicited in response to clinicians’ command 
were not included within this definition. The bolus type that evoked coughing was recorded on 
the data collection form. If the patient did not cough during the VFSS, the audio recording was 
deleted. If the patient coughed in response to penetration or aspiration during the VFSS, the 
audio recording was saved and exported to a laptop computer. A copy of the coughing event 




9.3 Data Extraction 
9.3.1 Acoustic Data Extraction 
Audio recordings were downloaded to a laptop computer and imported into AudacityÒ. 
Coughing sounds that corresponded to the airway invasion and coughing on VFSS were 
extracted from the acoustic waveform and saved as a separate file. All coughs were visible on 
the audio waveform. There was no perceived ambient noise during the cough events on the 
recordings. For all participants, only the expulsive phase of the first cough to aspiration or 
penetration was analysed only. Subsequent coughing events were not captured radiographically 
for all participants, as the fluoroscopy was stopped after the first or second cough, as deemed 
appropriate by the radiographers running the studies. Analysis of the first expulsive event 
ensured consistency across participants who had different cough frequencies within the cough 
epoch. The start and end of the expulsive phase of the first coughs was manually selected from 
the waveform. They were identified by large excursions on the acoustic waveform, and were 
confirmed perceptually, by listening to the audio recording. The start of the cough was defined 
as the point at which the acoustic signal increased in amplitude from baseline, and was 
associated with the onset of the characteristic cough sound, identified perceptually, by listening 
to the audio recording. The end of the cough was defined as the point at which the acoustic 
signal returned to baseline, or, in cases where the acoustic signal did not return to baseline, the 
point at which the next cough or an inhalation could be heard on the audio recording (see Figure 
17). Based on the outcome of the instrumentation reliability evaluation (described above), RMS 
was chosen as the acoustic parameter of cough strength, as it had a lower coefficient of 
variation. RMS was evaluated in decibel level relative to full scale (dBFS), which represents 
the unit of measurement of acoustic intensity in electronic equipment, where zero is the 
maximum acoustic intensity level.  
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Figure 17: An example of an expulsive phase of coughing (i.e. between the red lines), 




9.3.1.1 VFSS Data Extraction 
Instances of airway invasion and reflexive coughing were evaluated by two trained speech-
language therapists using the judgement criteria below (Table 27). A third speech-language 
therapist was consulted for any videos for which consensus was not reached.  




Material enters the airway, passes below the level of the vocal folds and 
is ejected from the laryngeal vestibule by coughing. 
Ineffective 
Clearance 
Material enters the airway, passes below the level of the vocal folds and 
is not ejected from the laryngeal vestibule by coughing. 
Penetration Effective 
Clearance 
Material enters the airway above the level of the vocal folds and is 
ejected from the laryngeal vestibule by coughing. 
Ineffective 
Clearance 
Material enters the airway, above the level of the vocal folds and is not 




9.4 Data Analysis 
Group means and standard deviations (SD) of the acoustic intensity (dBFS) of coughing for 
each subject group were calculated. Statistical comparisons were not made for this study due 





From the thirteen patients included in the study, ten instances of coughing to aspiration, and 
seven instances of coughing to penetration were analysed (three patients were included in both 
groups).  
 
9.5.1 Reflexive Coughing to Aspiration 
All coughing events to aspiration were in response to thin liquids. No coughs were effective at 
expelling aspirate from the laryngeal vestibule. The mean acoustic intensity of spontaneous 
reflexive coughing to aspiration was -46.9 (SD = 5.4) (95% CI, -50.33, -43.53) dBFS. 
 
9.5.2 Reflexive Coughing to Penetration 
Coughing to penetration was in response to a range of bolus textures (water n = 3, mildly thick 
juice n = 3, banana n = 1). Four coughs (57%) were effective (1 water, 2 mildly thick juice, 1 
banana) and three (43%) were ineffective (2 water, 1 mildly thick juice) in clearing penetration 
from the laryngeal vestibule. The mean acoustic intensity of effective coughing to penetration 
was -44.0 (SD = 7.3), (95% CI = -51.14, -36.86) dBFS. The mean acoustic intensity of 
ineffective coughing to penetration was -42.9 (SD = 2.0) (95% CI, -45.21, -40.59) dBFS. The 
mean difference in acoustic intensity between effective and ineffective coughing to penetration 
was 1.1 dBFS. 
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9.6 Discussion 
The intent of this study was to determine the cough strength, as measured by acoustic intensity, 
that is required to expel penetration and aspiration from the laryngeal vestibule in patients with 
dysphagia. However, conclusions could not be reached, due to a number of unanticipated 
methodological limitations and unexpected findings. No patient demonstrated clearance of 
aspiration on the first cough event, and VFSS recording were limited to the first cough, 
precluding evaluation of the effectiveness of subsequent coughing events. However, there are 
a number of observations from the current data that warrant discussion. An important, yet 
unanticipated finding from this study was the ineffectiveness of coughing for expelling 
aspiration from the laryngeal vestibule. In all ten cases of coughing to aspiration, the bolus 
remained at a sub-glottic level, despite participants eliciting a spontaneous cough in response. 
In contrast, coughing was observed to expel penetration from the laryngeal vestibule. These 
findings raise tentative questions on whether coughing has the capacity to expel sub-glottic 
material from the airway, or whether only material sitting in the supra-glottic space are expelled 
by high velocity airflow during the expulsive phase of the first cough response.  
 
Coughing is widely recognized in the dysphagia literature as the mechanism by which the 
airways are cleared of secretions and/or foreign materials (Hegland, Troche, et al., 2014; 
Hutcheson et al., 2018; Laciuga et al., 2016; Miles et al., 2014; Pitts et al., 2008; Troche, 
Brandimore, Okun, et al., 2014; Watts et al., 2016). As a result, it was hypothesized that some 
participants would effectively expel aspiration from the laryngeal vestibule in the current study. 
However, there is a lack of empirical evidence to support the role of coughing in expelling 
material from the airway in healthy individuals, or patients with dysphagia. While numerous 
studies demonstrate a relationship between impaired cough strength and presence of 
penetration and aspiration (Pitts et al., 2008; Pitts et al., 2010; Plowman et al., 2016; Smith 
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Hammond et al., 2009), no study has investigated the relationship between cough strength and 
clearance of penetration and aspiration.  
 
In the respiratory physiology literature, it has been demonstrated that mucus in the central 
airway (i.e. trachea and mainstem bronchi) is effectively expelled by coughing (Camner, 
Mossberg, Philipson, & Strandberg, 1979; Dickey, 2018; Hasani, Pavia, Agnew, & Clarke, 
1994; King, Brock, & Lundell, 1985; Van der Schans, 2007; Zahm et al., 1991). This suggests 
that coughing can effectively expel sub-glottic material. However, mucus clearance in these 
studies is initiated by volitional coughing after a full inspiration (Camner et al., 1979; Hasani 
et al., 1994; Pavia, Agnew, & Clarke, 1987). As a result, these findings cannot be extrapolated 
to spontaneous coughing to aspiration, due to differences in neurological control and 
physiological patterns (i.e. presence/absence of a preceding inspiration) between these two 
cough types. It is also important to note that some of these studies use machine models of 
stimulated coughing to expel artificial mucus in an artificial airway (King et al., 1985; Zahm 
et al., 1991). These models reproduce the biomechanics of coughing, but cannot emulate the 
afferent pathway of coughing, which is essential for cough elicitation in humans (Mazzone, 
2016; Polverino et al., 2012; Sant'Ambrogio, 1987). Thus, these findings must be interpreted 
with caution. Furthermore, the extent to which clearance of mucus mimics clearance of 
aspiration is unknown. The viscosity of mucus differs to that of aspirated food and fluid. 
Viscosity is known to be an important factor in the effectiveness of coughing (Rubin, 2014). 
Pathologic mucus, with higher viscosity and elasticity, is less easily expelled from the airway 
(Fahy & Dickey, 2010). It has also been suggested that extremely watery mucus is not easily 
expelled by coughing (Rubin, MacLeod, Sturgess, & King, 1991). As all aspiration and cough 
events in the current study were in response to thin fluids, it is unknown whether the viscosity 
of the aspirate may have affected the ability of the cough to expel the material from the airway.  
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A recent review by Steele and colleagues (2017) acknowledges that PAS scores of four (i.e. 
material enters the airway, contacts the vocal folds and is ejected from the airway) and six (i.e. 
material enters the airway, passes below the vocal folds and is ejected from the airway) are rare 
scores in dysphagia research and clinical practice. This corroborates the findings of the current 
study and further questions the role of coughing in expelling aspirate from the airway. 
However, an important consideration is whether the findings of this study, and the reports by 
Steele and colleagues (2017), are attributed to limitations of the methods used to evaluate 
clearance of aspiration. There are a number of methodological limitations in the current study 
that must be taken into consideration in interpreting the results.  
 
The first expulsive maneuver to penetration and aspiration was evaluated. This is typically the 
LER (Widdicombe et al., 2011), although, it is important to note that no physiologic measures 
were made to confirm this. As outlined in Chapter 2, the LER is a specific “anti-aspiration” 
mechanism (Widdicombe et al., 2011 p. 312), elicited in response to vocal fold stimulation 
(Korpas & Jakus, 2000). The absence of an initial inspiration is advantageous for preventing 
material entering further into the airway (Widdicombe et al., 2011). However, the LER arises 
from lower lung volumes, as it is not preceded by an inhalation (Korpas & Jakus, 2000). Thus, 
its capacity to expel sub-glottic material may be less than that of a cough preceded by a deep 
inspiration. Furthermore, limiting evaluation of cough effectiveness to the first cough may not 
provide an accurate representation of the effectiveness of coughing within a cough epoch, 
which is likely to involve both LERs and subsequent coughing preceded by inspiration 
(Fontana & Widdicombe, 2007; Widdicombe et al., 2011). As outlined in the methods section, 
methodological limitations precluded analysis of subsequent coughing events. The fluoroscopy 
was stopped after the second cough to aspiration in eight out of ten VFSS studies. However, 
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multiple coughs to aspiration were heard on the audio recordings. As this was an observational 
study, the aspects of the VFSS procedure were not controlled. Thus, a request could not be 
made that the fluoroscopic recordings continue until the end of the cough epoch.  
 
However, this observation raises a number of important issues. Firstly, do clinicians routinely 
observe for effective/ineffective clearance of penetration and aspiration during VFSS? 
Clearance of penetration and aspiration are not reported in previously published research. The 
most recently published standardized tool for VFSS evaluation – MBSImp (Martin-Harris et 
al., 2008) – also does not include cough, or cough effectiveness within the criteria for 
quantification of swallowing impairment or swallowing safety. It is also important to note that 
there is lack of standardization of VFSS procedures across clinics and laboratories (Martin-
Harris & Jones, 2008), and an absence of guidelines on how cough effectiveness should be 
evaluated. It is unclear how long fluoroscopic recordings should be continued after airway 
invasion to maximize the chance of accurately evaluating cough effectiveness, and whether 
judgements of cough effectiveness should be made after the first cough, or a cough epoch. This 
may explain why PAS scores of four and six are rare in dysphagia research and clinical practice 
(Steele & Grace-Martin, 2017), and also offers insight into the limitations of the current data 
in making definitive conclusions regarding the role of coughing in expelling aspiration.  
 
The role of cough frequency in clearing aspiration from the laryngeal vestibule warrants 
discussion. In reviewing the audio files of coughing to aspiration, it became apparent that cough 
frequency may play an important role in clearing aspirate from the airway. This is supported 
by findings in the respiratory physiology literature, in which rapid successive coughing was 
found to induce a significant increase in mucus clearance, when compared to a single cough in 
a simulated cough model (Zahm et al., 1991). This finding contradicts a study in healthy adults 
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(n = 20), that demonstrated a reduction in the mechanical effectiveness (as measured by the 
peak expiratory flow rate and cough expired volume) of each subsequent capsaicin induced 
cough (Hegland, Troche, & Davenport, 2013). However, there was no evaluation of the 
functional effectiveness of coughing in this study. Thus, whether this would translate to more 
or less effective clearance or aspiration, or endogenous material is not known. Further studies 
are necessary to evaluate the role of cough frequency in clearing aspiration on VFSS. It is 
possible that repeated coughing to aspiration may reflect awareness that a bolus has entered the 
airway and volitional attempts to clear the bolus. In this sense, repeated coughing to aspiration 
may reflect better sensory perception. However, further research is required to substantiate 
these hypotheses.  
 
The results of the current study demonstrate that coughing has the ability to expel penetration 
from the supraglottic airway, but this was only observed in a small number of participants (i.e. 
four out of seven participants). The reason for relatively few examples of coughing to 
penetration may be explained by the focus of this study on coughing, rather than a broader 
range of airway clearance behaviours. During data collection, it was observed that in many 
cases of penetration, the bolus was effectively cleared with swallowing, throat clearing, or 
expectorating. These findings are in line with the theoretical model by Troche and colleagues 
(2014) that describes a continuum of airway protective mechanisms. In the current study, it 
was decided to evaluate forced expulsive manoeuvres that were associated with a characteristic 
cough sound (Morice et al., 2007). This enabled the acoustic intensity of the same airway 
clearance mechanism to be evaluated across individuals. However, it is acknowledged that this 
precluded analysis of many attempts at airway clearance from the study. The mean difference 
between coughing that effectively versus ineffectively expelled penetration was 1.1 dBFS. 
There was a large standard deviation in the decibel level of effective coughing to penetration 
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and overlapping confidence intervals between the two groups, suggesting no true difference in 
these estimates. Therefore, acoustic intensity may not be sensitive in discriminating between 
effective and ineffective clearance of penetration on VFSS. However, due to the limited sample 
size and consequent lack of statistical analyses of the data, these results must be interpreted 
with caution.  
 
It is also important to acknowledge that the acoustic intensity of coughing to penetration is in 
response to different bolus types (i.e. water, thickened fluids and solids). Similar to the way in 
which the composition and quantity of secretions in the airway can influence the acoustic signal 
(Smith Hammond et al., 2001), it is possible that the texture (e.g. thin fluid, thick fluid, puree, 
solid) and quantity of food or fluid in the airway may influence the acoustic signal. Due to the 
limited number of participants, it was not possible to analyse coughing in response to 
penetration according to specific bolus types, providing a notable limitation in interpreting the 
acoustic intensity of coughing to penetration.  
 
In conclusion, the findings from this study have highlighted a number of gaps in the literature 
and uncovered further questions regarding the role of coughing in clearing aspiration. In light 
of the results and acknowledged methodological limitations, the next logical question that 
arises is: does coughing expel aspiration from the laryngeal vestibule in patients with 
dysphagia? In addressing this question, it is important that VFSS protocols are tailored to 
ensure the role of coughing can be adequately evaluated. This is vital information that is likely 
to have important implications on assessment and management of patients with dystussia and 




CHAPTER 10: Acoustic Intensity of Citric Acid Induced 
Coughing in Healthy Individuals and Patients with 
Dysphagia Following Stroke 
 
10.1 Study Aims and Hypotheses  
Objective measurement of cough strength during citric acid CRT remains challenging in 
clinical practice and is often based on unreliable subjective evaluation (Laciuga et al., 2016; 
Miles & Huckabee, 2013; Miles et al., 2014). This study aimed to determine whether acoustic 
intensity (i.e. decibel levels) was sensitive to differences in citric acid induced coughing 
between stroke patients with dysphagia and healthy individuals. Acoustic intensity was chosen 
as a measure of cough strength as it represents a non-invasive, inexpensive, clinically 
applicable means of measuring coughing. Healthy individuals were assumed to have adequate 
citric acid induced cough strength, and thus, were used as a reference population against which 
patients with dysphagia were compared. It was hypothesized that the decibel level of citric acid 
induced coughing would be significantly lower in patients with dysphagia compared to healthy 
controls. As a secondary objective, this study aimed to determine whether there was a 
difference in the number of coughs (i.e. cough frequency) to citric acid CRT in healthy 
individuals and patients with dysphagia. This objective arose from the findings of Chapter 9, 






Twelve patients with dysphagia following stroke, and sixteen aged-matched healthy controls 
were recruited. All participants were 65 years or older (mean age: 79 years, range: 67-94 years). 
Stroke patients with dysphagia were recruited from a sub-acute rehabilitation ward. Patients 
were eligible to participate in the study if they were on the clinical dysphagia caseload, and on 
a modified diet, as documented in the clinical notes. Patients were excluded if they had an 
absent cough to citric acid CRT on admission into the stroke ward (documented in the clinical 
notes), were unable to sign informed consent, drowsy, medically unstable, tracheostomized, 
requiring oxygen support or where participation would be contraindicated (e.g. patients with 
spinal injuries or increased intracranial pressure), according to clinical CRT guidelines. 
Healthy controls were excluded from the study if they had a history of any neurogenic 
disorders, a clinically significant respiratory disease (e.g. asthma, COPD, chronic bronchitis, 
emphysema), gastro-esophageal reflux, were taking ACE inhibitor or codeine-based drugs, 
were smokers, or had a recent (< 2 weeks) acute upper respiratory tract infection (URTI). This 
study was approved by the New Zealand Health and Disability Ethics Committee (HDEC). 
Locality authorisation of the District Health Board was granted prior to the commencement of 
data collection and all participants gave informed consent. 
 
10.2.2 Equipment & Preparation 
A RODE smartLav+ microphone was connected to an iPad Mini (iOS 10.3.2) with the RODE 
Rec audio recording application. This was the same instrumentation that was used in the 
previous study (Chapter 9). Given the clinical focus of this study, a validated clinical method 
of citric acid CRT (Miles, Moore, et al., 2013) was used to induce coughing in healthy 
individuals and patients with dysphagia. Citric acid (0.6 mol/L) diluted with 0.9% saline was 
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delivered via face-mask with a disposable nebulizer (Hudson Micro Mist Nebulizer, Standard 
Connector & Adult Mask, Hudson, RCI, NC, USA) (Miles, Moore, et al., 2013). A 
PulmoMate® Compressor Nebulizer (model 4650I) (DeVilbiss Healthcare LLC, 
Pennsylvania, US), with a restricted flow output of 6.6 L/min, was connected to the nebulizer. 
 
10.2.3 Protocol 
All participants were seated upright for citric acid CRT and cough acoustic measurements. The 
microphone was placed anterior to the tragus, facing towards the mouth, and secured with 
medical tape. The placement of the microphone at the tragus was for hygiene reasons, and 
ensured it was out of the trajectory of expelled secretions during coughing. The compressor 
was placed as far away from participants as possible to prevent interference in the sound 
recordings. Participants initially performed 15 s of tidal-breathing of 0.9% saline solution via 
the facemask, to acclimate them to the sound and sensation of the nebuliser, as recommended 
in the European Respiratory Society (ERS) Guidelines (Morice et al., 2007). Participants 
subsequently completed up to 15 s of tidal-breathing during nebulization of 0.6 mol/L citric 
acid, until a C2 cough response (defined as 2 consecutive coughs within 15 s) was produced 
(Morice et al., 2007). Participants were instructed to “breathe in and out through your mouth 
and try not to cough”. This aimed to prevent participants from producing a volitional cough in 
response to a sub-threshold tussigenic stimuli. Citric acid was presented up to three times to 
each participant, with at least 30 seconds between trials to prevent tachyphylaxis (Morice et 
al., 2007). The test was stopped when participants achieved a C2 response on two of three trials 
(referred to herein as CRT1 and CRT2). If no cough response was elicited on two of three trials 
data from the patient was excluded. Audio recordings of the C2 cough sounds were saved and 





10.3 Data Extraction 
10.3.1 Acoustic Data Extraction 
Audio recordings were downloaded to a laptop computer and imported into an acoustic analysis 
software, AudacityÒ. All coughs were above the level of any background noise and were 
visible on the acoustic waveform. For all participants, the acoustic intensity of the first cough 
of each CRT trial was analysed. This ensured consistency across participants who had different 
cough frequencies within the cough epoch. The start and end of each cough was manually 
selected from the waveform. They were identified by large excursions on the acoustic 
waveform, and were confirmed perceptually, by listening to the audio recording. The start of 
the cough was defined as the point at which the acoustic signal increased in amplitude from 
baseline. Baseline, in this case, was the noise artefact from the nebulizer (see Figure 18). The 
end of the cough was defined as the point at which the acoustic signal returned to baseline (see 
Figure 18).  
 
The peak dBFS of the selected acoustic signal was extracted using the ‘wave-stats’ plugin on 
AudacityÒ. It was originally intended to analyse the root mean square (RMS). However, as 
RMS is a value of the average, or continuous power of the acoustic signal, it was determined 
that the noise from the nebuliser may cause variability in the RMS signal due to varying room 
acoustics and position of the nebuliser across individuals. In this case, the peak dBFS was 
chosen as the acoustic parameter of citric acid induced coughing, as it was above the noise of 
the nebulizer for all participants. dBFS represents the unit of measurement of acoustic intensity 
in electronic equipment, where zero is the maximum acoustic intensity level. The number of 
coughs occurring up to 30 seconds following elicitation of the first C2 response was counted 
for all participants for each CRT trial.  
 
 184 
Figure 18: Example of a cough to citric acid CRT on the Audacity software (1 = the noise 
artefact from the nebulizer, 2 = the first cough to citric acid CRT). The subsequent bursts on 
the waveform represent additional cough events. 
 
 
10.4 Data Analysis 
IMM SPSS Statistics, Version 23 (IMP Corporation, Armonk, New York, USA) was used to 
analyse the data. An apriori alpha level of 0.05 was used. A between-subject three-way 
ANOVA was used to analyse the effects of gender (male/female), group (healthy/dysphagia) 
and trial (i.e. CRT1 and CRT2) on decibel level (dBFS) of citric acid induced coughing. Gender 
is known to influence cough sensitivity (Dicpinigaitis & Rauf, 1998). Thus, it was included as 
an independent variables to evaluate if any effects were related to gender. Previous studies 
have demonstrated a trial effect with acoustic intensity of citric acid CRT induced coughing 
(Mills et al., 2017). Thus CRT trail was included as an independent variable. to evaluate if any 
effects were related to CRT trial. An independent samples t-test was used to compare the 
number of coughs (cough frequency) within 30 seconds following citric acid inhalation 








All participants completed the citric acid cough test without adverse events. One patient with 
dysphagia (female) completed one CRT and declined further participation. Thus, 12 cough 
recordings are included for CRT1, and 11 cough recordings for CRT2 in the dysphagia cohort. 
A summary of the data is provided in Table 27. 
  







CRT1 -24.26 5.0 16 
CRT2 -23.51 5.1 16 
Total -23.90 5.0 32 
Dysphagia 
CRT1 -28.18 3.00 12 
CRT2 -26.65 6.26 11* 
Total -27.45 4.79 23 
 *One female patient with dysphagia did not complete a second CRT.  
 
10.5.1 Acoustic Intensity of Coughing 
Results showed no significant interaction effect between gender, group and trial on decibel 
level of citric acid induced coughing, (F (1, 47) = 0.138, p = 0.712). There was no evidence of 
a main effect of gender (F (1, 47) = 0.012, p = 0.913), or trial (F (1, 47) = 0.613, p = 0.438). 
However, there was a main effect of group (F (1,47) = 5.647, p = .022), with healthy individuals 
having higher decibel levels of citric acid induced coughing than the patients with 
dysphagia. Pairwise comparisons between the two groups revealed a mean difference of 3.53 
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dBFS (95% CI, 0.54 – 6.5, p = 0.022). Estimated marginal means of the effects of group on 
decibel level of citric acid induced coughing are showed in Table 28. 
 
Table 29: Estimated marginal means for the effects of group on decibel level of citric acid 
induced coughing. 
Group Mean dBFS SE 
95% Confidence Intervals 
Lower Limit Upper Limit 
Healthy -23.88 0.909 -25.71 -22.10 
Dysphagia -27.41 1.17 -29.77 -25.05 
SE = standard error. 0 dbFS = maximum acoustic intensity.  
 
10.5.2 Cough Frequency 
There was no difference in the cough frequency between healthy individuals and patients with 
dysphagia (t (53) = 2.21, p = 0.68). The mean (SD) number of coughs for healthy individuals 




The main finding from this study is that acoustic intensity, as measured by peak dBFS, is 
sensitive to differences in citric acid induced coughing between stroke patients with dysphagia 
and healthy individuals. Decibel level (dBFS) of citric acid induced coughing was 15% lower 
in stroke patients, compared to heathy controls. Current clinical protocols for citric acid CRT 
rely on subjective judgement of the cough response (i.e. perceptually strong or weak) (Miles, 
Moore, et al., 2013; Miles, Zeng, et al., 2013; Perry et al., 2019). However, research indicates 
that clinicians lack confidence and reliability in making such judgements (Laciuga et al., 2016; 
Miles & Huckabee, 2013; Miles et al., 2014). A key intent of the current research was to 
contribute to the development of a clinically applicable, objective measure of the strength of 
citric acid induced coughing. The use of acoustic intensity was favoured over measures of 
cough airflow or respiratory muscle activity, as it can be assessed without the need for complex 
and expensive instrumentation (Mills et al., 2017; Umayahara et al., 2018a). As a result, it is 
more easily translated into clinical practice. However, the meaning of ‘cough strength’ in the 
current study warrants discussion. Healthy individuals were assumed to have adequate citric 
acid induced cough strength, and thus, were used as a reference population against which 
patients with dysphagia were compared. However, if a strong cough is defined as a cough 
which effectively expels secretions and/or foreign material from the airway (as discussed in 
Chapter 8), the validity of acoustic intensity of citric acid induced coughing in measuring 
‘cough strength’ is unknown. In designing these studies, it was hypothesized that Chapter 9 
would provide insight into the validity of acoustic intensity as a measure of cough strength. 
However, such conclusions were not possible. As a result, conclusions of the current study are 
limited to stating that healthy individuals have a louder cough to CRT than patients with 
dysphagia. Whether the cough is stronger in healthy individuals, in terms of clearance of 
aspiration, remains to be directly tested. 
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The source of the cough sound is an important consideration in making sense of these findings. 
As outlined in Chapter 8, the cough sound is recognized as a function of airflow turbulence in 
the respiratory tract, and is influenced by the magnitude of the expiratory airflow (Sarkar et al., 
2015; Von & Isshiki, 1965). A strong linear correlation between airflow and acoustic intensity 
of voluntary coughing has been demonstrated (Lee et al., 2017). Given that airflow turbulence 
is the process by which the airway is cleared of secretions and foreign materials (Button & 
Button, 2013; Clarke, 1989), tentative conclusions may be made regarding potential differences 
in airway clearance mechanisms between the two groups. However, other studies have reported 
poor correlation between acoustic intensity and airflow during citric acid induced coughing 
(Mills et al., 2017). Thus, in the absence of aerodynamic measures of coughing in the current 
study, caution must be made in drawing such conclusions.  
 
Another important consideration is the nature of lower acoustic intensity of citric acid induced 
coughing. It is possible that patients with dysphagia had blunted sensory input, and thus, could 
more effectively diminish or suppress the intensity of their cough output as they were instructed 
to ‘try not to cough’. In contrast, for healthy individuals, the capacity for suppression or 
diminishing the intensity of cough output may be less, resulting in a higher acoustic intensity. 
In this respect, reduced cough output may be secondary to reduced sensory input. Differences 
in the sensory perception of the citric acid aerosol was not evaluated between the two groups. 
It is possible that asking participants to rate their urge-to-cough (UTC) may have provided 
more insight into the perceived intensity and higher order processing of the tussigenic stimulus 
between the two groups.  
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Although a statistically significant difference was identified between the two groups, there 
were large standard deviations in the decibel levels of coughing in healthy individual and 
patients with dysphagia and almost overlapping confidence intervals. This questions whether 
the findings would have clinical significance in reliably discriminating strong versus weak 
coughing. Alternatively, it is possible that some of the patients in the dysphagia group had 
adequate cough strength. The patients included in this study had a diagnosis of dysphagia based 
on a clinical swallowing evaluation, rather than instrumental evaluation. It is not known 
whether they had an effective or ineffective cough for expelling aspirate from the airway. 
Inclusion of patients who were observed to ineffectively expel aspiration form the airway on 
VFSS may have resulted in a larger difference between the two groups. Furthermore, 
longitudinal data on the development of aspiration pneumonia in these patients were not 
collected, but may have added substantial value to the findings.  
 
The methodological limitations of the citric acid CRT used in the current study must be 
acknowledged. Methods of citric acid CRT that optimize test-retest reproducibility (used in 
Chapters 6 and 7) were not considered clinically applicable for bedside evaluation of cough 
strength. As a result, the nebulizer output and the dose of aerosol delivered across participants 
and tests (i.e. CRT1, CRT2) may have differed, due to the use of a fixed-time (15 s) inhalation 
method, and the absence of a dosimeter. Differences in inhaled volumes of citric acid between 
stroke patients and healthy individuals may explain the difference in the acoustic intensity of 
the cough response. This probability is based on the knowledge that a reduction in lung 
volumes and chest wall movements are common after stroke (Billinger, Coughenour, Mackay-
Lyons, & Ivey, 2012). By not controlling for inhaled volume of citric acid across participants, 
it is possible that the observed differences in the acoustic intensity of coughing between healthy 
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individuals and stroke patients may be secondary to differences in inhaled volumes of citric 
acid across groups.  
 
In summary, the implications of these findings suggest that more research is necessary in order 
to draw definitive conclusions on the validity of differences in acoustic intensity of citric acid 
induced coughing between healthy individuals and stroke patients with dysphagia. Evaluation 
of acoustic intensity of coughing is clinically applicable. All measures were made at patients’ 
bedside without difficulty. Future studies should determine whether acoustic intensity differs 
between patients who develop aspiration pneumonia, versus those that do not. Development of 
a cut-off value of acoustic intensity of coughing for risk of aspiration pneumonia would be 




SECTION V: CONCLUSIONS 
  
 192 
CHAPTER 11: Conclusions  
 
This research program was inspired by the relationship between dystussia and dysphagia. The 
studies offer a substantial contribution to the literature by enhancing our understanding of 
assessment and modulation of the sensorimotor cough response, which can be applied to 
improving methods of assessment and rehabilitation of dystussia in patients with dysphagia. 
The findings from this thesis develop knowledge across three specific domains: (1) methods of 
citric acid cough reflex testing (CRT), (2) modulation of the sensorimotor cough response 
through sensory stimulation, and (3) the use acoustic intensity as a measure of cough strength 
for clearance of penetration and aspiration.  
 
Lack of standardization and inadequate data on test-retest variability of the citric acid cough 
thresholds necessitated further investigation into methods of citric acid CRT. Chapter 5 
represents the first study to systematically evaluate methods of citric acid CRT used across 
disciplines. The findings revealed substandard reporting of methods of citric acid CRT, and 
lack of progress in standardization since publication of the ERS guidelines over a decade ago. 
For the dysphagia researcher and clinician, these findings offer insight into the factors – such 
as the type of nebulizer used, the nebulizer output, methods of citric acid preparation - that may 
influence the diagnostic precision of the test in identifying patients at risk of silent aspiration. 
This is critical, as risk of negative outcomes, such as aspiration pneumonia and death, are 
higher in patients with silent aspiration. Standardization of citric acid CRT would enhance 
cough assessment in the dysphagia literature, affording better communication among 
researchers, and provision of cohesive practice recommendations to clinicians. It is anticipated 
that publication of these findings may contribute towards the development of standards of 
methods of citric acid CRT for research and clinical practice in the dysphagia literature, and 
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highlight the potential implications of changes in methodology on the outcome of the test. In 
the meantime, it is crucial that methods of citric acid CRT are adequately reported in published 
manuscripts to allow for full replication and interpretation of study outcomes.  
 
It is acknowledged the methods of citric acid CRT for research and clinical practice may differ. 
For research, where CRT may be used as an outcome measure to monitor changes in cough 
sensitivity, methods of CRT may require instrumentation and protocols that optimize dose to 
dose reproducibility across trails, such as the use of a dosimeter, a breath activated nebulizer 
and testing the reproducibility of the nebulizer output. For clinical use, complex 
instrumentation and protocols may render the test infeasible. An alternative method, where a 
single concentration of a tussigenic aerosol is free-flowing from a facemask for a fixed time 
(e.g. 15 seconds, or 1-minute) may be more applicable as a screening tool for identifying 
patients who may be at risk of silent aspiration (Miles, Moore, et al., 2013; Wakasugi et al., 
2008). However, caution may be warranted in using this method to monitor changes in cough 
sensitivity within or across individuals over time, as differences in the volume of citric acid 
inhaled may influence the outcome of the test.  
 
Further methodological studies on citric acid CRT are justified to extend understanding of the 
influence of instrumentation (e.g. nebulizer type, nebulizer flow rate) and CRT protocols (e.g. 
number of inhalations, solvent used in citric acid solutions), on citric acid cough thresholds and 
test-retest reliability. These data may provide empirically-based rationale for the use of one 
method over another. In view of the neurophysiology associated with differing cough types, 
different methods of citric acid CRT may be advantageous to evaluate the integrity of different 
cough pathways (e.g. the viscero-sensory versus somato-sensory cough pathways). 
Furthermore, the use of different tussive agents (e.g. capsaicin), or different methods of 
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eliciting cough (e.g. laryngeal air puff stimulation via endoscopy) in a comprehensive cough 
test protocol may have merit for assessing distinct neural cough pathways. The would enable 
clinicians or researchers to gain insight into the precise pathophysiology of dystussia in patients 
with dysphagia, and the effects of different cough therapies.  
 
The current research has provided valuable insight into test-retest variability of the citric acid 
CRT. The observed habituation to citric acid CRT over the three assessment sessions may 
represent a confounding variable that has implications on the use of the test as a viable outcome 
measure. These finding have relevance for the use of the test in the dysphagia literature, but 
also across disciplines, where citric acid CRT is used to evaluate the effects of anti-tussive 
medications and cough therapies in respiratory diseases. Quantification of this habituation 
effect was essential to interpret the effects of a sensory stimulation protocol that was 
subsequently evaluated. The habituation effect, combined with the observation that no change 
in citric acid cough thresholds were observed for the stimulation groups may, in fact, represent 
a sensitization effect of distilled water inhalations on cough sensitivity.  
 
Quantification of test-retest variability of citric acid CRT in a dysphagic population has never 
been evaluated, but warrants investigation. It is not known whether patients would demonstrate 
the same habituation effect as healthy individuals, or whether a downregulated sensory system 
would show a lack of habituation on subsequent testing. This information is crucial for the use 
of the citric acid CRT as an outcome measure to evaluate the effects of cough therapies in 
patient populations. Furthermore, this information would be clinically valuable to current CRT 
protocols, where repeating the test may be used to determine recovery of the sensorimotor 
cough response and guide clinical decision making regarding oral intake (Perry et al., 2019).  
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This research provides preliminary evidence that cough sensitivity can be safely modulated in 
response to distilled water inhalations in healthy individuals. It would be premature to come to 
any conclusions regarding the effects of the sensory stimulation protocol in an impaired 
sensory system. However, these findings provide the foundation for future studies to evaluate 
the safety and efficacy of the sensory stimulation protocol in patients with laryngeal sensory 
deficits, and subsequent silent aspiration. The ultimate question is whether the sensory 
stimulation protocol could mitigate the risk of aspiration pneumonia, by enhancing the 
sensorimotor cough response to aspiration. It is also possible that enhancing laryngeal 
sensitivity may improve airway protective mechanisms, such as timely glottic closure in 
response to a misdirected bolus, thus preventing aspiration. The sensory stimulation protocol 
is non-invasive, relatively inexpensive and portable, thus could be used in the clinical setting, 
hospital setting or in patients’ homes. Furthermore, it does not require activate participation on 
the patient’s behalf, allowing inclusion of patients with cognitive impairment, if deemed 
ethically appropriate. Future research into the safety and efficacy of the sensory stimulation 
protocol for patients with dysphagia should be prioritized, to determine whether it would 
represent a viable treatment option for patients with absent or blunted cough sensitivity and 
subsequent silent aspiration.  
 
Interestingly, this research indicated the potential for cough sensitivity to be decreased 
following 0.9% saline inhalations. Suppressed cough thresholds increased by almost double 
the test-retest variability that is expected when repeating the test on two alternate days. This 
may represent an area of further investigation for patients with chronic cough, where the goal 
is to reduce cough sensitivity. Collaborations between chronic cough and dysphagia cough 
research may provide insights into how cough is impaired in different diseases that result in 
contrasting clinical presentations (i.e. hyper- versus hypo- cough sensitivity). Whether similar 
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neural networks are involved in both diseases is unclear. A recent study speculates that 
impairment of the descending neural networks of coughing, that are responsible for inhibiting 
or facilitating the sensorimotor cough response, may give rise to up-regulated (e.g. chronic 
cough) or down-regulated coughing (i.e. silent aspiration) (McGovern et al., 2017). Evaluation 
of the neural networks activated by tussigenic aerosols in patients with chronic cough versus 
silent aspiration under imaging, may provide further insights into the neural control of hyper- 
versus hypo- cough sensitivity. It was suggested that the descending neural networks of 
coughing may provide a therapeutic target for normalising the sensorimotor cough response 
for both disorders (McGovern et al., 2017). However, methods of activating and modulating 
this pathway remain unknown. The underlying neural networks of the saline and distilled water 
inhalation protocols used in the current research are not known, but in light of their differential 
effects on cough sensitivity, warrant further investigation.  
 
The findings of this research were not able to support or refute the use of acoustic intensity as 
a measure of cough strength. There are many improvements to this study design that are 
necessary before definitive conclusions can be made. If VFSS methods are adapted to evaluate 
the effectiveness of coughing in clearing aspirate from the airway for longer periods after 
aspiration events, and the current findings are upheld, this raises questions on the role of 
coughing as an airway clearance mechanism. It is interesting that no study has empirically 
investigated the role of coughing in clearing the airway of aspirate material. Despite this, it 
remains a commonly held belief that coughing should be prompted, if not reflexively initiated 
following episodes of aspiration in patients with dysphagia. Video-fluoroscopy provides an 
ideal opportunity to evaluate the sensorimotor cough response to aspiration. Further research 
should evaluate whether coughing can expel aspirate from the airway, and what type of cough 
or airway clearance behaviours are triggered in response to aspiration. The current thesis 
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focused on the sensorimotor cough response, but it is possible that less overt airway clearance 
mechanisms, such as throat clearing or forced exhalations, are more effective. This information 
may also guide interpretation of cough and airway clearance behaviours in response to citric 
acid CRT.  
 
11.1 Final Remarks 
Research in the field of assessment and management of dysphagia and dystussia is still in its 
infancy. This research program has enhanced understanding of assessment and modulation of 
the sensorimotor cough response and provides important groundwork for future studies. 
Moving forward, it would be advantageous to incorporate an integrated model of cough 
evaluation in patients with dysphagia in the clinical setting, that may include assessment of 
motor, sensory and cognitive (i.e. UTC) components of the sensorimotor cough response. The 
current research offers important first steps towards achieving this goal, in terms of quantifying 
the test-retest variability of citric acid cough thresholds and UTC ratings in healthy individuals, 
and evaluating novel methods of cough strength testing in patient populations.  
 
Alongside enhancing our methods of assessment, it is important to continue to develop novel 
approaches to rehabilitate dystussia in patients with dysphagia. The distilled water sensory 
stimulation protocol was shown to be safe and potentially sensitize the cough response in a 
cohort of healthy adults. This research provides the first steps in developing a potential 
treatment for sensory cough impairments. However, further work is  required to evaluate the 
safety and efficacy of the sensory stimulation protocol in patients with laryngeal sensory 
deficits. This may present different challenges, as patients would be characterized as having 
relatively high, or completely absent, baseline cough thresholds and may not perceive the 
distilled water inhalations. Furthermore, whether the method of citric acid CRT described in 
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this thesis would be sensitive to detecting changes in citric acid cough thresholds in patient 
populations is unknown. It is possible that smaller increments of citric acid at higher 
concentrations, where patients with laryngeal sensory deficits are more likely to cough, may 
be required (e.g. 0.8, 1.0, 1.2, 1.4, 1.6 mol/L etc) 
 
Future work should focus on (1) evaluating test-retest reliability of citric acid cough thresholds 
and UTC ratings in patient populations, with the addition of smaller increments of higher 
concentrations citric acid (2) evaluating the safety and efficacy of the proposed distilled water 
sensory stimulation protocol in patients with laryngeal sensory deficits and (3) determining the 
role of coughing, and other airway clearance behaviours, in expelling aspirate from the airway. 
Continued research in this field is essential to reduce the negative consequences associated 
with the comorbidity of dysphagia and dystussia that is commonly seen in patients following 









Participant Information Sheet 
You are invited to participate in a research project on Cough Strength 
Testing 
 
What is the project about? 
A strong cough is important to protect our lungs if food/drink goes down the wrong way. 
Results from the study will give us more information on how we can measure cough strength 
to identify patients with a strong or weak cough. 
 
Why should I participate in the study? 
• Whether or not you take part is your choice  
• If you do not want to take part, you don’t have to give a reason. It will not affect your 
care in any way. 
• If you want to take part now, but change your mind later, you can pull out of the study 
at any time.  
 
What will I need to do? 
• You will need to sign a consent form. We can help you with this.  
• We will need to know some information about you.  
• You will be asked to wear a small microphone on your ear during a cough reflex test. 
• The Cough Reflex test involves wearing a face mask that is connected to a nebuliser. 
The air omitted form the face mask contains citric acid (the acid in oranges and 
lemons). This air may/may not make you cough.  
• The test will be repeated three times.  
• No additional time is required after this. 
• If you cough during your x-ray swallow study, the researcher will keep a copy of the 
audio file and the x-ray of your swallow study for further analysis. 
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• If you do not cough, your audio recording will be deleted and your information will not 
be included in the final analysis. 
 
What happens after this? 
• We will keep your information at the Rose Centre for Stroke Recovery and Research, 
St Georges Medical Centre. 
• Your name will be removed from all paperwork and you will be assigned a code 
number.  
• All information will be kept safely on a password protected computer.  
• The data will be stored for 10 years; after that it will be deleted.  
• The results of the study will be included in the researcher’s MSc thesis and may be 
submitted for publication in a peer reviewed journal. If you would like a copy of the 
study when it’s complete, please indicate this on the consent form. 
 
Are there any risks? 
• There are no risks in taking part in the study. Your participation will not affect your 
care in any way. 
• You will have the opportunity to ask questions and to find out more information from 
the researcher.  
 
What if I decide I do not want to be involved in the study? 
• You can withdraw from the study at any time by contacting the primary investigator. 
• If you do not wish to contact the primary investigator, you can contact your speech and 
language therapist who can inform the primary investigator on your behalf.  
 
You do not have to decide today whether or not you will participate in this study. Before you 
decide you may want to talk about the study with other people, such as family, whānau, friends, 
or healthcare providers. Feel free to do this. 
 
If you would like to participate in the study, please sign the consent form the accompanies this 
information leaflet, and bring it to your x-ray swallow study. 
 
What if I have more Questions? 
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Principal Investigator: Emma Wallace  
Email: emma.wallace@pg.canterbury.ac.nz / Phone: 027-456-21-69 
 
Supervisor: Prof Maggie-Lee Huckabee.  
The University of Canterbury Rose Centre for Stroke Recovery and Research.  
Email: maggie-lee.huckabee@canterbury.ac.nz/ Phone: +64 3364 2014 
 




• I have been given a full explanation of this project and have had the opportunity to 
ask questions.  
• I understand what is required of me if I agree to take part in the research.  
• I understand that participation is voluntary and I may withdraw at any time without 
penalty. Withdrawal of participation will also include the withdrawal of any 
information I have provided, if this is still possible.  
• I understand that any information or opinions I provide will be kept confidential to the 
researcher and supervisors, and that any published or reported results will not identify 
the participants.  
• I understand that a thesis is a public document and will be available through the UC 
Library.  
• I understand that all data collected for the study will be kept in locked and secure 
facilities and/or in password-protected electronic form and will be destroyed after ten 
years.  
• I understand that I can contact the researcher Emma Wallace, 
(emma.wallace@pg.canterbury.ac.nz) or her supervisor Maggie-Lee Huckabee 
(maggie-lee.huckabee@canterbury.ac.nz) for further information. 
Optional: I would like to receive a summary of the findings. If so, please provide email 
address:  
_________________________________________________________________  
By signing below, I agree with the statements above, and to participate in this research project.  
Print name of participant: _______________________________  




Participant Information Sheet 
You are invited to participate in a research project on Cough Strength 
Testing 
 
What is the project about? 
A strong cough is important to protect our lungs if food/drink goes down the wrong way. 
Results from this study will give us more information on how we can measure cough strength, 
to help us identify patients in hospital with a weak cough. 
 
Why should I participate in the study? 
• Whether or not you take part is your choice. 
• If you do not want to take part, you don’t have to give a reason. It will not affect your 
care in any way. 
• If you want to take part now, but change your mind later, you can pull out of the study 
at any time.  
 
What will I need to do? 
• You will need to sign a consent form. We can help you with this.  
• We will need to know some information about you e.g. past medical history.  
• You will be asked to wear a small microphone next to your ear during a cough reflex 
test. 
• The Cough Reflex test involves wearing a face mask. Air comes out of the face mask 
and it may/may not make you cough.  
• The test will be repeated three times. It will take in total no more than 30 minutes.  
• No additional time is required after this. 
 
What Happens Next? 
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• We will keep your information at the Rose Centre for Stroke Recovery and Research, 
St Georges Medical Centre. 
• Your name will be removed from all paperwork and you will be assigned a code 
number.  
• All information will be kept safely on a password protected computer.  
• The data will be stored for 10 years; after that it will be deleted.  
• The results of the study will be included in the researcher’s MSc thesis and may be 
submitted for publication in a peer reviewed journal. If you would like a copy of the 
study when it’s complete, please indicate this on the consent form. 
 
Are there any risks? 
• There are no risks in taking part in the study.  
• You will have the opportunity to ask questions and to find out more information from 
the researcher.  
• You can withdraw from the study at any time by advising the primary investigator. 
 
You do not have to decide today whether or not you will participate in this study. Before you 
decide you may want to talk about the study with other people, such as family, whānau, friends, 
or healthcare providers. Feel free to do this.  
 
What if I have more Questions? 




Supervisor: Prof Maggie-Lee Huckabee.  
The University of Canterbury Rose Centre for Stroke Recovery and Research.  
Email: maggie-lee.huckabee@canterbury.ac.nz 
Phone: +64 3364 2014 
 
Maori Health Support: If you require Māori cultural support talk to your whānau in the first 
instance. Alternatively, you may contact the administrator for He Kamaka Waiora (Māori 




Project Title: Cough Strength Testing in Acute Dysphagia Management 
• I have been given a full explanation of this project and have had the opportunity to 
ask questions.  
• I understand what is required of me if I agree to take part in the research.  
• I understand that participation is voluntary and I may withdraw at any time without 
penalty. Withdrawal of participation will also include the withdrawal of any 
information I have provided, if this is still possible.  
• I understand that any information or opinions I provide will be kept confidential to the 
researcher and supervisors, and that any published or reported results will not identify 
the participants.  
• I understand that a thesis is a public document and will be available through the UC 
Library.  
• I understand that all data collected for the study will be kept in locked and secure 
facilities and/or in password-protected electronic form and will be destroyed after ten 
years.  
• I understand that I can contact the researcher Emma Wallace, 
(emma.wallace@pg.canterbury.ac.nz) or her supervisor Maggie-Lee Huckabee 
(maggie-lee.huckabee@canterbury.ac.nz) for further information. 
Optional: I would like to receive a summary of the findings. If so, please provide email 
address:  
_________________________________________________________________  
By signing below, I agree with the statements above, and to participate in this research project.  
Print name of participant: _______________________________  
Signature of participant: ________________________________  
Date: _______________________  
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Participant Information Sheet 
Reliability of Citric Acid Cough Reflex Testing in Healthy Participants 
What is this project about? 
The cough reflex test (CRT) is currently used on all stroke patients admitted to hospital in the 
Canterbury District Health Board (CDHB) in New Zealand. This is a useful test that tells us 
about patients’ cough sensitivity and whether they can protect their airway if food or liquid 
goes down the wrong way. The CRT can also tell us how sensitive a healthy person’s cough 
reflex is, depending on what concentration of citric acid they cough to. This is called the 
reflexive cough threshold. This study examines whether a person’s cough threshold changes 
over 5 days, and if so, by how much, when we control for the volume and inspiratory flow rate 
of citric acid inhalations in healthy participants.  
 
What will I need to do? 
• Participants will include healthy males and females, over the age of 18 with no known 
history of any respiratory diseases. Any participant with a history of neurogenic 
disorders, gastro-esophageal reflux, individuals taking ACE inhibitor drugs or codeine 
based drugs, smokers, or participants with an upper respiratory tract infection in the 
previous 2 week will be excluded from participating in the study.  
• Data collection will take place across 3 locations: The Rose Centre for Stroke Recovery 
and Research, The University of Canterbury and at local nursing and residential homes, 
to facilitate participation of both young and elderly individuals. 
• To ensure confidentiality, your name will be removed from all paperwork and you will 
be assigned a code number.  
• Participation will involve 1 hour, 3 days per week (Monday, Wednesday and 
Friday) within one week. 
• You will be required to brush your teeth immediately prior to testing. A new unused 
toothbrush will be provided for you.  
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• Each day you will be required to inhale increasing concentrations of citric acid through 
a facemask. The volume and flow rate of each citric acid inhalation will be controlled. 
• You will have 30 s short breaks in-between inhalations.  
• The mists may or may/not make you cough.  
 
What happens after this? 
• All information collected from you will be kept on a password protected computer.  
• The data will be stored for 10 years, after which it will be deleted.  
• The results of the study will be included in the researcher’s PhD thesis and may be 
submitted for publication in a peer reviewed journal. No information that could identify 
you will be included in these publications 
• If you would like a copy of the results of the study, please indicate this on the consent 
form. 
 
Are there any risks? 
• There are no risks associated with single sessions of citric acid cough reflex testing.  
• If you feel uncomfortable, we can immediately stop the study. 
 
What if I decide I do not want to be involved in the study? 
• If you want to take part now, but change your mind later, you can withdraw from 
study at any time, without any consequences.   
• You can do this by contacting the primary investigator, Emma Wallace (e-mail: 
emma.wallace@pg.canterbury.ac.nz or phone: 027-456-21-69).  
 
What if I have more questions? 
For more information, please contact the principal investigator, or her supervisor:  
 
Principal Investigator:  
Emma Wallace, PhD Candidate 
The University of Canterbury Rose Centre 
for Stroke Recovery and Research.  
Email: emma.wallace@pg.canterbury .ac.nz  
Phone: +64 33642307/ 027-456-21-69 
Supervisor:  
Dr. Phoebe Macrae 
The University of Canterbury Rose Centre 
for Stroke Recovery and Research.  
Email: phoebe.macrae@canterbury.ac.nz  




Alicia Ang, BSLP Year 4 







“Methodological Study: Reliability of Citric Acid Cough Reflex Testing in Healthy Participants” 
• I have been given a full explanation of this project and have had the opportunity to ask 
questions.  
• I understand what is required of me if I agree to take part in the research.  
• I understand that participation is voluntary and I may withdraw at any time without penalty. 
Withdrawal of participation will also include the withdrawal of any information I have 
provided, if this is still possible.  
• I understand that any information or opinions I provide will be kept confidential to the 
researcher and supervisors, and that any published or reported results will not identify the 
participants.  
• I understand that a thesis is a public document and will be available through the UC Library.  
• I understand that all data collected for the study will be kept in locked and secure facilities 
and/or in password-protected electronic form and will be destroyed after ten years.  
• I understand that I can contact the researcher Emma Wallace, 
(emma.wallace@pg.canterbury.ac.nz) or her supervisor Dr. Phoebe Macrae 
(phoebe.macrae@canterbury.ac.nz) for further information.  
Optional: I would like to receive a summary of the findings. If so, please provide email address:  
_________________________________________________________________  
By signing below, I agree with the statements above, and to participate in this research project.  
Print name of participant: _______________________________  
Signature of participant: ________________________________  





Participant Information Sheet 
You are invited to take part in research on cough rehabilitation 
“Modulation of the Cough Reflex using Ultrasonically Nebulized Distilled 
Water (UNDW) in Healthy Participants” 
 
What is the purpose of this study? 
The purpose of this study is to learn whether it is possible to safely alter the cough reflex in 
healthy participants using ultrasonically nebulized distilled water.  
 
Research has shown that many stimuli (e.g. cigarette smoke, menthol, oral stimulation, 
capsaicin, citric acid and distilled water) can alter the cough reflex. Distilled water has been 
chosen for this study because it’s non-toxic and has a neutral pH, making it safer than other 
stimuli.  
 
The results of this study will provide information on how we can alter cough reflex sensitivity 
in patients with an absent cough reflex, who are unable to protect their airway in the event of 
aspiration (when food or liquid go down the wrong way).  
 
The study is being conducted by the Rose Centre for Stroke Recovery and Research in 
conjunction with the Respiratory Physiology Lab at Christchurch Hospital.  
 
What will my participation in the study involve? 
Participants will include healthy males and females, over the age of 18 with no known history 
of asthma or any respiratory diseases. Any participant with a history of neurogenic disorders, 
gastro-esophageal reflux, individuals taking ACE inhibitor drugs or codeine-based drugs, 
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smokers, or participants with an upper respiratory tract infection in the previous 2 week will 
be excluded from participating in the study for their safety.  
 
A brief medical history will be taken on the first day, to determine your eligibility to participate 
in the study. Your name will be removed from any health information collected during the 
study (e.g. spirometry results, medical history questionnaire). 
 
Participation will involve 5 consecutive days, 1 session per day (morning or afternoon), with a 
maximum of 2 hours per session at the Respiratory Physiology Lab in Christchurch Hospital. 
 
Each session will involve breathing a mist from a nebulizer in 4-minute cycles for up to an 
hour. You will have short breaks in-between nebulizer inhalations. You will be assigned to one 
of three groups with different types of mists and stimulations. The mists may or may/not make 
you cough, depending on what group you’re assigned to.  
 
One day 1, 3 and 5, you will breathe a mist of citric acid at increasing levels until you cough. 
This is an outcome measure that tells us how sensitive your cough is. We will also take 
spirometry measurements each day to ensure that your airway is not under stress 
(bronchoconstriction) from the inhalations.  
 
What are the possible benefits and risks of this study? 
Distilled water has been shown to cause bronchoconstriction in asthmatics thus, if you have a 
history of asthma, even as a child, it is important to make the researcher aware of this because 
you are not safe to participate in the study. There are no known risks of bronchoconstriction 
for those who have no history of asthma, however, you may/may not experience a change in 
breathing pattern or an increased respiratory rate during the inhalations. If you feel 
uncomfortable at any stage, we can immediately stop the study.  
 
A trained researcher will be present for all procedures and medical doctor will be available at 
all times.  
Spirometry will be performed on any participant who shows signs of bronchoconstriction. Data 
collection will be stopped and treatment with a bronchodilator will be provided to reverse signs 
of bronchoconstriction if indicated.  
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All participants will be provided with the contact details of Dr. Michael Epton, a medical doctor 
and respiratory physician who is part of the research team, should they experience any 
respiratory distress after treatment sessions. 
 
Who pays for the study? 
Participant will not incur any costs 
Participants will be reimbursed $100 for their time and costs (transport) in participating in the 
study.  
 
What if something goes wrong? 
There are no known side effects of this treatment protocol and no known risk of 
bronchoconstriction for those with no history of asthma. However, in the unlikely event that 
you are injured in this study, you would be eligible to apply for compensation from ACC, just 
as you would be if you were injured in an accident at work or at home. This does not mean that 
your claim will automatically be accepted. You will have to lodge a claim with ACC, which 
may take some time to assess. If your claim is accepted, you will receive funding to assist in 
your recovery. 
 
If you have private health or life insurance, you may wish to check with your insurer that taking 
part in this study won’t affect your cover. 
 
What are my rights? 
Participation in the study is voluntary and you are free to decline to participate, or to withdraw 
from the research at any practicable time, without experiencing any disadvantage. 
You will have the right to access information about you collected as part of the study.  
You will be informed of any new information about adverse or beneficial effects related to the 
study that becomes available during the study that may have an impact on their health  
 
Participants’ names will be removed from any data collected as part of the study. All 
participants will be assigned a code number, which will appear on all documents.  
 
What happens after the study, or if I change my mind? 
Any data collected as part of the study will be kept in a password protected computer or locked 
cabinet in a secure room at the Rose Centre for Stroke Recovery and Research for 10 years, 
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after which it will be destroyed. The results will be included in the researcher’s PhD thesis, 
which will be submitted in February 2019 and may be submitted for publication in a peer 
review journal. 
 
Who can I contact for more information or if I have any concerns? 
 
If you have any questions, concerns or complaints about the study at any stage, you can contact:  
 




If you want to talk to someone who isn’t involved with the study, you can contact an 
independent health and disability advocate on: 
 
Phone:  0800 555 050 
Fax:   0800 2 SUPPORT (0800 2787 7678) 
Email:  advocacy@hdc.org.nz 
 
For Maori health support please contact : 




You can also contact the health and disability ethics committee (HDEC) that approved this 
study on: 
 Phone:  0800 4 ETHICS 






“Modulation of the Cough Reflex using Ultrasonically Nebulized Distilled 
Water (UNDW) in Healthy Participants” 
 
Please tick to indicate you consent to the following 
I have read, or have had read to me in my first language, and I 
understand the Participant Information Sheet.  
  
I have been given sufficient time to consider whether or not to 
participate in this study. 
  
I have had the opportunity to use a legal representative, whanau/ 
family support or a friend to help me ask questions and understand 
the study. 
  
I am satisfied with the answers I have been given regarding the study 
and I have a copy of this consent form and information sheet. 
  
I understand that taking part in this study is voluntary (my choice) and 
that I may withdraw from the study at any time without this affecting 
my medical care. 
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I consent to the research staff collecting and processing my 
information, including information about my health. 
  
If I decide to withdraw from the study, I agree that the information 
collected about me up to the point when I withdraw may continue to 
be processed. 
Yes o No o 
I consent to my GP or current provider being informed about my 
participation in the study and of any significant abnormal results 
obtained during the study AND I consent to providing the contact 
details of my GP to the researcher.  
Yes o No o 
I agree to an approved auditor appointed by the New Zealand Health 
and Disability Ethic Committees, or any relevant regulatory authority 
or their approved representative reviewing my relevant medical 
records for the sole purpose of checking the accuracy of the 
information recorded for the study. 
  
I understand that my participation in this study is confidential and that 
no material, which could identify me personally, will be used in any 
reports on this study. 
  
I understand the compensation provisions in case of injury during the 
study. 
  




I understand my responsibilities as a study participant.   
I wish to receive a summary of the results from the study. Yes o No o 
 
Declaration by participant: 





Declaration by member of research team: 
 
I have given a verbal explanation of the research project to the participant, and have answered 
the participant’s questions about it.  
 
















Appendix 2: Pre-Participation Questionnaire  
 
   
Pre-Participation Questionnaire  
 
Please answer all questions to assess your eligibility to participate in the study. 
 
§ Are you under the age of 18 years?      YES /  NO 
§ Have you ever had a stroke or brain injury?    YES /  NO 
§ Are you on medication for gastro-esophageal reflux?  YES /  NO 
§ Do you have any respiratory diseases?    YES /  NO 
§ Are you taking ACE inhibitor drugs for blood pressure?  YES /  NO 
§ Are you taking codeine?      YES /  NO 
§ Are you a smoker?       YES /  NO 
§ Have you had a chest infection in the past 2 weeks?     YES /  NO 
 
If you answered YES to any of the questions above, you are not suitable to participate in 
the study.  
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Appendix 3: Search Strategy for Systematic Review of Methods of Citric 
Acid CRT  
 
1  coughing/ or chronic cough/ or experimental coughing/ or irritative coughing/ 
2  cough*.tw.  
3  1 or 2 
4  citric acid/ 
5  citric acid.tw.  
6  4 or 5  




Appendix 4: Citric Acid Concentrations for Systematic Review of Methods 
of Citric Acid CRT  
Table 30: Citric acid concentrations - single dose method 
Citric Acid Concentration 
(mol/L) 
Citric Acid Concentration 
(as reported in the study) 
Studies 
(first author, year) 
0.04 mol/L 
0.68% citric acid 
 
Ogihara, 1991, Morice, 1987, 
Morice, 1992 
0.05 mol/L 1% (w/v) 
Guillen-Sola, 2015, Lee, 
2014, Wakasugi, 2014, 
Wakasugi, 2008, Sato, 2012 
0.09 mol/L 18 g/L Kenia, 2008 
0.2 mol/L 0.2 M Stone, 1992 
0.3 mol/L 5% (w/v) 
Packman, 1991, Winning, 
1986, Packman, 1977, 
Winning, 1988, Winning, 




Enright, 1980, Griffin, 1982, 
Moghadamnia, 2003, Abdul-
Manap, 1999, D'Souza, 1988, 
Van Meerhaeghe, 1986, Hull, 
2002, Hull, 2002, Lavietes, 
1998, Rostami-Hodjegan, 
2001 
100 g/L Cross, 1994 
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0.6 mol/L 0.6 mol/L  Holmes, 2016 
0.8 mol/L 15% (w/v) Noel, 1962 
1 mol/L 20% (w/v) Lavorini, 2007, Lee, 2013 
1.3 mol/L 25 % (w/v) 
Bickerman, 1965, Calesnick, 
1967 
1.6 mol/L 30% w/v Nishino, 2008 
0.000033 mol per 0.125 ml 
*reported as the dose 
delivered 






Threshold concentration Threshold concentration Bickerman, 1960 
The concentration that 
participants produced 3 - 
6 coughs. 
The concentration that 


















(first author, year) 
0.00001 – 0.0033 mol/L 
2.5 - 640 
mg/L 
doubling 
Barros, 1991, Barros, 
1990 
0.0001 - 1.33 mol/L 0.03 - 256 g/L NR Boulet, 1994 
0.0001 – 0.5 mol/L 10-4 - 0.5 M NR Di Franco, 2001 
0.001 – 1 mol/L 
1mM – 1,000 
mM 
log incremental 
Wright, 2010 (Mefar) 






0.001 - 0.8 mol/L 
0.3125 -160 
g/L 
doubling Thompson, 2009 
0.001 - 1 mol/L 1 mM to 1 M 
half log, quarter log 
and linear 
Leow, 2012 
0.001 - 1.9 mol/L 
0.03 - 36% 
w/v 
doubling Nakajoh, 2000 
0.001 - 0.9 mol/L 
0.03 - 18% 
w/v 
doubling Katsumata, 1991 
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0.002 – 0.8 molL 
0.3125 – 160 
g/L 
doubling 
Mason, 1999, Barry, 
1997 
0.003 - 1.9 mol/L 
 
0.7 - 360 g/L 
 
doubling 
Gui, 2010, Gui, 2014, 
Yamanda, 2008, 
Kanezaki, 2010, Sato, 
2016, Ebihara, 2011, 
Watando, 2004, 
Ebihara, 2003, Gui, 
2012 
0.003 - 0.5 mol/L 0.7 - 90 g/L doubling Kashiwazaki, 2013 
0.003 - 1.7 mol/L 
0.625- 320 
g/L 
doubling Schmidt, 1997 
0.005 – 2.7 mol/ 1 – 512 g/L doubling 
Auffarth, 1991, Ziora, 
2005, Auffarth, 1991 
0.0078 – 1 mol/L 




Wright, 2010 (KoKo) 
0.007 - 1.7 mol/L 0.125 - 32 % x 4 concentrations Midgren, 1992 
0.05 - 2.6 mol/L 1 - 50% w/v 
random 1, 2, 5, 10, 
20, 50% 
Rees, 1983 
0.01 - 1 mol/L 
0.25 - 20% 
w/v 
random Empey, 1976 
0.01 – 1 mol/L 
10 – 1,000 
mM 
10, 30, 100, 300 
mM, and 1 mol/L 
Laude, 1993 
 Log incremental 
Wong, 1999, Gorden, 
1997, Morice, 1992 
(b), Wong, 1999 
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0.01 – 3.3 mol/L 






0.03 - 1.7 mol/L 0.5 - 32% w/v doubling Pounsford, 1985 
0.03 – 1 mol/L 
30 – 1,000 
mM 




0.03 – 1 mol/L 
0.03 – 1 
mol/L 
ascending 
Smith, 2006, Smith, 
2006 
doubling Decalmer, 2007 
0.03 – 4 mol/L 
 
0.03 – 4 
mol/L 
 
ascending West, 2012 
doubling 
Smith, 2010, Young, 
2009, Marsden, 2008, 
Kelsall, 2009 
0.03 - 3.3 mol/L 




0.5, 1, 2, 4, 6, 8, 12, 
16, 24, 32, 38 63% 
of crystalline citric 
monohydrate 
Taylor, 1988 
0.03 - 1 mol/L 0.5% -20% 0.5%, 1%, 2.5% Empey, 1979 
0.03 - 3.5 mol/L 5.2 - 675 g/L multiples of 1.5 Riordan, 1994 
0.05 - 3.3 mol/L 10 - 640 g/L doubling Kondo, 1998 
0.05 - 5.2 mol/L 1 - 100% w/v 
random order of 1%, 
2%, 5%, 10%, 20%, 
Vianna, 1988 
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50%, and 100% 
(w/v) 
0.05 - 1.6 mol/L 1 - 30% 0.5%, 1%, 2.5% Karttunen, 1987 
0.0625 - 2 mol/L 
62.5 - 2000 
mM 
doubling Lin, 1999 
0.07 - 1.3 mol/L 
1.25%- 25% 
 
1.25%, 2.5%, 5%, 
7.5%, 10%, 15%, 
20%, 25% 
 
Bickerman, 1957 (first 
study) 
0.07 - 4.2 mol/L 
1.25 - 80% 
w/v 
doubling Belcher, 1986 
0.1 – 1.2 mol/L 





0.1 - 2.6 mol/L 
2 – 50 
g/100ml 
Stepwise (0, 2, 4, 10, 
20, 35, 50g/100ml) 
Stockwell, 1993 
0.1 - 0.5 mol/L 2.5 - 10% w/v doubling Bickerman, 1954 
0.1 - 0.8 mol/L 2 - 15% w/v 




0.125 - 0.2 
M/L 
doubling Dilworth, 1990 
0.2 - 1 mol/L 0.3% -20% 
doubled every 3 
mins 
Cox, 1984 
0.2 - 1.7 mol/L 4 - 32% w/v doubling Rietveld, 2000 
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0.3 - 1 mol/L 5 - 20% w/v doubling Costello, 1985 
0.3 - 1.3 mol/L 5 - 25% w/v 
5% increments 
Winther, 1970 (CRT 
training period) 
NR Sevelius, 1965 
0.4 – 0.8 mol/L 
0.4 – 0.8 
mol/L 
0.2 mol 
Kallesen, 2016, Miles, 
2013, Kelly, 2016 
0.4 mol Mills, 2017 
0.5 - 5.2 mol/L 10 - 1000 g/L 
(10, 20, 50, 100, 500 
mg/ml and 1 g/ml, 
Behera, 1995 





5% and 1% Karttunen, 1988 
0.5 mol/L – no maximum 
dose stated 
10% 6% then 2% Karttunen, 1988 
0.5 - 1 mol/L 10 - 20% w/v NR Simonsson, 1967 
0.5 - 2 mol/L 10 - 40% w/v NR Bossi, 1988 




0.8 - 2.6 mol/L 0.8 - 2.6 M/L 0.2 mol/L Monroe, 2014 
1 mol/L and 0.5 mol/L 
200 g/l and 
100g/l 
NA Thomson, 1979 
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1mol/L - 1.95mM 
1mol/L - 
1.95mM 
serial dilutions Faruqi, 2011 
six serial dilutions from a 




serial dilutions Mincheva, 2014 
Starting dose not 




Max dose of 
20% 
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